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Abstract 
This study aims to approach common issues encountered when detecting pharmaceuticals in 
surface waters and biofluids, using six compounds, Ethyl-3-aminobenzoate (3AB), Ethyl-2-
aminobenzoate (2AB), Benzocaine (BZ), Mangiferin (MA), Tranilast (TR) and Axinitib (AXI). 
The work can be seen as involving two main parts: an analytical and a physicochemical part. 
In the analytical part two fluorimetric methods were developed to facilitate the detection of 
the compounds in different media. In the first section new quantification methods were 
developed to determine the drugs and molecules at the ppt level in both water and a real 
sample (canal water). 
This method utilised β-CDP to increase the fluorimetric signal of the six compounds, up to ≈70 
times. A recently proposed fluorimetric model was then used to characterise the drug-β-CDP 
inclusion complexes and stoichiometries, overcoming the limitations of the unknown 
molecular weight of β-CDP. This model was able to indicate that each compound formed 
either partial or multiple complexes with β-CDP, allowing for non-integer values to be 
considered, which could not be obtained using previous inclusion complex models. 
To enable the compounds to be quantified in the presence of HSA, the decrease in the 
fluorimetric signal induced by an interaction between each of the six compounds and HSA 
was utilised. Through use of a novel application of Stern-Volmer equations, each compound 
was able to be successfully detected in the presence of HSA, providing a rapid, easy way to 
detect these compounds, without removal of the protein. 
The proposed analytical methods using cyclodextrin nanosponge and human serum protein 
were proven to be robust and reliable, and each method was able to detect concentrations 
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of the compounds of ≈0.06ppb and ≈1ppb, respectively, representing a new way to improve 
detection and quantification of organic molecules, which could be extended to compounds 
other than those used in this study. 
The physicochemical part dealt with the characterisation of the selected drugs and molecules 
in the absence and presence of nanosponges and human serum protein. After studying the 
evolution of the photodegradation of the compounds in a set of specific conditions, the -order 
kinetics tool made it possible to prove that the quantum yield of the forward and reverse 
photoreaction of TR in ethanol was wavelength dependent, increasing from 245nm-350nm, 
and that TR could be employed as an actinometer for the determination of unknown reaction 
parameters. 
In addition the photostability of the studied molecules (TR and AXI) was significantly improved 
(more than 90% reduction of degradation) upon addition of increasing concentration of 
nanosponge or human serum albumin. This is particularly important for drug formulation and 
might explain the higher photostability of drugs in the blood stream.  
In conclusion, each developed method was able to assist with the detection of the compounds 
in the outlined media, providing advantages that may be beneficial for future research of 
pharmaceuticals in biofluids and surface waters. 
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List of Abbreviations  
 
 
A= Native species of photounstable sample 
𝑨𝒕𝒐𝒕
𝝀𝒊𝒓𝒓(𝟎)= The total absorbance of the reaction irradiated photounstable parent compound 
before irradiation 
𝑨𝒕𝒐𝒕
𝝀𝒊𝒓𝒓(∞)= The total absorbance of the reaction solution at the photostationary phase of the 
reaction 
𝑨𝒕𝒐𝒕
𝝀𝒊𝒓𝒓
𝝀𝒐𝒃𝒔(𝒕)= Absorbance reading at a specific time in the photoreaction, when irradiated at a 
particular wavelength and observed at another 
𝑨𝒕𝒐𝒕
𝝀𝒊𝒓𝒓
𝝀𝒐𝒃𝒔(∞)= Absorbance reading at the photostationary state in the photoreaction, when 
irradiated at a particular wavelength and observed at another 
𝑨𝒕𝒐𝒕
𝝀𝒊𝒓𝒓
𝝀𝒐𝒃𝒔(𝟎) = Absorbance reading at the beginning of the photoreaction, when irradiated at a 
particular wavelength and observed at another 
𝑨𝒕𝒐𝒕
𝝀𝒊𝒓𝒓
𝝀𝒊𝒓𝒓(𝟎)= Absorbance reading at the beginning of the photoreaction, when irradiated at a 
particular wavelength and observed at the same wavelength 
𝑨𝒕𝒐𝒕
𝝀𝒊𝒓𝒓
𝝀𝒊𝒓𝒓(∞)= Absorbance reading at the photostationary state in the photoreaction, when 
irradiated at a particular wavelength and observed at the same wavelength 
𝑨 ⇄ 𝑩= Reversible photoreaction between parent compound and photoproduct 
AC= Association constant of the compound-cyclodextrin complex 
AXI= Axitinib 
B= Photoproduct 
𝑩𝟏 → 𝑩𝟐 = The phototransformation of photoproduct 𝐵1 to a different photoproduct 𝐵2 
𝑩𝟐 → 𝑩𝟑= The phototransformation of photoproduct 𝐵2 to a different photoproduct 𝐵3 
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BZ= Benzocaine 
C𝑷𝝀𝒊𝒓𝒓= Calculated radiant power 
C= Canal water 
Cβ-CDP= β-cyclodextrin polymer and canal water 
𝑪𝑩(∞)= The concentration of the photoproduct 
𝑪𝑨= The concentration of the unirradiated sample 
C𝚽= Quantum yield determined using the mathematical equations 
𝑪∞ = The concentration of the sample at the phtostationary phase 
[CD]= Concentration of β-cyclodextrin polymer 
[𝑪𝑫𝒑]𝟎,𝐱= Zero concentration of β-cyclodextrin polymer 
[𝑪𝑫𝒑]𝟎,𝐢,𝐣= Concentration ‘j’ of β-cyclodextrin polymer 
DMSO= Dimethyl sulfoxide  
E𝑷𝝀𝒊𝒓𝒓= Experimentally determined radiant power 
ELISA= Enzyme-Linked Immunosorbent Assay 
EL-β-CDD= Ethylenediamine linked β-cyclodextrin dimer 
ES-β-CD= Ethyl substituted β-cyclodextrin 
E𝚽 = Experimentally determined quantum yield 
FRED= Field-Ready Electrochemical Detector 
F= Relative fluorescence intensity of the complexed guest compound 
F0= Relative fluorescence intensity of HSA in the absence of drug 
Fobs= Relative fluorescence intensity of the guest compound with β-cyclodextrin polymer, at 
the appropriate maximum wavelength 
𝑭𝝀𝒊𝒓𝒓(∞)= The time-independent photokinetic factor 
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𝑭𝒍𝒕𝒐𝒕,𝒊,𝒋
𝝀𝒐𝒃𝒔 = Total fluorescence intensity of the medium in the presence of ‘j’ concentration of 
β-cyclodextrin polymer and ‘i’ concentration of guest compound 
𝑭𝒍𝒐𝒃𝒔= Observed fluorescence intensity 
𝑭𝒍𝟎,𝑮,𝒊
𝝀𝒐𝒃𝒔= The native fluorescence intensity of a specific ‘i’ concentration of the guest  
𝑭𝒍𝟎,(𝑮𝒏:(𝑪𝑫𝒑)𝒎)
𝝀𝒐𝒃𝒔 = The fluorescence intensity when every guest molecule is completely 
complexed 
𝑭𝑿= Relative fluorescence intensity of compound X 
FPT, PCA and PGA= The main photoproducts of folic acid 
[G]= Concentration of guest compound 
[𝑮]𝟎,𝒊
𝒏−𝟏= A specific ‘i’ concentration of the guest compound 
𝑮𝒏: (𝑪𝑫𝒑)𝒎= The complex formed between one or more molecules of guest ‘n’ with one or 
more cyclodextrin polymer units ‘m’, which may be comprised of ‘p’ cyclodextrin monomer 
units 
HP-β-CD= Hydroxypropyl-β-cyclodextrin 
2-HP-β-CD= 2-Hydroxyl-propyl-β-cyclodextrin 
HSA= Human Serum Albumin 
ICH= International Conference on Harmonisation of Technical Requirements for Registration 
of Pharmaceuticals for Human Use  
ICH Q1B= Harmonised Tripartite Guideline on Stability Testing of New Drug Substances and 
Products  
kq= The bimolecular quenching constant 
𝒌𝑿
𝝀𝒊𝒓𝒓= The overall photoreaction rate of sample X 
𝒌𝑨⇌𝑩
𝝀𝒊𝒓𝒓 = The exponential factor representing the overall rate-constant of an A⇌B 
photoreversible reaction 
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𝑲𝑨⇌𝑩
𝝀𝒊𝒓𝒓 = The equilibrium constant for thermodynamic reactions 
 𝑲𝑺𝑽= Stern-Volmer quenching constant 
𝑲′𝑮𝒏:(𝑪𝑫𝒑)𝒎= The drug-β-cyclodextrin polymer pseudo-association constant of the complex 
𝑲𝑮𝒏:(𝑪𝑫𝒑)𝒎= The drug-β-cyclodextrin polymer association constant of the complex 
LOD= Limit of detection 
LOQ= Limit of quantification 
M-β-CD= Mono (6-ethylene-diamino-6-deoxy)-β-cyclodextrin 
[M+H+]= Molecular ion (used in LC/ MS) 
n= Number of calibration points 
Pp= Photoproduct 
Ppb= Parts per billion 
Ppt= Parts per trillion 
Pss/ ∞= Photostationary state 
𝑷𝝀𝒊𝒓𝒓= Irradiation radiant power 
[Q]= Concentration of compound used as quencher 
r= Correlation coefficient 
RFI= Relative fluorescence intensity  
RSD= Relative Standard Deviation 
S= Stoichiometry of drug-β-cyclodextrin polymer complex 
s.d.= Standard deviation 
SIM= Positive single-ion monitoring (used in LC/ MS) 
S-β-CD= Sulfobutylether-β-cyclodextrin 
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t= Specific reaction time in photoreaction when an equilibrium between the parent and 
photoproduct has been reached 
TMS= Tetramethylsilane 
TR= Tranilast 
Try= Tryptophan 
UV-A= Ultraviolet region from approximately 320nm-400nm 
UV-B= Ultraviolet region from approximately 290nm-320nm 
UV-C= Ultraviolet region from approximately 110nm-290nm 
W= Water 
3AB= Ethyl-3-aminobenzoate 
2AB= Ethyl-2-aminobenzoate 
λobs= The wavelength at which the sample is observed 
λirr= The wavelength at which the sample is irradiated 
𝑰𝝀𝒐𝒃𝒔= The optical path length of the light within the sample 
𝑰𝝀𝒊𝒓𝒓= Optical pathlength of sample at the specific irradiation wavelength 
𝝀𝒊𝒓𝒓/𝝀𝒐𝒃𝒔= Photoreaction irradiated at a specific wavelength and monitored at a specific 
wavelength, which may or may not be the same wavelength 
εB2= Extinction coefficient of photoproduct 𝐵2 
εB1= Extinction coefficient of photoproduct 𝐵1 
𝝊𝟎
𝝀𝒊𝒓𝒓/𝝀𝒐𝒃𝒔= The initial velocity of the photoreaction 
𝝊𝟎(𝒄𝒍𝒅.)
𝝀𝒊𝒓𝒓/𝝀𝒐𝒃𝒔= The calculated initial velocity of the photoreaction 
𝜷𝝀𝒊𝒓𝒓= A proportionality factor between the overall rate-constant and the radiant power 
𝚽𝑨→𝑩
𝝀𝒊𝒓𝒓 = The forward quantum yield of the photochemical reaction for the transformation 
from A→B, at a specific irradiation wavelength 
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𝚽𝑩→𝑨
𝝀𝒊𝒓𝒓 = The reverse quantum yield of the photochemical reaction for the transformation from 
B→A, at a specific irradiation wavelength 
*%REC= Average percentage recovery of compound recorded in the sample 
≠CDet/ ppb= Average concentration of compound detected in the sample 
+CAdd/ ppb= Concentration of compound added to the sample 
τ= The fluorescence lifetime of the unquenched molecule 
α-CD= α-cyclodextrin 
β-CD= β-cyclodextrin 
γ-CD= γ-cyclodextrin 
β-CDP= β-cyclodextrin polymer 
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Chapter 1: Literature survey 
 
1.1.1 Detection of drugs 
 
Concentrations of drugs, frequently below detection limits of most available instruments, can 
be present in surface waters (Owens, 2015), often existing for long periods of time (Rozman, 
Hrkal, Váňa, Vymazal, & Boukalová, 2017). The quantity of drug able to cause toxic effects is 
specific to each individual (Voicescu & Bandula, 2015). By accumulating or interacting with 
other compounds, potentially fatal consequences may result, such as antibiotic resistance 
(Owens, 2015). HPLC can be used to achieve low detection (Ulbrich & Lamprecht, 2011), 
however, less expensive methods, results often lack accuracy (Kumar et al., 2014). There is 
therefore the necessity for a technique that is able to accurately quantify low concentrations 
of compounds. 
In addition, compounds are often sensitive to the polarity of the media. Such matrices are 
rarely free from interferences (Lakowicz, 2006), this can complicate analysis, requiring 
extensive sample preparation, use of an additional compound (Abdolmohammad-Zadeh & 
Talleb, 2015), or time-consuming and expensive equipment (Von Tungeln et al., 2011). As 
mentioned, HPLC can provide good detection, but at the expense of costly solvents, and 
sufficient separation of multiple compounds may be time-consuming (Ulbrich & Lamprecht, 
2011). Cheaper techniques can provide sensitivity, specificity, and rapid analysis, able to 
detect concentrations as low as 0.04ppb, however, to accomplish this, sample preparation is 
required (Hurtado-Sánchez, Lozano, Rodríguez-Cáceres, Durán-Merás, & Escandar, 2015). To 
allow for routine testing to be conducted in biofluids, an easy-to-carry-out technique should 
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be developed which can detect relatively low concentrations of the pharmaceuticals, without 
need for sample preparation. 
Pharmaceutical compounds do not necessarily interact with other pharmaceuticals in the 
sample. There are, however, a number found to interact with species present in the 
environment, and also with light. Such occurrences can have just as fatalistic consequences, 
as they can photodegrade to form toxic photoproducts which can cause such effects as 
photoxicity or photoallergy, affecting cellular function (Moore, 2004), or can inactivate the 
effects of the compound (Tønnesen, 2004). These photounstable compounds can alter in their 
photostability in different media, including blood (Nilsson, 2010). Such photoproducts may 
inhibit analysis, increasing or decreasing the compound concentration measured and 
resulting in incorrect quantification of the compound in the initial sample (Moore, 2004). The 
extent of the photodegradation of the sample should therefore be determined for accurate 
analysis of the sample. 
1.1.2 Current detection methods and their limitations 
There are currently a number of techniques available able to detect low concentrations of 
drug compounds in surface waters. 
Techniques such as HPLC-UV and solid-phase microextraction coupled with gas 
chromatography isotope ratio mass spectrometry either lack the sensitivity required or are 
unsuitable for thermally unstable compounds. The most sensitive methods tend to be liquid 
chromatography tendem mass spectrometry, and gas chromatography coupled to mass 
spectroscopy, however solid-phase extraction is often required before an injection can be 
carried out (Mu, 2015). Even though techniques such as graphite furnace atomic absorption 
spectroscopy and inductively coupled plasma mass spectrometry are reliable, they are often 
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time-consuming and require expertise. Enzyme-Linked Immunosorbent Assay (ELISA) has 
the ability to provide rapid detection but is limited by its sensitivity (Kuang et al., 2013). In 
order to provide sensitive analysis in a short-period of time methods such as Field Ready 
Electrochemical Detector (FRED) (FREDSense, 2018) and lateral flow assay, using a 
heterogenously sized gold amplified probe to create a strip immunosensor, may be 
employed. These are easy, rapid, cost effective and able to provide lower sensitivity than 
ELISA, however, lateral flow assay does require some sample preparation (Kuang et al., 
2013), and although FRED can be used on-site it takes ≈1 hour to generate results. Although 
able to provide detection of ≈190ppb and 1ppb (FREDSense, 2018; Kuang et al., 2013), and 
useful for routine analysis, both the latter methods lack the sensitivity able to be achieved 
using LC-MS/MS methods, which are able to detect concentrations as low as 0.05ppb (Mu, 
2015). 
In regards to compounds in biofluids, precision and accuracy of the compounds can be 
accomplished using LC-MS/ MS, however, not only did this require use of mobile-phase 
solvents, but centrifugation, evaporation and removal of the supernatant was also 
necessary (Sahoo, Sahu, Rao, & Ghosh, 2014). Furthermore, methods which overcome the 
requirement for sample pretreatment, such as Shodex ODP2 HP, a polymer-based reversed-
phase HPLC column, can exclude the biological matrix, however, not only require more 
expensive equipment, but have relatively high limits of detection (Ito, K., Wakayama, R., 
Denko, K. K. S., Komiyama, Y., Showa Denko, S., Hara, 2013) (DIRECT ANALYSIS). 
1.2.1 Cyclodextrins 
 
Often used in pharmaceutical studies for drug delivery, cyclodextrins are cyclic 
oligosaccharides which possess a polar exterior and non-polar interior cavity, within which 
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they can encapsulate non-polar molecules by forming hydrogen bonds to create a complex. 
Hydroxyls on the cyclodextrin can rotate, reducing the cavity size more on the primary side, 
than the other, secondary side (Fig. 1). Such complexes have various pharmaceutical 
applications, including increasing drug stability and enhancing concentrations of drug 
compound present in the solution (Szejtli, 2005). 
 
Figure 1: Molecular structure of cyclodextrin, representing cavity, hydrophilic exterior and 
hydrophobic interior (Nikolić et al., 2013)  
 
Of the three main cyclodextrins, α-, β- and γ-cyclodextrin, β-cyclodextrin has proved the most 
useful. Inclusion complexes formed with guest molecules can be observed spectroscopically 
through various changes including increases, and shifts (Szejtli, 2005). 
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Such spectral observations can occur when the compound is protected from environmental 
effects, such as solvents and light (Tejashri, Amrita, & Darshana, 2013), often resulting in 
spectra intensity increases and shifts (Szejtli, 2005). This is not necessarily the case, however, 
as sometimes decreases (Ishiwata & Kamiya, 1997) or no observable effects (Varghese, Al-
Busafi, Suliman, & Al-Kindy, 2015) are encountered. 
1.2.2  Cyclodextrin derivatives 
 
The functional groups on the primary or secondary face of the cyclodextrin can be modified 
with various substituents to form derivatives, sometimes increasing its solubility, and when 
complexed with a guest compound can provide advantageous effects to this compound 
(Huang, He, Lu, Ge, & Guo, 2011). As can be observed (Table 1), each compound can interact 
uniquely with the different forms of cyclodextrin, whether it be α-, β-, or γ-cyclodextrin, or a 
derivative form. If the latter has superior properties compared to those of the native 
cyclodextrins monomers, then a greater association constant and an enhancement in 
fluorescence intensity may occur for the compound (Table 1). 
Table 1: Details of the previously observed effects of cyclodextrin monomers on 3AB, 2AB, BZ, 
MA, TR and AXI, the fluorimetric increases and ratio of fluorescence increase (fold), their 
association constants (AC) and stoichiometries (S) formed. α-CD=α-cyclodextrin, β-CD=β-
cyclodextrin, γ-CD=γ-cyclodextrin, S-β-CD=Sulfobutylether-β-cyclodextrin, HP-β-
CD=Hydroxypropyl-β-cyclodextrin, ES-β-CD=Ethyl substituted β-cyclodextrin, M-β-CD=mono 
(6-ethylene-diamino-6-deoxy)-β-cyclodextrin, EL-β-CDD=Ethylenediamine linked β-
cyclodextrin dimer, β-CDP=β-cyclodextrin polymer (Ferreira et al., 2013; Hirayama, Utsuki, & 
Uekama, 1991; Iglesias, 2011; Maestrelli, González-Rodríguez, Rabasco, Ghelardini, & Mura, 
2010; Merzlikine, Abramov, Kowsz, Thomas, & Mano, 2011; Pinto et al., 2005; Tang, Liang, 
Tong, & Li, 2006; Utsuki, Hirayama, & Uekama, 1993; Yan Lee, 2016; Yang et al., 2013). 
 
Compound Cyclodextrin  Medium Increase/ fold S/ AC 
BZ α-CD Neutral ≈0.043-3.09/ 71.86 1:1 
β-CD Neutral ≈0.048-0.529/11.02 1:1/ 780 dm3 mol-1 
γ-CD Neutral ≈0.048-0.257/ 5.35 1:1 
S-β-CD Neutral - 1:1/ 759.24M-1 
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β-CD Neutral - 1:1/ 315M-1 
HP-β-CD Neutral - 1:1/ 352M-1 
β-CD Neutral - 1:1/ 549M-1 
2AB α-CD Neutral ≈0.604-4.2/ 6.95 1:1/ 49 dm3 mol-1 
β-CD Neutral ≈0.723-6.6/ 9.13 1:1/ 184 dm3 mol-1 
γ-CD Neutral ≈0.58-5.3/ 9.14 1:1/ 34 dm3 mol-1 
3AB α-CD Neutral ≈0.024-1.96/ 81.67 1:1 
β-CD Neutral ≈0.021-1.22/ 58.10 1:1/ 185 dm3 mol-1 
γ-CD Neutral ≈0.036-0.77/ 21.39 1:1 
MA β-CD pH=8 ≈120-250/ 2 - 
ES-β-CD pH=8 ≈75-500/ 7 2:1/ 3.04 x 106L2/ mol2 
HP-β-CD pH=8 ≈50-210/ 4 1:1/ 3480 ± 20 L/mol 
S-β-CD pH=8 ≈30-100/ 4 1:1/ 2103 ± 60 L/mol 
β-CD pH=8 - 1:1/ 1113 ± 60 L/mol 
M-β-CD pH=8 - 1:1/ 3763 ± 80 L/mol 
β-CD pH=7 - 1:1/ 1.6 ± 0.7 x 105L mol-1 
β-CD pH=7 - 1:1 
TR γ-CD pH=7 - 2:1 or 1:1 (dependant on concentration) 
α-CD pH=7 - 1:1/ 60± 20 dm3 mol-1 
β-CD pH=7 - 1:1/ 220± 15 dm3 mol-1 
γ-CD pH=7 - 2:1/ 2210± 90 dm3 mol-1 
EL-β-CDD pH=2 ≈50-190/ 3.8 1:1/ 8.39 x 103mol-1 
AXI HP-β-CD pH=7 2.51 1.09:0.82/ 2041 L/mol 
β-CDP pH=7 93.1 0.98: 0.79/ 3.33 g/L 
 
1.2.3 Cyclodextrin polymers 
 
Although it has the lowest solubility of the three native cyclodextrins, the greater complexing 
ability of β-cyclodextrin, when compared to the other cyclodextrins, means that this 
cyclodextrin is most commonly used to create polymeric cyclodextrins 
(nanosponges)(Tejashri et al., 2013). Although similar in structure to the monomers, these 
polymers boast the advantages of both monomers and polymers (Gidwani & Vyas, 2014). This 
can enable them to include more guest molecules, both within their cavity, and adsorbed to 
their exterior (Morin-Crini & Crini, 2013), and their ‘looser’ structure may increase the size of 
their secondary cavities and increase their solubility (Szejtli, 2005), boosting their complexing 
and stabilising ability (Tejashri et al., 2013). Spectroscopic benefits of β-cyclodextrin polymer 
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(β-CDP) include movement restriction, and microenvironment alteration, effects to which 
spectroscopy is especially sensitive. There are fewer fluorimetric studies dedicated to these 
polymers when compared to those of the monomers, however, where they have been studied 
they can lead to greater increases in fluorescence intensity than those with the monomers 
(Hamai, 1999)(Table 1). 
It has been observed that in the presence of β-CDP the fluorescence intensity of such 
compounds as Azulene and 2-anilino-6-naphthalenesulfonic acid have been increased, and 
their fluorescence spectrum red shifted and blue shifted respectively. The different effects on 
each compound indicated each was included within the β-CDP cavity, in an alternative way to 
the other (Hamai, 1999). Such increases in intensity and blue shifts occurring (Lakowicz, 2006) 
may be attributed to a change in molecular rotation of the compounds (Neckers, Volman, & 
Bünau, 1996), their relocation to a more polar environment, and a smaller amount of energy 
lost through excited state solvent collisions processes (Lakowicz, 2006). Such studies 
sometimes addressed the fluorimetric effects occurring but did not always quantify the drug 
compound (Hamai, 1999). 
1.2.4  Inclusion complex 
 
In order to evaluate how effective cyclodextrins are for the complexation of a specific guest 
molecule the stoichiometry and stability constant can be determined. The former provides 
information on the number of guest compounds binding to a single cyclodextrin unit, whilst 
the latter measures the strength of the guest: host binding (Jones, Marand, & McGrath, 2004), 
by comparing the ratio of host-guest complex formed to that of the free host and guest 
remaining (Angelova, Ringard-Lefebvre, & Baszkin, 1999)(Fig. 2). The higher the association 
constant is, the more stable the complex (Domańska, Pelczarska, & Pobudkowska, 2011). 
29 
 
It has been reported that β-CDP may be comprised of multiple units of β-cyclodextrin 
monomer, and thus that multiple drug molecules may be bound to its inclusion site. These 
effects are not accounted for when determining the inclusion complex and stability constant 
(Hamai, 1999), as an average molecular mass of β-CDP is provided (Fülöp, Kurkov, Nielsen, 
Larsen, & Loftsson, 2012). 
Studies involving β-CDP have taken various other approaches to measure the stability 
constant, such as recording the heat of inclusion through titration microcalorimetry (Wenz & 
Weickenmeier, 1996), and through carrying out solubility experiments (Zhang et al., 2013). 
Furthermore, use of spectroscopic methods, such as absorbance spectroscopy, have been 
used to determine the stoichiometry, however, data conclusions were based solely on 
spectroscopic changes, such as the presence of isosbestic points, bathochromic shifts, and 
increases in spectra (Hamai, 1999). 
Many analysis methods tend to require knowledge of the β-CDP molecular weight, which can 
range from 1-2,000kDa (Fülöp et al., 2012). Accurate determination of the molecular weight 
is challenging as it is not only influenced by the formation ratio of β-cyclodextrin, 
epichlorohydrin and glycidyltrimetylammonium chloride used, but is additionally influenced 
by the crosslinking step, the temperature at which the crosslinking was carried out and the 
reaction time (Junthip, Tabary, Leclercq, & Martel, 2015). Such issues have been addressed 
through techniques such as Job’s continuous variation plot to determine the stoichiometry of 
one cyclodextrin monomer unit alone (Zhang et al., 2013). Alternatively, in studies, 
conduction of elemental analysis, with knowledge of the polymerisation degree, have been 
made on the β-CDP to determine the molecular weight of one unit of its monomer, and then 
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double reciprocal plots created, based on spectral changes, to determine the rate-constant 
(Hamai, 1999). 
These inclusion complexes are based on a set of pre-determined stoichiometry values, and 
therefore such methods may not provide accurate information on the stability complex (Fülöp 
et al., 2012). 
1.2.5  Modes of inclusion 
 
It has been shown that the inclusion of compounds within the cyclodextrins cavity tend to 
occur predominantly through encapsulation of the aromatic ring of the compound, forming 
the greatest stability constant and thus the strongest complexation (Hergert & Escandar, 
2003). It has been reported that although one molecule of cyclodextrin is often complexed 
with one molecule of the guest compound, forming a 1:1 complex (Huang et al., 2011), more 
than one molecule of either compound or cyclodextrin may interact with the other to form 
various other inclusions, including 2:2, 2:1 or 1:2 complexations (Deng et al., 2016)(Figure 2). 
Figure 2: Stoichiometries formed between guest compounds and cyclodextrins (Uekama, 
Hirayama, & Arima, 2006) 
 
Studies have shown that it may be energetically favourable for the compound to be included 
in more than one way (Aki, Niiya, Iwase, & Yamamoto, 2001) or not necessarily fully 
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encapsulated within the cyclodextrin cavity (Hamai, 1999). Such an effect has been observed 
with cyclodextrin monomers (Fernandes, Carvalho, Pereira da Costa, & Veiga, 2003). 
In cases where multiple inclusion complexes have been reported, the results were supported 
through use of 2D NMR. Spectroscopic and evidence of interactions between both aromatic 
ends of the studied compound and the inner cavity of cyclodextrin were observed. Such 
effects have been reported in multiple studies and with various compounds, indicating that 
this phenomenon was possible and evidencing that cyclodextrins had the ability to 
accommodate more than one drug molecule (Fernandes et al., 2003). 
As mentioned, β-CDP may have multiple binding sites (Hamai, 1999), and thus the use of pre-
determined stoichiometries would not be useful for their evaluation. A technique has 
previously been proposed by our group which utilises fluorimetry and a set of mathematical 
equations. In this equation the molecular weight of β-CDP is represented in g/L, and multiple 
data sets are encompassed to determine the inclusion complex. Such a model has been 
proven to be able to determine the stoichiometry of both partial and multiple inclusions, 
increasing the reliability of the results (Yan Lee, 2016). The model has been utilised in the 
presence of both hydroxypropyl-β-cyclodextrin and β-CDP for the assessment of Axitinib and 
8-Anilino-1-naphthalenesulfonic acid ammonium salt, however, it has not yet been applied to 
other compounds. 
1.3  Human serum albumin (HSA) 
 
The presence of proteins in biofluids (Abdolmohammad-Zadeh & Talleb, 2015), or organic 
compounds in surface waters has been found to influence drug concentrations (Sciences, 
2014), resulting in challenging analysis of serum (Bonnier, Baker, & Byrne, 2016). 
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Although the sensitivity of fluorimetry may mean that it is the method of choice for 
pharmaceutical determination, proteins, such as HSA, have been found to possess a 
fluorophore, causing it to fluoresce and complicating analysis (Rub, Khan, Azum, & Asiri, 
2017). Such a fluorophore (tryptophan residue) often fluoresces at a similar wavelength to 
that of pharmaceuticals, masking their signal (Tayyab, Zaroog, Feroz, Mohamad, & Malek, 
2015). In addition the protein can bind to guest compounds, altering both its own properties 
and that of the quencher (Yue, Chen, Qin, & Yao, 2009). 
As can be observed (Fig. 3) when the protein is in its native state, and thus folded, the 
structure of the protein protects the fluorescent tryptophan residue, allowing for the 
fluorophore to be spectroscopically detected. However, once the protein is unfolded the 
tryptophan residue is accessible to the polar solvent. This can be observed as wavelength 
shifts, depending on the medium, or when it is exposed to a guest compound (Yue et al., 
2009).  
If the tryptophan residue is inaccessible to the compound then no binding occurs, as would 
be observed by a small increase upon addition of the compound (Abdollahpour, Asoodeh, 
Saberi, & Chamani, 2011). If accessible and bound a decrease in fluorescence intensity may 
occur (fluorescence quenching), as will be explained with the following diagram (Figure 3): 
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Figure 3: Process of protein unfolding. When unfolded the tryptophan residue in the protein is 
exposed to the polar solvent and the fluorescence spectroscopic signal of the protein decreases 
(Fluorescence Spectroscopy: A tool for Protein folding/unfolding Study PC3267, 2007) 
 
The existence of HSA in proteins (Lakowicz, 2006) means that it is present in a number of 
biofluids, hindering spectroscopic analysis. Such biofluids are useful for representing drug 
concentrations in patients, and are relatively non-invasive. Although fluorescent detection 
limits in serum may sometimes be below 1ppb (Ferdig, Kaleta, Thanh Vo, & Buchberger, 
2004), they are often thousands of ppb in size (Tang, Jia, & Shi, 2005). Therefore, low 
detection limits only appear to be achieved by using more expensive techniques alongside 
(Ferdig et al., 2004). There is therefore the lack of a method that involves little sample 
preparation, and can provide rapid quantification of drugs in serum, simply, cheaply and 
reliably (World Health Organization., 2010). 
1.4.0  Photostability  
1.4.1  Photostability  
 
For the evaluation of a drug compound before it is released onto the market, The 
International Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for Human Use (ICH) Harmonised Tripartite Guideline on Stability Testing of 
New Drug Substances and Products (ICH Q1B) has proposed for it to be compulsory to provide 
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data on the photostability of a drug. Carried out through various stability measurements, 
including stress testing (H. Tønnesen, 2004) and forced degradation studies (International 
Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals 
for Human Use ICH Harmonised Tripartite Guideline Stability testing: Photostability Testing of 
New Drug Substances and Products Q1B, 1996), these experiments should assess the overall 
photostability of the drug under various conditions (H. Tønnesen, 2004), including in its 
medium, which may be a real sample, such as blood (Cairns, 2012). If deemed photounstable 
it becomes necessary to identify the photodegradation pathways the compound takes and 
the photoproducts it forms (Cairns, 2012). It is crucial to conduct such stability studies before 
packaging and labelling the drug, to ensure its maximum preservation (H. Tønnesen, 2004), 
to identify whether its photoproducts are toxic and to determine the length of time the 
compound is stable for (Watson, 2012). 
Issues arise when performing photostability experiments as there are currently no 
requirements on the specific photostability tests that should be carried out, and instead they 
are left for the experimenter to decide (H. Tønnesen, 2004). 
1.4.2  Kinetics of photodegradation 
 
Information on the rate of photodegradation is often acquired by measuring the absorbance 
spectrum of the compound, as the change in absorbance is proportional to the number of 
photons absorbed (Cairns, 2012), and the collected data is treated using reaction order 
kinetics. 
Such results have been described by zero-, first- and second-order equations. When the data 
obeyed more than one reaction order, authors have been found to make conclusions based 
on small differences in the correlation coefficients of the equations of such plots (Roman, 
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Breier, & Steppe, 2011). Moreover, it has been acknowledged that different light 
environments can give different results (Guerra, Gosetti, Marengo, Llompart, & Garcia-Jares, 
2019), and demonstrated that irradiation wavelength and power intensity influenced the 
degradation rate (W. Maafi & Maafi, 2013). Therefore, even though fitting to a single rate 
order may be the case (Tian & Acevedo, 2018), these models may be a poor representation 
of the data. 
A new method has been proposed by our group (W. Maafi & Maafi, 2013) for the evaluation 
of photochemical reactions. This semi-empirical integrated rate-law has been found to relate 
two measureable quantities (absorbance and time), encompassing factors known to influence 
the rate of photodegradation. Such a model may therefore be useful for mathematical 
comparisons of data, and highlight the necessity for all other conditions to remain constant 
to allow for data comparisons (M. Maafi & Maafi, 2016), overcoming significant differences 
in results between stability testers (H. Tønnesen, 2004). 
The model can not only determine whether a compound photodegrades in the UV-Vis region, 
but also the sub-band of UV light and specific wavelength range that is able to cause the most 
photodegradation to the compound (Table 2).  
Table 2: UV-Vis absorption region  
High energy wavelengths                                             Low energy wavelengths 
Region UV-C UV-B UV-A Visible 
Wavelength 110-290 290-320 320-400 380-760 
 
This method has been found useful for describing the photokinetics of a number of 
compounds (M. Maafi & Lee, 2015a, 2015b). In addition this model has been applied to 
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determine the quantum yield of a reaction to represent the efficiency of the reaction, and in 
actinometry to determine the light intensity from an unknown light source (M. Maafi & Al-
Qarni, 2018). Such studies have only been applied to a small number of compounds, and thus 
there is the potential for further research in this area, using alternative compounds, to 
ascertain how they behave and whether they obey these rate equations, enhancing the 
reliability of the technique, and allowing for photoreaction information on the compounds to 
be determined. 
1.4.3 Cyclodextrins and photostability 
 
The application of cyclodextrins to allow for greater compound photostability has been 
demonstrated in a number of studies (Hirayama et al., 1991), and it is well documented that 
they can provide stability to compounds (Tejashri et al., 2013), although this is not always the 
case (Utsuki et al., 1993). The accommodation of the compound within the cavity protects it 
from the quencher, preventing it from forming hydrogen bonds with the solvent and reducing 
its molecular rotation by forming tight molecular bonds (Bortolus, Monti, Energia, & Area, 
1996). 
It has previously been evidenced that cyclodextrins can influence the rate of 
photodegradation, depending upon the specific ratio of compound to cyclodextrin used. 
When compounds undergo multiple photoprocesses, the macromolecules may not 
necessarily have the same influence on each stage of the photoreaction (Hirayama et al., 
1991). Furthermore, whilst one cyclodextrin may reduce the rate of photodegradation, 
another may accelerate it (Utsuki et al., 1993). 
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1.4.4 HSA and photostability 
 
It has been found that proteins may affect the photochemistry of a drug (Alarcón, Edwards, 
Aspée, Borsarelli, & Lissi, 2009), although there appears to be fewer photostability studies 
dedicated to this area than to the effects of cyclodextrins on photostability. Proteins such as 
β-lactoglobulin have been found to reduce the photodegradation of compounds by oxidising 
the protein residues, increasing its carbonyl content, and thus enhancing the stability of 
tryptophan residues (Wang et al., 2019). 
The most abundant protein in human serum (Bonnier et al., 2016), HSA, has been found to 
maintain a greater fluorescence intensity of curcumin after 9 hours, when compared to that 
in its absence (Jain, 2017), and similar observations of its photoprotecting effects have been 
reported in other studies (Vayá, Lhiaubet-Vallet, Consuelo Jiménez, & Miranda, 2014). Of 
most interest to the current study was the reduction in photodegradation rate of folic acid 
in HSA. Further investigations in this study found that in tryptophan alone a decrease in 
photodegradation appeared to occur. However, this effect was less prominent than that 
with HSA, as was explained by the authors in Fig. 4 (Fig. 4): 
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Figure 4: A proposed scheme for folic acid photodegradation, including absorption spectra of 
the folic acid photoproducts. Photolysis of FPT and PCA form product X (which may be an 
excited form of protein or an active oxygen species) appearing to degrade folic acid. In 
tryptophan or the amino acids in HSA (including tryptophanyles) there is competition between 
the indole ring in tryptophan or the tryptophanyles. FPT, PCA and PGA are the main 
photoproducts of folic acid (Vorobey, Steindal, Off, Vorobey, & Moan, 2006) 
 
The study concluded that the photostabilisation was a result of the tryptophan in HSA. They 
supported their statement by stating that the enhanced photostability in HSA occurred 
because the tryptophan residue in the HSA (tryptophanyl) was more stable than the 
tryptophan in solution (Vorobey, Steindal, Off, Vorobey, & Moan, 2006). This highlighted the 
fact that proteins containing tryptophan residues may affect the photodegradation rate of 
compounds, and thus it would be necessary to conduct more research in this field.  
1.4.5 New approaches for the assessment of photostabilisers on 
photounstable compounds 
 
The recently proposed Φ-order kinetics method has previously been utilised to determine the 
photokinetics of pharmaceutical compounds in the presence of photoprotectants or 
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absorption competitors. Decreases in the rate-constant were observed using this model, and 
this effect was enhanced when the concentration of photoprotectant was increased (M. 
Maafi & Maafi, 2015). The model has additionally been applied to cyclodextrins to determine 
differences in rate-constants between their monomeric and polymeric forms (Yan Lee, 2016), 
providing increased photostability in each cyclodextrin and information on the rate of the 
photoreactions occurring (Yan Lee, 2016). 
1.5.0 Conclusion 
 
Poor detection of drug species in biofluids and surface waters can result in hazardous effects. 
Such issues can occur from imprecise quantification of the pharmaceuticals, or from 
techniques insensitive enough to be able to identify the low concentrations of the 
pharmaceuticals. 
In addition, interactions with proteins in the biofluid, or the photodegradation of the drug, 
can make analysis more challenging. 
Improved detection in such media is therefore required to ensure more accurate and precise 
analysis of drugs in these samples and to minimise unnecessary health costs and improve 
drug-containing surface water assessment. 
Cyclodextrins have attracted attention for their ability to form strong complexations with 
pharmaceuticals and improve their solubility. 
In addition they are able to protect the compound from such processes as photodegradation. 
Although photostability testing of drugs is now required there are no specified methods for 
treating such data, and thus, factors that can influence the photodegradation rate are not 
accounted for in analysis. 
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Polymeric derivatives of cyclodextrins have piqued interest in the pharmaceutical field as they 
have the ability to form stronger complexes, although there are fewer studies dedicated to 
these derivatives than other cyclodextrins. 
Furthermore, pharmaceuticals in biofluids can prove difficult to detect as they can interact 
with other pharmaceuticals and possess proteins which can contain fluorescent amino acids. 
There are various aspects able to influence the detection of pharmaceuticals. Therefore, each 
factor will be addressed in this study. 
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Chapter 2: Introduction 
 
2.1.0 Aims 
 
As has been previously reported pharmaceuticals can be excreted or disposed of into surface 
waters (Owens, 2015). When considering their removal, currently available techniques are 
limited by their  poor selectivity and sensitivity (Saul, 2017), and lack precision. Furthermore, 
proteins, such as HSA, and environmental effects, such as light, may further hinder analysis 
of the pharmaceuticals. 
The ingestion of pharmaceuticals, present in surface waters, by unsuitable subjects can result 
in toxicity (Tønnesen, 2004), or, in the case of antibiotics, a build-up can cause antibiotic 
resistance (Karthikeyan & Meyer, 2006). Such drug concentrations are often below the limits 
of detection (LODs) of even highly sensitive instruments, and techniques which overcome this 
limitation tend to lack the precision and accuracy required for routine screening. Current 
available methods are time consuming, lack the sensitivity required (Kuang et al., 2013), or 
are costly (Von Tungeln et al., 2011). 
Fluorescence spectroscopy has the sensitivity to make it a potential technique for evaluating 
changes in the microenvironment of the guest compound (Hamai, 1999). Work published has 
also highlighted the benefits of cyclodextrins for enhancing concentrations of drug 
compounds present in solution (Szejtli, 2005), and the fact that cyclodextrins polymers display 
more advantageous properties than monomeric cyclodextrins (Tejashri, Amrita, & Darshana, 
2013). 
The first section of this thesis aims to reduce the concentration of drug able to be detected in 
canal water. It is intended for polymer cyclodextrins to be utilised to identify lower 
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concentrations of the compounds than have previously been determined using monomeric 
cyclodextrins. 
To the best of our knowledge there is no published work able to accurately quantify low 
concentrations of the specific drugs in biofluids and surface waters, or on the photokinetics 
of these drugs in such matrix. 
This study aims to address these issues using Ethyl-3-aminobenzoate, Ethyl-2-aminobenzoate, 
Benzocaine, Tranilast, Mangiferin and Axitinib as model drugs, and resolve them in the 
chapters. 
The first section can be further split into two parts. The first part aims to reduce the 
concentration of drug able to be detected in canal water and serum, and the second section 
aims to provide photokinetic data on the photounstable drugs used in the study. 
Such methods would require evaluating the interaction of the drug with both the matrix and 
the cyclodextrin. This will be achieved through current techniques, and a recently developed 
mathematical equation for the characterisation of cyclodextrin polymer complexes. The latter 
method overcomes the issues of unknown polymer molecular masses, and does not make 
assumptions on stoichiometries, allowing for the possibility of multiple stoichiometries and 
partial interactions to be considered. 
In the second part of this section a novel method will be proposed with the goal of overcoming 
some of the current limits of drug detection in biofluids, using an easy to apply, rapid method. 
Biofluids, such as human serum, are largely comprised of the protein, human serum albumin 
(Luque-Garcia & Neubert, 2007). Such protein levels can vary in individuals, potentially 
resulting in larger quantities of the free drug, and drug side effects (Deeb et al., 2014). In the 
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presence of an acidic pharmaceutical this protein can be denatured, and the polar regions on 
its primary structure may be exposed to the compound, altering its properties (Singh, 
Shandilya, Kundu, & Kayastha, 2015) and resulting in background noise (Luque-Garcia & 
Neubert, 2007). 
The removal of this protein is therefore necessary, prior to analysis, and can be carried out 
using techniques such as affinity chromatography, antibody or size-exclusion filtration (Jain, 
Jawade, Pingle, Tumane, & Thakkar, 2015), centrifugal ultrafiltration or solid phase extraction. 
Such techniques are costly, time consuming, tend to require a large amount of sample 
preparation, are prone to errors  and moreover, they can result in loss of components binding 
to the protein (Luque-Garcia & Neubert, 2007). 
Once exposed to environmental effects, such as light, the drug may undergo photochemical 
changes. The current lack of photokinetic techniques able to provide specific information on 
the drug prevents accurate determination of the initial concentration of the drug at the time 
of sampling, hindering its analysis and resulting in the detection of under or overestimated 
concentrations. 
This second half of the thesis aims to provide photokinetic data on the photounstable drugs 
used in the study. The intentions are to provide photostability to the drugs and to evaluate 
their photokinetics. It is intended for the recently developed Φ-order kinetics model to be 
used, as it has been shown to better describe the photostability of compounds, taking all 
known photodegradation factors into consideration. Such factors are the limitations of classic 
zero, first and second thermal reaction orders. 
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In this thesis the first three chapters provide information on previous attempts to overcome 
the complications addressed, the problems that will be covered and proposed methods to be 
used in the study. The final chapter will cover the work presented and the main results from 
the study, along with suggestions for future work in this area. 
2.2.0 References 
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Chapter 3: Experimental 
 
3.1.0    Chemicals, solvents and compounds 
 
3.1.1    Chemicals and compounds 
 
Ethyl-3-aminobenzoate (3AB), Ethyl-2-aminobenzoate (2AB), Benzocaine (BZ), Mangiferin 
(MA), Tranilast (TR), Axitinib (AXI), Human Serum Albumin (HSA), β-cyclodextrin polymer (β-
CDP) and 2-hydroxyl-propyl-β-cyclodextrin (2-HP-β-CD) were purchased from Sigma-Aldrich, 
UK. These were used without any further modification. 
3.1.2    Solvents 
 
Ethanol (99.8%), 0.1M sodium hydroxide and 0.1M hydrochloric acid were purchased from 
Fisher Scientific, UK. 99% dimethyl sulfoxide (DMSO)(containing tetramethylsilane (TMS)), 
≥99.9% HPLC grade acetonitrile, ≥99.9% HPLC grade methanol, ≥99.9% HPLC grade 0.1M 
acetic acid were purchased from Sigma-Aldrich, UK. Distilled water was also used as a solvent. 
3.1.3    Chemicals 
 
Buffer pH=7 and pH=4 tablets were purchased from Sigma-Aldrich, UK. All solvents and 
chemicals were of analytical grade or higher. 
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Table 1: The molecular weight and structure for all compounds used in the study 
Compound Structure Compound Structure 
3AB 
(165.19 g/mol) 
2AB 
(165.19 g/mol) 
BZ 
(165.19 g/mol) 
MA 
(422.34 g/mol) 
TR 
(327.33 g/mol) 
AXI 
(386.47 g/mol) 
HSA 
 (66,478 g/mol) 
Β-CDP 
(2,000-300,000 g/mol) 
2-HP-β-CD 
                                        (1,460 g/mol)  
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3.2.0    Instruments and apparatus 
 
3.2.1    Fluorescence spectrometer 
 
Fluorescence spectra were recorded using FL WinLab Version 4.00.03 software on a Perkin-
Elmer Model LS 55 fluorescence spectrophotometer equipped with a 230V xenon lamp (UK). 
10nm excitation and emission bandwidths were used with a monochromator scan rate of 
500nm/min. Spectra were obtained in a 1cm 200-2500nm quartz macro cuvette (Hellma 
Analytics, UK), using the FL Win Lab Program provided by PerkinElmer (USA). 
3.2.2    Syringes 
 
Analyte was added to each sample using a 50µL microsyringe (Phenomenex, UK). 
3.2.3    NMR analysis 
 
Single pulse 1H NMR spectra were acquired on an AV 500 Bruker Avance Spectrometer 
(George Porter building, University of Leicester, Leicester, UK) with an operating frequency of 
499.94 MHz at 298 K. 1H and 13C NMR spectra were acquired with 6.5 μs pulses, 32,768 data 
points and a spectral width of 4,800 Hz, with 128 scans and 1024 scans, respectively. All data 
were processed in Topspin 2.1 (Bruker, UK). 
3.2.4    Diode Array Spectrometer 
 
For monochromatic irradiation studies, absorption spectra were recorded with an Agilent 
8453 Diode Array Spectrophotometer, UK, using Agilent ChemStation kinetics software, UK 
from Agilent Technologies. Measurements were conducted in a thermostatically controlled 
Peltier 1cm cuvette holder. 
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3.2.5    Monochromatic irradiation set-up 
 
For monochromatic irradiation an Ushio 1000 W xenon arc-lamp housed within a shell (model 
A6000) was used, and powered by a power supply (model LPS-1200), all from Photon 
Technology International Corporation. This lamp was connected to a monochromator (model 
101), and a f/2.5 monochromator with a 1200 groove/300 nm blaze grating to enable 
selection of the irradiation wavelength. 
3.2.6    Radiant Power Meter 
 
A Radiant Power/ Energy Meter (Oriel Model 70260) was used to measure the radiant power. 
Light intensity was given as milliwatts per centimetre squared (mW/cm2). 
3.2.7    HPLC analysis 
 
Separation was achieved on a Waters (UK) Symmetry C18 5µm (3.9x 150mm) column fitted to 
a PerkinElmer Series 200 LC pump (UK). The pump was equipped with a UV/Vis detector and 
vacuum degasser. Data was acquired using TotalChrom software (PerkinElmer, USA). 
3.2.8    LC/MS analysis 
 
The sample was irradiated using a UVP C-10 Mini Cabinet For Compact and Handheld Lamp 
P/N (6 Watt, 0.12 Amps, 254/265nm). An Agilent Technologies, UK, 6120 Quadrupole LC/MS 
was used for detection and Agilent OpenLAB CDS ChemStation Edition LCMS software used 
for data acquisition and analysis. Data was acquired using the same Waters Symmetry C18 
5µm (3.9x 150mm) column above (3.2.7). Operation was carried out at a flow-rate of 
1mL/min, with a run-time of 7 mins. 
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3.3.0    Methods 
 
3.3.1    Preparation of stock solutions 
 
Stock solutions of each compound, 3AB, 2AB, BZ, MA, TR, AXI, β-CDP and HSA, were accurately 
prepared in the appropriate solvent. Solvents used were pH=7 for 3AB, 2AB, BZ, MA, β-CDP 
and HSA, ethanol for TR, and water: ethanol (98/2) for AXI. Prepared solutions were wrapped 
in foil and kept refrigerated at 3°C-5°C when not in use, thus reducing exposure to heat or 
light. 
All samples for NMR analysis were prepared in 99% dimethyl sulfoxide (DMSO), containing 
tetramethylsilane (TMS) as an internal reference. 
Ethanolic solutions were used for monochromatic and polychromatic studies. Dilutions for 
photostability studies (Chapter 8) were prepared in buffer pH=7. Studies for actinometry, 
HPLC and photokinetics (Chapter 7) were prepared in ethanol. 
3.3.2    Preparation of diluted solutions 
 
The concentration of the solutions was calculated using: 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑀) =
𝑀𝑎𝑠𝑠 (𝑔)
𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 (
𝑔
𝑚𝑜𝑙
)
𝑉𝑜𝑙𝑢𝑚𝑒 (𝐿)
     Eq. 1 
Working solutions were prepared using a Gilson® pipette and diluting a specific volume of the 
stock solution in the buffers outlined. 
3.3.3    Real samples 
 
Canal water was collected on 23rd May 2016 from the River Soar, Leicester, United Kingdom. 
This was purified by being filtered twice. The first filtration was carried out using Whatman 
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70mm filter paper, Grade 5, and the subsequent filtration used a 0.45μm Nylon Millipore 
syringe.  The water was then diluted 1 in 50 times in buffer pH=7. 
3.3.4.0    Fluorescence analysis 
3.3.4.1    Calibration graphs 
 
Blank solutions for fluorescence spectroscopy consisted of buffer pH=7 for 3AB, 2AB, BZ and 
MA, pH=4 for TR, and water: ethanol (98/2) for AXI. Various concentrations of sample were 
added to the relevant blank solution, and the sample thoroughly stirred. The excitation and 
emission spectra were recorded and the relative fluorescence intensity (RFI) at the 
appropriate maximum wavelength (Fobs) measured and plotted against increasing 
concentrations of the solution. The same procedure was used for all calibration graphs. 
For analysis with macromolecules the cuvette was washed, replaced with 2mL of a specific 
concentration of β-CDP or HSA, and the fluorescence spectra obtained. The analyte was then 
added, and the sample analysed again. 
3.3.4.2    Isotherm construction 
 
The relative fluorescence intensities obtained for each analyte concentration were plotted 
against the concentrations of β-CDP, until a plateau in the relative fluorescence intensity was 
obtained. This was repeated with various concentrations of the compound to construct 
several isotherms, each of which was analysed in triplicate. 
3.3.5    Proton NMR analysis 
 
Samples were thoroughly mixed before being transferred to standard 5mm NMR tubes 
(Norell, UK). The proton and carbon spectra were acquired and assigned based on their 
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chemical shift and coupling patterns. Various concentrations of isomeric compound were 
observed in the presence of increasing β-CDP, and changes in the spectra characterised. This 
was then repeated using a constant concentration of β-CDP and increasing the concentration 
of the compound. Job’s method of continuous variation was carried out by mixing equal molar 
concentrations of BZ and 2-HP-β-CD, in increasing ratios of 0.1-1, and plotting the change in 
chemical shift between each molar ratio. 
3.3.6.0    Validation of the method 
Analysis was carried out using the same procedure as described above (3.3.4). 
3.3.6.1    Accuracy of the method 
For recovery of the compounds in water and canal water known analyte concentrations from 
the upper, lower and middle ends of the linearity range of each compound were added to the 
samples. Percentage differences between the concentrations added and those calculated 
from the equation of the calibration graphs were determined. The same procedure was used 
for all recovery studies. 
3.3.6.2    Robustness of the method 
 
The excitation and emission wavelengths of each sample were analysed at ±2-5nm and 
recovery studies conducted. In addition, recovery studies were also carried out using a 
different fluorescence instrument, of the same model. 
3.3.6.3    Effect of the pH 
 
Solutions of buffer pH=7 were altered using various amounts of 0.1M hydrochloric acid or 
0.1M sodium hydroxide to obtain solutions of pH≈1-11, measured using a Jenway 350 pH 
61 
 
meter (UK). The relative fluorescence intensity of the drug was plotted against the pH of the 
solution. 
3.3.6.4    Limit of detection and quantification 
 
The limits of detection (LOD) and quantification (LOQ) were defined as the lowest 
concentration of analyte able to be differentiated from the blank sample, with a limit of 
confidence; and the lowest concentration of the analyte able to be measured, with a limit of 
confidence, respectively. These were estimated as three or ten times the standard deviation 
of the blank experiment, accordingly. 
Limits of detection and quantification were calculated through use of the following equations 
(Eq.2-3) (Shrivastava & Gupta, 2011): 
𝐿𝑂𝐷 = 
𝑠.𝑑.  𝑅𝐹𝐼 𝑜𝑟 𝑠.𝑑.
𝐹𝐻𝑆𝐴
𝐹𝑜𝑏𝑠
𝑠𝑙𝑜𝑝𝑒 𝑜𝑓 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝑔𝑟𝑎𝑝ℎ
*3.3     Eq. 2 
 
𝐿𝑂𝑄 =  
𝑠.𝑑.  𝑅𝐹𝐼 𝑜𝑟 𝑠.𝑑.
𝐹𝐻𝑆𝐴
𝐹𝑜𝑏𝑠
𝑠𝑙𝑜𝑝𝑒 𝑜𝑓 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝑔𝑟𝑎𝑝ℎ
*10     Eq. 3 
 
In which: 
s.d.= Standard deviation of the samples 
RFI= Relative fluorescence intensity 
3.3.7.0    Photolysis procedures 
 
The instrument setup was described in 3.2.4-3.2.5. 
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3.3.7.1    Continuous irradiation 
 
The monochromator was set to a specific wavelength for irradiation (λirr) and the excitation 
beam guided through an optical fibre to the top of the sample cuvette so that the direction 
of the irradiation and analysis light were perpendicular. 
2 mL of solvent was placed in the 1 cm quartz cuvette and a blank (zero concentration of the 
analyte) recorded on the spectrophotometer. Buffered double distilled water pH=7 was used 
for all studies. For studies in HSA or β-CDP the blank contained either the protein or polymer, 
respectively, to enable observation of only the spectra corresponding to the drug. 
The optical fibre was placed perpendicularly onto the radiometer probe to measure the 
intensity of light. Readings taken before and after each photolysis confirmed the intensity 
remained the same throughout analysis. 
Specific concentrations of the compound were added to the blank sample. 
UV-Visible spectra were recorded at set intervals throughout photolysis, using the Agilent 
8453 ChemStation kinetics computer program, UK. This was continued until the end of the 
photoreaction, indicated by little or no change in absorbance. 
For all analyses the sample was continuously stirred with a magnetic flea, to ensure 
homogenisation of the solution and maximum exposure to light. A temperature of 22°C was 
maintained, and the sample was shielded from ambient light. 
3.3.7.2    Polychromatic photolysis procedure  
 
The same method as in 3.3.7.1 was used, however, at set intervals the sample was removed 
from the light source, and its absorption spectra measured.  
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For the calibration graph in UV-Vis the blank experiment consisted of 2mL of the solvent. 
Increasing concentrations of the drug were added to the cuvette and the absorbance 
spectrum measured and recorded. The absorbance against increasing concentrations of drug 
was plotted and the line of best fit outlining the linearity range was determined (y =
31877x − 0.0099). 
3.3.7.3    Chromatographic analysis 
 
Separation of the sample and its photoproducts was achieved using a mobile phase consisting 
of acetonitrile/ methanol/ 0.1M acetic acid (126/280/38). 20μL injections were made and the 
UV detector set to 330nm. 
3.3.7.4    Kinetic data treatment 
 
Based on the proposed photodegradation mechanism, differential equations were used to 
describe the concentration behaviour of the species in the reaction. 
The values were converted into absorbance and fitted with the experimental data in 
Microsoft Excel. The data was inputted for the unknown reaction until there was a fit between 
the theoretical traces and experimental traces. 
3.3.8    LC-MS analysis 
 
LC-MS was carried out using the same mobile phase given above (3.3.7.3). 2 scan modes were 
used in the positive ion monitoring mode, mass range 150-750m/z. Positive single-ion 
monitoring (SIM) was also monitored at 328.3m/z, representing molecular ion [M+H+] and 
sodium ion at 350 [M+Na+]. Parameters used were: Drying gas flow 3.0L/min, nebulizer 
pressure 20psig, drying gas temperature 300°C and capillary voltage 3,000V at room 
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temperature. An initial chromatogram of the sample was obtained. The sample was then 
irradiated using the UV-light source and a second chromatogram recorded. 
3.4.0    References 
 
Shrivastava, A., & Gupta, V. (2011). Methods for the determination of limit of detection and 
limit of quantitation of the analytical methods. Chronicles of Young Scientists, 2(1), 21–
25. 
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Chapter 4: The fluorescence properties of molecules in various 
media 
4.1.0 Introduction 
4.1.1 Introduction 
 
Precise and accurate detection of trace pharmaceuticals in biofluids and surface waters is 
limited as many techniques lack sensitivity and specificity (Saul, 2017). There is therefore the 
necessity for techniques that possess these properties and are rapid and low cost (Hurtado-
Sánchez, Lozano, Rodríguez-Cáceres, Durán-Merás, & Escandar, 2015). 
Such a technique is required as many drugs are successful through interacting with biological 
membranes. As a consequence, there is less of the free drug remaining in biofluids, because 
it can bind to proteins, making detection more challenging (Rub, Khan, Azum, & Asiri, 2017). 
Fluorimetry has the sensitivity to allow for these low concentrations to be detected, however, 
drug compounds can additionally bind to these proteins, altering the fluorescent properties 
of both themselves and HSA. To allow for reliable detection of the compounds in HSA the 
extent of the alteration in the compound needs to be controlled and considered (Lakowicz, 
2006). 
Furthermore, in both biofluids and surface waters, concentrations of drug compound below 
instrument detection limits may be present. Other approaches are therefore required. 
Cyclodextrins have proved to have a number of beneficial effects, such as altering the 
environment of non-polar, poorly soluble compounds. This property has resulted in an 
improvement in drug solubility (Deng et al., 2016) and the compound is protected from bulk 
solution quenchers (Huang, He, Lu, Ge, & Guo, 2011), enhancing the fluorescence intensity 
(Lakowicz, 2006).  
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A groups of select compounds were chosen for their properties and their fluorimetric 
characteristics determined in water, and various environments, in the presence or absence 
of one of these macromolecules (HSA, β-CDP). This would be expected to provide fluorimetric 
information on their properties. 
4.1.2 Fluorescence spectroscopy 
 
Fluorescence spectroscopy is a quantitative and qualitative technique (Mura, 2014) that is 
able to provide information about the structure of trace concentrations of rigid, conjugated 
compounds, and their interaction with solvents and other compounds (Sheehan, 2009). As 
thus, it is able to provide information on the microenvironment of the compound, and the 
binding occurring. 
Variations in polarity of the medium and the amount of vibrational energy each compound 
possesses can alter their fluorescence properties, making fluorimetry particularly useful for 
differentiating between compounds. The high sensitivity of the instrumentation enables it to 
be used to detect small changes in the environment of a species. Fluorimetry can therefore 
be used to differentiate between compounds, variations in the medium and interactions with 
other species (Lakowicz, 2006). The technique utilises high-energy UV-light to excite 
fluorophores from their ground state to excited singlet state. Through absorbing a specific 
number of high-energy photons, within a particular excitation wavelength range, the 
fluorescent compound can be promoted to its excited state. The maximum number of 
photons, ‘extinction coefficient’, a compound can embody falls into this wavelength range, 
and this specific wavelength can differ depending on environmental effects. The compound 
can then be promoted from its spin-paired ground state to its distinctive singlet excited state, 
where it is able to remain for an amount of time, ‘excited state lifetime’, before relaxing back 
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to its ground state and emitting photons at a longer wavelength. Over its excited state lifetime 
it loses energy through various internal conversion processes, including the transfer of heat 
to the solvent, intersystem crossing to the triplet state to produce phosphorescence, and 
interactions with other molecules. Such processes bring the compound to a lower excited 
state before emission. Similar to the excitation spectrum, the most intense fluorescence in 
this spectra range, ‘emission maximum wavelength’, is also affected by the environment 
(Lakowicz, 2006). 
4.1.3 Factors influencing fluorescence properties 
 
The fluorescence spectra produced by a compound can be affected by a number of factors. 
This includes: the structure of the compound; the solvent; and any interactions with other 
molecules (Sheehan, 2009)(Table 1). 
Table 1: Factors that can affect fluorescence spectra 
 
If the polarity of the solvent is varied then the fluorescence intensity and maximum emission 
wavelengths may be influenced. In the presence of more polar solvents, the amount of energy 
the compound possesses, following internal conversion, is reduced, increasing the amount of 
Fluorescence Factor 
Solvent polarity 
altered 
Structure of 
compound 
Different volume of 
sample solution 
Change in sample 
concentration 
SHOWN IN FLUORESCENCE SPECTRA 
 
 
 
Alteration in 
vibrations and 
rotations of 
compound 
 
 
 
Number of functional 
groups on compound 
 
 
Number of single 
and double bonds 
on compound 
 
 
Interactions with other 
compounds 
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energy lost via vibrations to the solvent and therefore shifting the emission spectra to higher 
wavelengths. The greater the polarity the greater the shift. This effect can also occur when 
the compound is able to form hydrogen bonds with the solvent (Lakowicz, 2006). 
The proportion of photons emitted to those initially absorbed is the ‘quantum yield’. The 
quantum yield of a specific compound, and thus the fluorescence intensity, can additionally 
be affected by factors in the Beer-Lambert law: the concentration of the sample; the 
absorption coefficient (and thus the wavelength of the compound); and the pathlength of the 
cell (Lakowicz, 2006). 
In order to be fluorescent, the compound should possess a rigid structure, however the more 
non-bonding pairs of electrons it has, the more freely they can move, increasing its excited 
state lifetime, and red shifting the spectra, and may increase the fluorescence intensity. If 
these non-bonding pairs of electrons are electron donating, such as amine or alcohol groups, 
the fluorescence intensity can be enhanced (Brandt, 1999). If the structure of the compound 
contains more single σ-bonds than double π-bonds, then more energy is required to break 
them, demanding more excitation energy and red shifting their emission spectrum (Sauer, 
Hofkens, & Enderlein, 2011). 
Some compounds are able to interact with other molecules. When such interactions occur 
the planarity of the compound can be altered, as can the extinction coefficient, influencing 
the energy required for excitation (Sauer et al., 2011). Interaction of a compound with a 
protein may quench the protein as it undergoes changes in its structure. This may involve 
energy transfer from the protein, which acts as a hydrogen donor, to the compound, and thus 
less photon energy is emitted. In addition, the wavelength of the compound can be red shifted 
if the compound binds to the polar region of the protein (Lakowicz, 2006). 
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Alternatively, if presented with a macromolecule, such as cyclodextrin, the compound may 
be ‘shielded’, protecting it from the solvent, and quenching from oxygen. This reduces non-
radiative processes in internal conversion, and the compound can accept protons from the -
OH (hydroxyl) groups within the cyclodextrin cavity, increasing the quantum yield and thus 
the fluorescence intensity (Lakowicz, 2006). Encapsulation within the cyclodextrin, restricts 
movement of the compound, thereby reducing its vibrations and rotations and thus 
increasing its fluorescence intensity (Mitra et al., 2014). 
4.2.0  Selection of the molecules for analysis by fluorescence spectroscopy in 
water 
 
Aromatic compounds selected as models for fluorimetric analysis were chosen for a variety 
of reasons. Each was a poorly water-soluble compound, and thus they represented assorted 
medicines. Although BZ and its isomer 3AB are popular for their local anaesthetic properties 
(da Silva, Grobério, Zacca, Maldaner, & Braga, 2018), the former licenced for use to manage 
acute or chronic pain for a short period of time (Shipton, 2012), 2AB tends to be used as a 
wine flavouring (Moio, 1995). The medicinal properties of the other compounds varied. MA 
is used in Indian medicine for the treatment of immune-deficiency diseases, such as arthritis 
(de Souza et al., 2009), TR has been used to treat asthma, keloids, hypertrophic scarring and 
allergic conjunctivitis in South Korea and Japan (U.S. Food & Drug Administration, 2018), and 
AXI has been identified as an anti-cancer drug (Yan Lee, 2016), able to increase levels of 
various enzymes and proteins in the body (Shi et al., 2011). The latter two compounds, AXI 
and TR, were able to reduce tumour growth and insulin levels in the body by inhibiting 
vascular endothelial growth factor receptors (Gross-Goupil, Françlois, Quivy, & Ravaud, 
2013), and inhibiting the secretion of insulin, respectively. The latter through binding to 
calcium permeable channels (Darakhshan & Pour, 2015). 
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Various groups on the compounds would not only be responsible for their pharmaceutical 
effect, but would be able to influence their interactions with various media and host 
molecules (Table 2). Each of the compounds possessed non-bonding pairs of electrons, thus 
enabling them to form hydrogen bonds to interact with both electron withdrawing groups, 
such as halogens, and electron donating groups, such as: electron donating groups on 
solvents; amines on proteins; alcohols within cyclodextrins; and hydroxyls on the exterior of 
cyclodextrins. Research shows that amides, with a low electronegativity, are the group most 
electrostatically attracted to hydrogen atoms to form hydrogen bonds. The position of the 
amide functional group on BZ and its isomers 2AB and 3AB can alter the fluorescence spectra. 
The highly acidic carboxylic acid group on TR could act as a proton donor, whilst dipole-dipole 
interactions could form between other functional groups, such as ketone groups on MA and 
BZ, and ions or negatively charged parts of other compounds. 
Table 2: The structures of compounds used in the study 
3AB, 2AB, BZ TR 
MA AXI 
 
R1= 2AB 
R2= 3AB 
R3= BZ 
R= NH2 
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The size of such groups can affect the overall size and shape of the compound, influencing 
their binding with other molecules. Such effects can occur from functional groups in the 
solvent medium and interactions with macromolecules and proteins. Each different 
interaction would therefore have a unique effect on the fluorescence spectra. 
With the exception of AXI, the compounds were all derived from natural sources, enabling 
their administration in the form of herbal teas or foods (Medina Ramírez et al., 2016). It was 
possible to obtain TR and MA, from nandina plants (Ogawa et al., 2010), and mangos (Medina 
Ramírez et al., 2016), respectively, and BZ from the esterification of mushroom and whole 
grain-derived (Medline Plus, 2019) para-aminobenzoic acid (Aronson, 2016), enabling their 
acquisition and worldwide use. 
It would be interesting to observe BZ and its isomers for several reasons. BZ is used as a 
bulking agent in street cocaine (da Silva et al., 2018), users of this illicit drug may therefore 
have traces of BZ in their biofluids. Ingestion of such drugs, through consumption of 
contaminated tap water can have toxic effects, which are not necessarily specific to this 
category of drug (Karthikeyan & Meyer, 2006). Each of the compounds had previously been 
observed by fluorimetry, implying they possessed the necessary properties to be able to 
absorb light and emit fluorescence (Huang et al., 2011; Iglesias, 2011; Tang, Liang, Tong, & Li, 
2006; Tayyab et al., 2016). Their analysis through this technique could therefore be 
monitored. 
To allow for comparisons of the compounds in different environments, three environments  
were elected: canal water was selected as a surface water, likely to have a different 
environment to water; HSA was selected as a protein in a biofluid, which could form 
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interactions with various compounds; and β-CDP was chosen as a supramolecular molecule 
able to encapsulate compounds within its structure (Iglesias, 2011). 
4.3.0 Results 
4.3.1 Fluorimetric properties of the compounds in water 
 
Initially, the fluorimetric properties of the compounds, including their various wavelength 
positions and shapes, were observed in water to see how they responded to this neutral 
medium, and to compare the spectra between the various compounds, and how this was 
reflected in their fluorescence properties (Fig. 1). Such a medium was deemed typical of both 
surface water and biofluid conditions (Huang et al., 2011; Iglesias, 2011; Tayyab et al., 2016; 
Yan Lee, 2016). 
Previous fluorimetric observation of these compounds had been acquired in water. Despite 
the large number of σ-bonds the chemical structure of MA was comprised of, and the 
indistinguishable chemical formulas of BZ and its isomers, each compound was able to 
produce a distinct, detectable fluorescence spectrum (Fig. 1, Annexe Fig. 4-5). 
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Figure 1: Emission spectra of (A)(left to right) 9.73 x 10-7M HSA, 4.93 x 10-6M BZ, 1.16 x 10-6M 
AXI, 6.10 x 10-8M 2AB, 2.44 x 10-7M 3AB, 4.89 x 10-6M TR and 8.54 x 10-7M MA in water, (B) 
Emission spectra of hosts and media (left to right) 9.21 x 10-8M HSA, buffer pH=7, 12.17mg/mL 
β-CDP (the host was subtracted from the spectra in the presence of the compound) 
 
The different species fluoresced at different wavelengths, and, as previously suggested 
(4.2.0), their spectra varied in intensity and shape. 
It can be observed (Fig. 1, Annexe Fig. 4-5) that the emission spectra of BZ and MA differ by 
almost 200nm. The much longer wavelength of emission observed for MA would be indicative 
of its electron donating groups and high ratio of single bonds, requiring more energy for 
excitation (Sauer et al., 2011), and thus absorbing light at a longer wavelength. 
In order to obtain emission spectra of a similar intensity, various concentrations of each 
compound were used. It can be observed that 2AB has an intensity ≈6 times greater than TR, 
but using a concentration ≈80 times lower. TR may exhibit a smaller intensity, as it possesses 
a greater number of electron accepting groups than 2AB. These excess vibrations are lost 
through internal conversion processes and so less energy is emitted as photons (Sauer et al., 
2011).  
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In comparison to TR the shape of the spectrum of AXI appears narrower. A possible 
explanation for this could be that TR was able to undergo more molecular vibrations than AXI, 
resulting in poorly-resolved, broad vibrational transitions, and thus broad emission spectrum 
(Sheehan, 2009).  
Of additional interest is the emission spectra of BZ and its isomers. Not only does the similar 
shape in spectrum of 2AB and BZ, and much broader one of 3AB, suggest more vibrational 
collisions occurred in the latter compound, but the intensity and wavelengths differed. 
The increase in emission wavelengths of the isomers, in the order 3AB>2AB>BZ, differed 
slightly to those previously observed in another study, which were attributed to the different 
electron densities. In addition, these compounds have been found to be sensitive to solvent 
effects. These effects could therefore not only contribute towards the different emission 
wavelengths observed for each compound, when compared to the previous study (Iglesias, 
2011), but also the spectral shifts. 
Whilst 2AB and 3AB have similar wavelengths, that of BZ is much shorter. A much shorter 
wavelength would indicate less energy was required for non-radiative internal conversion 
processes with this compound than the other two compounds. A similar effect has previously 
been observed for isomers and assigned to the longer lifetimes in the meta and ortho 
position. This would account for the greater red shift of 3AB and 2AB, when compared to that 
of BZ (Promkatkaew et al., 2014). The emission spectra of proteins tend to be characterised 
by their amino acid spectra. In HSA this is tryptophan, which can be excited at 280nm, emitting 
fluorescence from ≈320nm-355nm. The specific emission wavelength is dependent on the 
polarity of the environment. In the relatively polar medium of water, the indole on the protein 
can be denaturised, reducing energy and red shifting as a result of energy lost through the 
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unfolding of the protein (Lakowicz, 2006). This would explain the presence of an emission 
peak at 343nm (Fig. 1, Annexe Fig. 3). 
4.3.2 Effect of AXI degradation on its fluorimetric properties 
 
AXI had previously been deemed to be photounstable (Yan Lee, 2016), therefore prior to 
analysing its behaviour in various media, its behaviour in experimental light conditions was 
observed. Studying the fluorescence intensity of an AXI sample over a period of 3 hours 
showed a decrease of ≈4 times before a plateau was observed. In the presence of β-CDP an 
increase of ≈30% was observed in the spectrum before a plateau was reached, suggesting it 
was being stabilised against photodegradation (Glass et al., 2001). This effect was found to 
be reproducible in both water and canal water medium. 
Comparison of the fluorescence spectrum of the compound, and the compound-β-CDP 
solution, prior to light exposure, showed little or no differences in fluorescence intensity 
increase (Fig. 2, Annexe Fig. 6). 
Figure 2: Excitation and emission spectra of 3.01ppb AXI in water and ethanol (98/2)(dashed 
lines), and 3.01ppb AXI in 15.08mg/mL β-CDP, respectively (plain lines), at room temperature, 
the maximum spectra of which are labelled 
Following irradiation, ≈7 times greater intensity was observed at the plateau region of the 
compound isotherms, in the presence of β-CDP, when compared to that in its absence 
0
100
200
300
400
500
600
700
800
900
1000
240 290 340 390 440 490
R
e
la
ti
ve
 F
lu
o
re
sc
e
n
ce
 In
te
n
si
ty
Wavelength/ nm
Water
Water 
and β-
CDP
AXI
394nm
341nm
384nm
334nm
77 
 
(Annexe Fig. 7). Such an effect may be attributed to stabilisation of the compound by 
cyclodextrin, decreasing the production of photoproducts (Ioele, De Luca, Tavano, & Ragno, 
2014). 
Further fluorimetric analysis of the compound was therefore conducted after light exposure 
of the sample cuvette for a period of 3 hours.  
4.3.3 Fluorimetric properties of 3AB, 2AB, BZ, MA, TR and AXI in the various 
environments 
 
To ascertain the effect of altering the environment on the fluorescence properties of the 
compound, the excitation and emission spectra of the compounds were recorded in canal 
water, in both the presence and absence of β-CDP, and in HSA (Fig. 3, Annexe Fig. 1-3). 
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Figure 3: Excitation and emission spectra of (A) 0.0014ppb HSA in the absence (dashed lines) 
and presence (solid lines) of 1.94ppb 3AB, and 24.33ppb 3AB (dashed lines), respectively, (B) 
0.65ppb 3AB and 25.20mg/mL β-CDP (plain lines), and 29.24ppb 3AB in canal water (C) 
(dashed lines) and (C) 0.65ppb 3AB in 25.13mg/mL β-CDP and canal water (Cβ-CDP)(plain 
lines), at room temperature, the maximum spectra of which are labelled 
 
In canal water (Fig. 3, Annexe Fig. 2) red shifts in the emission spectra were observed, when 
compared to water (Fig. 3, Annexe Fig. 1), as can occur when the compound is transferred to 
a more polar environment (Lakowicz, 2006). Such effects have been attributed to the energy 
required for hydrogen bond formation between the solvent and compound, reducing the 
energy of the fluorophore following internal conversion, and causing it to emit photons at a 
longer wavelength (Sheehan, 2009). 
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In the presence of HSA, the emission spectra of the compound additionally red shifted. This 
was indicative of compound-drug binding, as would occur if the compound was binding to the 
polar amino acid residues on the HSA (Sheehan, 2009). When a compound binds to a protein 
the hydrogen bonds are destroyed and structure of the protein broken down. This can alter 
its secondary structure, causing the protein to unfold, reducing its α-helix content, β-sheet 
and turn structures (Moradi, Ashrafi-Kooshk, Chamani, Shackebaei, & Norouzi, 2018). It has 
been hypothesised that this involves π-π stacking forces, van der Waals forces and hydrogen 
bonding between polar groups on the compound, such as hydroxyl groups, and the main 
polypeptide chain of the amino acid (Liu et al., 2018). 
It can additionally be observed that the fluorescence intensity of HSA was reduced in the 
presence of five of the compounds (Fig. 3, Annexe Fig. 3). This may be attributed to the 
unfolding of the protein, and exposure of its fluorophores to the polar quencher (Lakowicz, 
2006). Furthermore, the fluorescence emission spectrum of BZ overlaps the absorption 
spectrum of HSA (Annexe Fig. 3). Such an effect can result in the transfer of energy from HSA 
to the compound, decreasing the energy of this donor and increasing the intensity of BZ. Such 
an interaction involves dipole-dipole interactions and the passing of excited state energy from 
the fluorescing HSA to BZ. This can arise when the donor and acceptor compound share a 
common vibration level, and transfer energy between the two until one emits (C. A. Parker, 
1967). This can be supported by the greater emission intensity of BZ in the presence of HSA, 
when compared to that in its absence. The fluorescence spectrum of BZ obstructed the 
spectrum of the protein as a result and therefore the effect of BZ on HSA was observed at 
≈320nm. Although the fluorescence intensity of two of the concentrations of HSA were 
quenched in the presence of AXI, the protein displayed a different effect in 0.0011ppm HSA. 
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Such an effect may indicate AXI may be bound to a hydrophobic region on the protein, 
forming more hydrogen bonds and stabilising the complex (Naik, Pawar, Tandel, & J, 2018). 
In the presence of β-CDP blue shifts, previously observed between a compound and β-CDP 
(Hamai, 1999), were observed in the wavelengths of the compounds in both canal water and 
water. This would indicate that the compounds were being located to a less polar 
environment, such as that in the β-CDP cavity, and the presence of isosbestic points in all 
compound-β-CDP spectra would indicate the compound in its bound and complexed state 
(Hamai, 1999). Larger shifts observed when canal water was used over water would evidence 
that canal water had a more polar environment than the cavity, requiring a larger amount of 
energy for realignment (Connors, 1997). 
A greater intensity of the compounds in both media was additionally observed. This could 
also be attributed to shielding from internal conversion processes (Lakowicz, 2006), which 
could potentially occur from vibrational restriction of the compound, which would reduce 
excess vibrational energy loss (Mitra et al., 2014). 
Comparison of the spectral shifts of the compound in the various environments may be able 
to provide information on the amount of time the compound resides in its excited state for. 
This can be affected by various factors including interactions with other molecules and the 
solvent (Sheehan, 2009). Such information can be obtained from the Stoke’s shift, by 
measuring the energy difference between the fluorescence emission and excitation 
wavelengths. 
The smaller Stoke’s shifts observed in water and canal water, in the presence of β-CDP (Table 
3), could be attributed to the lower polarity groups on the compound when within the cavity 
of the β-CDP (Hamai, 1999). Differences in the Stoke’s shift of each compound, in water and 
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canal water, were compared in the presence and absence of β-CDP (Table 3). The greater 
shifts of 3AB, 2AB and TR in canal water may implicate that this environment was more polar 
for the compounds, when compared to water, requiring more energy for realignment of the 
solvent (Lakowicz, 2006). Greater shifts observed in water in the presence of the other 
compounds, MA and AXI, was suggestive of more non-fluorescent pathways. This may be 
attributed to more similar polarities of the two compounds, to that of the buffered solution, 
and thus less vibrational energy lost through solvent vibrations (Sheehan, 2009). The energy 
difference between the compounds in the different media could be indicative of the proton 
donating and accepting abilities of the compound. Such evidence as the lower pKa values of 
2AB and 3AB, in comparison to BZ, may indicate their greater ability to accept electrons and 
therefore form hydrogen bonds with the hydroxyl groups on the β-CDP (Hamai, 1999). 
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Table 3: Fluorescence features of 3AB, 2AB, BZ, MA, TR and AXI in water and canal water 
(W, C, respectively), in water and β-CDP (β-CDP), in canal water and β-CDP (Cβ-CDP), and the 
emission spectra of the compounds in HSA (HSA) 
a The maximum excitation and emission spectra of the compounds, alone (See Table 3), are 
underlined, whilst shoulders are displayed in brackets 
b The Stoke’s shift is calculated from the difference in the energy of the maximum emission 
spectra and the maximum excitation spectra of the compound 
 
 
Compound Medium Fluorescence 
excitation/ nma 
Fluorescence emission/ 
nm 
Stoke’s shift/ 
nmb 
3AB W (283) 304 446 142 
β-CDP  (300) 324 426 102 
C 306 451 145 
Cβ-CDP 328 (314) 425 97 
HSA - 456 - 
2AB W 329 424 95 
β-CDP 342 409 67 
C 329 424 95 
Cβ-CDP 341 407 66 
HSA - 413 - 
BZ W 286 360 74 
β-CDP 296 (328) 344 48 
C 284 (344) 359 75 
Cβ-CDP (279) 295 (329) 344 49 
HSA - 357 - 
MA W 377 528 151 
β-CDP 378 520 142 
C 379 529 150 
Cβ-CDP (279) 378 521 143 
HSA - 522 - 
TR W (pH=4) 323 441 118 
β-CDP 326 436 110 
C 326 437 111 
Cβ-CDP 342 434 92 
W (pH=7) 326 427 101 
HSA - 414 - 
AXI W 334 394 60 
β-CDP 341 384 43 
C 328 394 66 
Cβ-CDP 333 394 61 
HSA - 404 - 
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The change in polarity between the environment of the canal water and that of water was 
further evidenced by the slightly lower intensity of the species in canal water, in the absence 
of β-CDP. This may indicate that the compound was more ionised in water than in canal water 
(Sahoo, Sahu, Rao, & Ghosh, 2014). 
In the presence of β-CDP the intensity of each of the compounds was increased. This could 
indicate that β-CDP shielded the compounds from non-radiative processes by reducing their 
rotations and donating protons (Lakowicz, 2006). 
Comparisons between the three isomers found that 3AB exhibited larger Stoke’s shifts in each 
of the medium used. This may be attributed to the difference in the electron density of 3AB 
in comparison to its isomers (Lakowicz, 2006). 
4.4.0 Conclusion 
 
The properties of selected pharmaceuticals: 3AB, 2AB, BZ, MA, TR and AXI, which may be 
present in surface waters and biofluids, were observed by fluorimetry in water and their 
spectra compared to those in a macromolecule or in canal water. In the presence of β-CDP 
the fluorescence intensity was increased for all compounds, indicating their stabilisation 
against non-radiative processes. In the presence of the compounds the spectrum of HSA was 
quenched, implying an alteration in the structure of the protein. Shifts in the spectra of all 
compounds in the presence of one of these macromolecules, or in canal water, were 
indicative of their transfer to a less polar environment. 
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Chapter 5: Complexation of guest molecules with cyclodextrin to 
form a 𝑮𝒏: (𝑪𝑫𝒑)𝒎 complex 
 
5.1.0 Introduction 
5.1.1 Introduction 
 
Knowledge of the stoichiometry and inclusion complex formed between a host and guest is 
necessary as it assesses the ability of the host to: solubilise guest compounds, improve drug 
release and efficiently encapsulate insoluble drugs (Gidwani & Vyas, 2014). 
Cyclodextrins have been found to form water-soluble inclusion complexes with various 
compounds (Limousin et al., 2007), allowing them to be used in the pharmaceutical industry 
as drug delivery agents. Cyclodextrins have been the subject of a number of studies, with over 
170,000 studies published by the end of 2003 (Szejtli, 2005). 
Increasing attention has been paid to cyclodextrin polymers, as polymerising monomers 
enables them to maintain the advantages of β-cyclodextrin (β-CD), with the addition of 
polymer benefits, including a high molecular weight and solubility (Gidwani & Vyas, 2014). 
These polymeric derivatives have a high adsorption capability, enabling them to rapidly 
adsorb (Moulahcene et al., 2015) a greater number of poorly soluble compounds (Erdoğar & 
Bilensoy, 2018) with large structures (Li, Xiao, Li, & Zhong, 2004) (Li et al., 2004). Furthermore, 
they can increase the fluorescence intensity of guest compounds (Cavalli et al., 2009), and 
protect these guests against chemical degradation processes (di Cagno, Terndrup Nielsen, 
Lambertsen Larsen, Kuntsche, & Bauer-Brandl, 2014). 
The complexation between a molecule of guest compound and unit of cyclodextrin monomer 
is often evaluated using Job’s continuous variation plot (Upadhyay & Kumar, 2009), however, 
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this method utilises concentrations of drug and cyclodextrin, and involves plotting the 
changes in fluorimetric signal against varying molar ratios to provide an indication of the 
stoichiometry (Upadhyay & Kumar, 2009). As the molecular weight of β-CDP is affected by 
the polymerisation reaction conditions (Junthip, Tabary, Leclercq, & Martel, 2015), and 
number of monomers it contains (Murdan, 2013), its molecular weight can not be accurately 
determined. When utilising a cyclodextrin polymer, fluorimetric determination of a 
complexation has only been possible through methods, such as assigning a ‘molecular weight’ 
to a unit of polymer (Hamai, 1999). 
The application of isothermal models (Limousin et al., 2007) to guest-β-CDP complexes does 
not appear to have yet been reported in the literature. 
Although studies for the evidence of β-CDP complexes have been conducted using fluorimetry 
(Hamai, 1999), these are more often evidenced by thermal analysis techniques, such as 
Differential Scanning Calorimetry (Tejashri, Amrita, & Darshana, 2013). The current study 
aims to monitor the guest-β-CDP interaction and quantify and analyse the findings to 
determine the stoichiometry of the complex. 
A new method has been proposed by our group and demonstrated (Yan Lee, 2016). Outlined 
in the next section (5.1.2) this method was applied to the six compounds: 3AB, 2AB, BZ, MA, 
TR and AXI, in the presence of β-CDP. 
5.1.2 Mathematical model for a 𝑮𝒏: (𝑪𝑫𝒑)𝒎 complex 
 
The association between one or more molecules of guest with one or more cyclodextrin 
polymer units, which may be comprised of ‘p’ cyclodextrin monomer units, form a 
𝐺𝑛: (𝐶𝐷𝑝)𝑚 complex. Thus, when a monomer cyclodextrin is complexed, ‘p’=1 (Pinto et al., 
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2005). It is expected that the complex occurs rapidly (Moulahcene et al., 2015) and each of 
the binding sites on the cyclodextrin has a different stability complex (Fülöp, Kurkov, Nielsen, 
Larsen, & Loftsson, 2012). 
The association reaction can be represented by: 
𝑛𝐺 + 𝑚𝐶𝐷𝑝 ⇌ 𝐺𝑛: (𝐶𝐷𝑝)𝑚        Eq. 1 
The variation in the fluorescence intensity signal occurring (𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 ), with concentration ‘j’ of 
β-cyclodextrin polymer ([𝐶𝐷𝑝]0,i,j), for a 𝐺𝑛: (𝐶𝐷𝑝)𝑚 complex can be described by Eq. 2: 
(𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 )𝑛
𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠 =
(𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠)𝑛−1
𝑛 × 𝐾
𝐺𝑛:(𝐶𝐷𝑝)𝑚
× [𝐺]0,𝑖
𝑛−1 ×
1
[𝐶𝐷𝑝]0,𝑖,𝑗
𝑚     Eq. 2 
In which (𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 ) is the fluorescence intensity when every guest molecule is 
completely complexed, 𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠 is the native fluorescence intensity of a specific ‘i’ 
concentration of the guest [𝐺]0,𝑖
𝑛−1, and 𝐾𝐺𝑛:(𝐶𝐷𝑝)𝑚 represents the drug-β-cyclodextrin 
polymer association constant of the complex. 
Linearising Eq. 2 allows for the following formula to be derived (Eq. 3). This can enable the 
stoichiometry of the complex to be determined in three stages. 
𝐼𝑛 [
𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠
𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠 × [𝐺]0,𝑖] = 𝑛 × 𝑙𝑛 [
𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠
𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠
0
× [𝐺]0,𝑖] + 𝑙𝑛 [𝑛 ×
𝐾𝐺𝑛:(𝐶𝐷𝑝)𝑚
× [𝐶𝐷𝑝]0,𝑖,𝑗
𝑚 ]         Eq. 3 
The gradient of the linear relationship, Eq. 3, is ‘n’. This can be determined from Eq. 3 if the 
total fluorescence intensity of the medium (𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 )  is recorded for ‘i’ experiments at a 
specific β-CDP concentration [𝐶𝐷𝑝]0,x. This can be achieved by vertically drawing a line on the 
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isotherms and obtaining the fluorescence intensity readings where the line intersects each 
isotherm. The intercept 𝑙𝑛 [𝑛 × 𝐾𝐺𝑛:(𝐶𝐷𝑝)𝑚
× [𝐶𝐷𝑝]0,𝑥
𝑚 ] for the particular  [𝐶𝐷𝑝]0,x 
concentration will therefore be a constant. 
Once ‘n’ has been determined the data obtained from one of the ‘i’ isotherms (where [𝐺]0,i x 
is a constant and [𝐶𝐷𝑝]0,i,j is a variable) can be treated using the following equation derived 
from Eq.2 (Eq. 4): 
𝑙𝑛 [
(𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 )
𝑛
𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠 ] = −𝑚 × 𝐿𝑛[𝐶𝐷𝑝]0,𝑖,𝑗 + 𝐿𝑛 [
(𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠)𝑛−1
𝑛 × 𝐾
𝐺𝑛:(𝐶𝐷𝑝)𝑚
× [𝐺]0,𝑖
𝑛−1 ]  Eq. 4 
Using the gradient from Eq. 4 will allow the determination of parameter ‘m’. 
Once ‘m’ and ‘n’ have been determined the value of the association constant (Eq. 5) can be 
established from the intercept formula and the value of Eq. 4: 
𝐾𝐺𝑛:(𝐶𝐷𝑝)𝑚
=
(𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠)
𝑛−1
𝑛 × 𝑒𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 × [𝐺]0,𝑖
𝑛−1       Eq. 5 
 
For the majority of cyclodextrin polymers the relative molecular mass cannot be accurately 
determined, therefore, the cyclodextrin concentrations can be expressed in g/L, rather than 
molarity. An ‘alternative pseudo-association’ constant 𝐾′𝐺𝑛:(𝐶𝐷𝑝)𝑚(Eq. 6) can be used, given 
in (g/L)1-m-n, or similar. 
𝐾𝐺𝑛:(𝐶𝐷𝑝)𝑚
′ =  𝐾𝐺𝑛:(𝐶𝐷𝑝)𝑚
× [𝑅𝑀𝑀(𝐺)]0,𝑖
1−𝑛 × [𝑅𝑀𝑀(𝐶𝐷𝑝)]0,𝑖
−𝑚    Eq. 6 
The shape of the isotherms may be able to reflect the stoichiometry of the inclusion complex. 
It has previously been suggested that if the isotherm is ‘S-shaped’ then the host molecule may 
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have large pores, enabling it to adsorb more than one guest molecule (Limousin et al., 2007). 
Simulations performed indicated this could suggest that m>1. Alternatively, if the isotherms 
are exponential-like in shape then it is expected that m=1, and one unit of cyclodextrin 
polymer is involved in the complexation of the guest (Yan Lee, 2016). The shape of the 
isotherm can therefore provide information on the number of β-CDP units involved in the 
complexation. 
The model treats the data collected for a series of isotherms of ‘i’ concentrations of guest 
molecule, in the presence of increasing ‘j’ host concentrations. To overcome problems with a 
single isotherm it uses various concentrations of guest in the presence of a constant host 
concentration. The method is similar to Job’s continuous variation, in that the variation in 
host concentration is also accounted for. 
For a Job’s continuous variation plot to be constructed, the total concentration of guest and 
host should remain constant, whilst the molar fraction of guest [G] to cyclodextrin [CD] is 
varied. Such methods, however, are not often applied in fluorimetry, as significantly lower 
concentrations of the guest are required for analysis (Tang, Liang, Tong, & Li, 2006), as large 
concentrations of compounds can result in self-adsorption and self-quenching (Sheehan, 
2009). 
In addition, Job’s method requires knowledge of the molecular weight of the compounds. As 
this cannot be accurately determined for the majority of cyclodextrin polymers, the proposed 
method uses g/L unit for concentrations instead of molarity units. 
Unlike Job’s plot, the proposed model doesn’t base the treatment of the isotherm data on 
the current complex stoichiometries in the literature (H Aki, Niiya, Iwase, & Yamamoto, 2001). 
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The approach therefore allows for all stoichimetries to be taken into consideration and, 
what’s more, provides information on the association constant of the complex. 
5.2.0. Results 
5.2.1.1 Fluorimetric effects of altering  the guest concentration in β-CDP 
 
The excitation and emission spectra of the compounds: 3AB, 2AB, BZ, MA, TR and AXI have 
been recorded in both water and canal water, and in the presence of β-CDP (Chapter 4). 
It was observed that when using either water or canal water as media, the fluorescence 
properties of the compounds were altered, and their emission spectra blue shifted in the 
presence of β-CDP. Furthermore, the excitation spectra of each compound was red shifted 
(≈1-22nm) when presented with β-CDP (Chapter 4- Fig 3., Annexe Fig. 1-2), and the Stoke’s 
shift subsequently increased (Chapter 4-Table 3). 
When compared to those recorded in the absence of β-CDP, the relative fluorescence 
intensities in both canal water and water were ≈70 times (BZ in water), and ≈60 times (3AB in 
canal water) greater in the presence of β-CDP (Table 1). 
Such increases in the fluorescence intensity of low polarity drugs in the presence of β-CDP 
have been attributed to a reduction in non-fluorescent pathways. The effect can occur when 
the compound is relocated to a less polar environment, in which its molecular vibrations are 
reduced and rigidity increased (Sheehan, 2009). 
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Table 1: Fluorescence features of 3AB, 2AB, BZ, MA, TR and AXI in the presence and absence 
of β-CDP 
𝑭𝒍𝟎,(𝑮𝒏:(𝑪𝑫𝒑)𝒎) 
𝝀𝒐𝒃𝒔
𝑭𝒍𝝀𝒐𝒃𝒔
a 
Compound 3AB 2AB BZ MA TR AXI 
Medium 
Water 1 1 1 1 1 1 
β-CDP 12.68 7.38 69.5 14.93 14.64 5.53 
Canal water 1 1 1 1 1 1 
Canal water and β-CDP 58.38 6.73 45.5 8.18 8.40 17.44 
 
a The fluorescence intensity of the numerator corresponds to either the maximum fluorescence intensity of 3AB, 
2AB, BZ, MA, TR or AXI, when in water, or canal water, or the maximum intensity observed when in excess β-
CDP, whilst the denominator corresponds to the fluorescence intensity of 3AB, 2AB, BZ, MA, TR or AXI in water 
or canal water (𝐹𝑙𝑜𝑏𝑠is equal to 𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠) 
 
 
The data (Table 1) was indicative of the formation of a guest-β-CDP inclusion complex, 
indicating all six compounds were capable of forming a complex with β-CDP. 
This enhancement in the fluorescence intensity of the compounds agreed with previous 
results obtained for these species (Ferreira et al., 2013; Hirayama, Utsuki, & Uekama, 1991; 
Huang, He, Lu, Ge, & Guo, 2011; Iglesias, 2011; Pinto et al., 2005; Tang et al., 2006; Utsuki, 
Hirayama, & Uekama, 1993; Yan Lee, 2016; Yang et al., 2013) , in which greater, or similar 
increases were observed in the presence of cyclodextrin monomers (Ferreira et al., 2013; 
Hirayama et al., 1991; Huang et al., 2011; Iglesias, 2011; Pinto et al., 2005; Tang et al., 2006; 
Utsuki et al., 1993; Yang et al., 2013), or β-CDP (Yan Lee, 2016). The enhancement was 
suggested to alter between the compounds as they each possessed differing polarities, and 
were of various sizes, affecting how they interacted with the host (Iglesias, 2011). AXI was the 
only compound in which the increase in fluorescence intensity had previously been observed 
in the presence of β-CDP (Yan Lee, 2016). Although the increases in fluorescence intensity 
observed with AXI in the current study were greater than those observed in the presence of 
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hydroxyl-propyl-β-cyclodextrin (HP-β-CD), they were not as high as those previously observed 
with β-CDP (Yan Lee, 2016). This difference could occur from slightly differences in the 
preparation of the samples, which could potentially influence the solution polarity, as has 
previously been found to occur in the presence of low concentrations of ethanol (as used to 
prepare the AXI solutions)(Bortolus, Monti, Energia, & Area, 1996). 
5.2.1.2 Effect of guest concentration in the presence of β-CDP 
 
In the presence of increasing concentrations of β-CDP the fluorescence intensity was seen to 
increase (Fig. 1, Annexe Fig. 10-11). 
 
Figure 1: Evolution of the fluorescence emission spectra of 2.60ppb 3AB in water, with 
increasing concentrations of β-CDP, at room temperature 
 
Various drug concentrations were selected so that their spectra did not exceed the limit of 
the fluorimeter upon addition of excess β-CDP, and so that isotherms spanned the range of 
the fluorimeter. Based on how the fluorescence intensity of the compounds evolved in the 
presence of β-CDP, increasing concentrations of β-CDP were added. Isotherms were 
constructed for the compounds, at the fluorescence emission maxima. Increasing 
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concentrations of β-CDP were found to result in a subsequent fluorescence intensity increase 
of the compounds, before reaching a plateau was reached (Fig. 2, Annexe Figure 12-13). 
Various concentrations of each guest appeared to reach plateaus at approximately the same 
concentrations of β-CDP, producing isotherms of a similar shape. This indicated that altering 
guest concentration had no influence on the stoichiometry of the complex. 
All constructed isotherms appeared to be ‘‘L’-shaped’, in which increasing the β-CDP above a 
specific concentration did not result in any further enhancement in the relative fluorescence 
intensity of the drug. This indicated that cyclodextrin had a limited sorption capacity for the 
drug molecules (Hernandez-Montelongo et al., 2014). The absence of an ‘S’ shaped isotherm 
(Hernandez-Montelongo et al., 2014) may indicate that a single polymer unit of cyclodextrin 
was involved in the complexation (Pinto et al., 2005), and thus that ‘m’ was close to unity for 
the complexes formed with each of the studied compounds. 
 Figure 2: Isotherms of 0.50ppb-6.73ppb MA, in water, with increasing concentrations of β-
CDP, at room temperature 
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5.2.1.3 Determination of the stoichiometry of the complex 
 
The isotherm data for ‘i’ concentrations of compound in the presence of varying ‘j’ 
concentrations of β-CDP were treated using Eq. 4. For each isotherm the fluorescence spectra 
were recorded in the absence of the β-CDP, 𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠, at a specified concentration of β-CDP, 
𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 , (e.g. 12mg/mL for MA) and at the plateau region, 𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 . Plots were then 
acquired for Yn against Xn (Eq. 7) to produce straight lines. 
Xn= 𝐿𝑛 [
(𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 )×[𝐺]0,𝑖
𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠 ]         Eq. 7a 
Yn= 𝐿𝑛 [
𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠×[𝐺]0,𝑖
𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠]                Eq. 7b 
The gradient of this linear plot (Yn=f(Xn)) represents the number of guest molecules in the 
complex ‘n’ (Eq. 4). Using Eq. 8 the intercept of (Ym=f(Xm)) can allow for the number of host 
molecules ‘m’ to be determined, using data from one of the isotherms. 
Xm= 𝐿𝑛[𝐶𝐷𝑝]0,𝑖,𝑗                                                Eq. 8a 
Ym= 𝐿𝑛 [
(𝐹𝑙0,(𝐺𝑛:(𝐶𝐷𝑝)𝑚)
𝜆𝑜𝑏𝑠 −𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 )
𝑛
(𝐹𝑙𝑡𝑜𝑡,𝑖,𝑗
𝜆𝑜𝑏𝑠 −𝐹𝑙0,𝐺,𝑖
𝜆𝑜𝑏𝑠)
]                                  Eq. 8b 
The association constant of each guest can then be determined for monomers using Eq. 5 and 
the value of the intercept. Eq. 5 requires knowledge of the molecular weight of the 
cyclodextrin. This is not accurately known for β-CDP, and thus only the pseudo-association 
constant can be determined (Eq. 9). 
𝐾𝐺𝑛:(𝐶𝐷𝑝)𝑚
′ =  𝐾𝐺𝑛:(𝐶𝐷𝑝)𝑚
× 𝑅𝑀𝑀(𝐶𝐷𝑝) =
𝑒𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡
𝑛 × [𝐶𝐷𝑝]0,𝑖,𝑗
𝑚
 
       Eq. 9 
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In which [𝐶𝐷𝑝]0,𝑖,𝑗
𝑚  is given in g/L, and 𝐾′𝐺𝑛:(𝐶𝐷𝑝)𝑚 is given in (g/L)
1-m-n, or similar. 
As can be observed (Fig. 3, Table 2, Annexe Fig. 14-17) the various stoichiometries obtained 
ranged from 0.65:0.85 for MA and 0.74:1.51 for 3AB. A previous study had already 
determined the stoichiometry between AXI and β-CDP to be 0.98:0.79 (Yan Lee, 2016). 
Although not comparable to the pseudo-order association constants, similar stoichiometries 
of 1:1 had previously been observed between 3AB, 2AB, BZ, MA and TR and monomeric β-
cyclodextrins (Iglesias, 2011; Pinto et al., 2005; Utsuki et al., 1993; Yang et al., 2013).  
The current results using β-CDP indicate that in the solution any one molecule of compound 
may interact with a single β-CDP unit differently to another molecule of this compound. This 
model represents an average of the overall complexes formed (Fernandes, Carvalho, Pereira 
da Costa, & Veiga, 2003), is multimodal, and therefore accounts for the multiple interactions 
(Hatsumi Aki et al., 2004). 
Figure 3: Determination of coefficient (A) ‘n’ and (B) ‘m’ for 3AB-β-CDP complexes, using 
various concentrations of β-CDP (circles=18mg/mL β-CDP, open circles=3mg/mL β-CDP, 
squares=7mg/mL β-CDP, triangles=12mg/mL β-CDP) 
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Table 2: Correlation coefficients, stoichiometries and association constants for 3AB, 2AB, BZ, 
MA and TR complexes with β-CDP 
 
a ‘n’ is the number of guest molecules 
b int is the intercept of the linear relationship 
c r is the correlation coefficient of the linear relationship 
d ‘m’ is the number of cyclodextrin molecules 
 
The stoichiometries obtained for 3AB, BZ, MA and TR may indicate partial inclusion of the 
compounds, whilst that obtained for 2AB may indicate it possesses multiple binding sites 
(Fernandes et al., 2003). This could imply either full or partial inclusion of each compound 
within the cavity of a single cyclodextrin unit, to form the most energetically favourable 
inclusion complex (Connors, 1997); and is expected to vary between each molecule of a single 
compound. 
The K’ values determined for 3AB were ≈9 times greater than those determined for MA. This 
may indicate that the differing sizes of the compounds affected their ability to have a 
complementary fit within the cavity of the cyclodextrin. The larger value of K’ would imply a 
better fit (Mennini, Bragagni, Maestrelli, & Mura, 2014), and would indicate fewer 2AB 
molecules remained uncomplexed in the final solution, when compared to MA. Each 
complexed compound formed greater K’ than had previously been observed between AXI and 
β-CDP (3.33g/L)(Yan Lee, 2016). 
Complex Conc. of   β-
CDP (mg/mL) 
na Interceptb rc md int r K’ 
(g/L) 
3AB/ β-CDP 12 0.74 -2.51 1 1.51 1.25 0.99 16.13 
2AB/ β-CDP 6 1.19 4.63 1 1.53 1.95 1 5.32 
BZ/ β-CDP 3 0.90 0.61 1 1.74 -0.29 1 31.50 
MA/ β-CDP 2.7 0.65 -3.90 1 0.85 -2.03 1 3.41 
TR / β-CDP 7.5 0.86 -0.41 0.99 1.53 0.93 0.99 16.73 
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Former studies have determined the dimensions of β-CDP monomer as ≈6.8Å wide and ≈7.8Å 
long (Iglesias, 2011)(Fig. 4). When comparing the sizes of this β-CD monomer to those 
previously reported for 3AB, 2AB and BZ (Yousef, Zughul, & Badwan, 2007), it is possible that 
(assuming one unit of β-CDP has the same dimensions as one unit of β-CD monomer) 2AB and 
3AB could be encapsulated diameter-wise within the cavity. The greater length that had been 
determined for BZ may prevent it from being completely included within the cavity (Iglesias, 
2011), although the results indicated partial inclusions with both BZ and 3AB (Table 2).  
Figure 4: Dimensions of the molecules of 3AB, 2AB and BZ, respectively 
Potential modes of complexation were considered. Past studies have suggested that the 
aromatic ring of BZ may be completely inserted within the cyclodextrin cavity (Pinto et al., 
2005; Voicescu & Bandula, 2015), in which the amine group on each of the three isomers 
could form hydrogen bonds with the alkoxide group of the cyclodextrin cavity, or 
alternatively, hydrogen bonds may form between the ester group of the isomer and –OH 
group of cyclodextrin (Iglesias, 2011). The former compound-cyclodextrin complexation has 
8.5Å 
5.0Å 5.8Å 
6.1Å 
5.1Å 
7.3Å 
BZ 2AB 3AB 
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only been reported in alkaline medium (Iglesias, 2011), but may occur for all three of the 
isomers with β-CDP. 
Although the sizes of TR and MA had not been measured, previous literature has proposed 
that the aromatic ring of either of these compounds could be encapsulated within the cavity, 
close to the primary hydroxyl groups on the cyclodextrin (Yang et al., 2013)(Fig. 5g, i), or its 
other aromatic ring included (Fig. 5h, j)(Utsuki et al., 1993). The latter inclusion had not 
previously been reported for MA. As the size of the β-CDP cavity can be altered through the 
addition of substituents (Baglole, Boland, & Wagner, 2005), or the polymer type (Letellier, 
Maupas, Gramond, Guyon, & Gareil, 1995). This would merely be theoretical for β-CDP, 
proving an indication of the mode of complexation. 
The K’ values obtained for β-CDP in our study were in the order of BZ>TR>3AB>2AB>MA. Such 
results could indicate that the position of the amine group, in respect to the ester group, could 
influence the strength of hydrogen bonds between the ester group on the guest and the OH 
on the H-3 proton of the cyclodextrin (Pescitelli, Bilia, Bergonzi, Vincieri, & Di Bari, 2010). 
Furthermore, the complexes observed are expected to be stronger than β-CD with β-CDP (di 
Cagno et al., 2014). When compared to the other compounds, the molecular weight is much 
greater for MA. The larger number of functional groups it posesses may therefore imply that 
more ‘bulky’ compounds form a lower K’. 
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Figure 5: Possible complex formations between a β-cyclodextrin unit and BZ (a, d), 2AB (b, e), 
3AB (c, f), MA (g, h) and TR (i, j), respectively 
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Larger association constants with β-cyclodextrin monomers have previously been 
determined, when compared to those with either α- or γ-cyclodextrin (Utsuki et al., 1993; 
Iglesias, 2011). The greatest association constant formed occurred between β-CD and BZ, 
supporting the induced-fit hypothesis (Utsuki et al., 1993). Moreover, use of cyclodextrin 
derivatives have influenced the strength of inclusion complexes. This has been observed in 
previous studies for MA, in which mono (6-ethylene-diamino-6-deoxy)-β-cyclodextrin was 
superior to hydroxylpropyl-β-cyclodextrin or sulfobutyl ether β-cyclodextrin (Yang et al., 
2013), and TR, in which a stronger complex was formed with ethylenediamine linked β-
cyclodextrin dimer (Tang et al., 2006), to that in native cyclodextrins (Utsuki et al., 1993). 
Although incomparable to these complex strengths, β-CDP is expected to form more stable 
complexes than either monomer. This is expected to involve both hydrogen bonds and van 
der Waals forces (Astray, Gonzalez-Barreiro, Mejuto, Rial-Otero, & Simal-Gándara, 2009), 
and, as mentioned in 5.1.2, may form multiple associations with each compound. 
Implications of multimodal associations have previously been proposed for nicardipine 
hydrochloride and with either β-cyclodextrin or hydroxyl-propyl-β-cyclodextrin. In this study 
both aromatic ends of the guest were able to be energetically-favourably included within the 
cavity to form a rigid inclusion complex, and the inclusion mode considered to be dynamic 
(Fernandes et al., 2003). 
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5.2.1.4 NMR analysis of compounds in the presence of cyclodextrin 
 
To provide further evidence of a complexation the proton and carbon NMR spectra were 
acquired and assigned for all compounds but MA and AXI. Job’s plot of continuous variation 
was firstly applied to BZ in the presence of 2-hydroxyl-propyl-β-cyclodextrin (2-HP-β-CD). 
Using equal concentrations of drug and 2-HP-β-CD, the ratio was varied from 0.1-1, and the 
change in chemical shift between each molar ratio concentration plotted. Duplicate 
measurements showed a maximum change in the chemical shift at 0.5-0.7, indicative of a 1:1 
stoichiometry (Baglole et al., 2005), alongside downfield drug chemical shifts (Fig. 6).  
Figure 6: Change in chemical shift of protons corresponding to the doublet ‘c’ in the aromatic 
region on BZ, acquired by 1H NMR, after varying the ratio of (A) 50.85mM BZ: 49.9mM 2-HP-
β-CD from 0-1, or (B) increasing the concentration of BZ from 1.91-10.52mM in 50mg/mL β-
CDP 
 
Variation of the drug concentration in a constant concentration of β-CDP also slightly shifted 
the guest protons downfield. The slightly narrower peaks and larger integral values (Fig. 6) 
were indicative of increasing free drug in the solution. These trends were additionally 
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observed for 2AB and 3AB. Altering the β-CDP concentration in constant concentrations of 
each drug was found to further support the data (broadening peaks, shifting the spectra 
downfield and reducing integral values). This supported the fluorescence data and suggested 
a similar interaction for all three compounds with β-CDP. 
5.2.2.0 Fluorescence study of the guest in HSA 
5.2.2.1 Fluorescence properties of the guest in HSA 
 
The excitation and emission spectra of the compounds: 3AB, 2AB, BZ, MA, TR and AXI have 
been recorded in water, in the presence of HSA (Chapter 4), and the effect of the protein on 
the fluorescence properties studied. 
When the compound was added to HSA the emission spectra of both the compound and the 
HSA red shifted. In addition, when compared to that recorded in the absence of the 
compound, the relative fluorescence intensity of HSA decreased (Chapter 4). 
Such decreases in the fluorescence intensity of proteins have been observed. It has been 
found that proteins contain fluorophores which are shielded from the solvent. In HSA, the 
specific fluorophore, a single tryptophan residue, contains a rigid indole group, allowing for it 
to fluoresce. This tryptophan is sensitive to the solvent and thus when its indole group forms 
hydrogen bonds in polar solvents the emission spectra is red shifted, whilst it is expected to 
blue shift when ‘folding’ in an apolar environment. Such effects can occur as the protein is 
constructed of a 3–dimensional network of amino acids which can break down in a process 
known as ‘unfolding’. The magnitude of such a shift depends on how exposed to the 
environment the fluorescent amino acid is, and thus the extent of the folding (Lakowicz, 
2006). The shifts in the HSA emission spectra were not necessarily similar to those reported 
106 
 
in previous studies. Blue shifts previously observed in the presence of MA or TR (Yue, Chen, 
Qin, & Yao, 2009; Tayyab, Zaroog, Feroz, Mohamad, & Malek, 2015) were attributed to the 
less polar environment surrounding the tryptophan residue (Yue et al., 2009). Furthermore, 
the absence of shifts in the presence of AXI were indicative of little change in the protein 
structure (Feroz, Mohamad, Lee, Malek, & Tayyab, 2015). Although each of these studies 
maintained a neutral pH throughout analysis, the difference in shifts, to those in the current 
study, may occur as a result of the different solvents used for the preparation of the stock 
solutions (Connors, 1997; Tayyab et al., 2016, 2015). 
In addition, the intensity of such protein fluorophores can decrease when they make contact 
with the quencher and are either returned to their ground state without emitting a 
fluorophore, or form a non-fluorescent complex. Such effects have previously been observed 
in studies between HSA and MA (Yue et al., 2009), AXI (Tayyab et al., 2016) and TR (Tayyab et 
al., 2015). 
Alternatively, it may be energetically favourable for the excited state amino acid residue on 
the HSA to lose an unpaired electron and donate it to an unpaired electron on the ground 
state guest compound. For such effects to occur the acceptor and donor protons must be 
within 7nm of each other, and the spectra of the two compounds should overlap (Xu et al., 
2017). 
The extent of the fluorescence decrease in HSA depends on the distance between the 
fluorophore and quencher. This information can be derived from Stern-Volmer plots 
(Lakowicz, 2006). 
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5.2.2.2 Effect of guest compound on HSA 
 
In the presence of increasing concentrations of HSA the fluorescence intensity was observed 
to decrease (Fig. 7, Annexe Fig. 18, Table 3). 
Monitoring the maximum emission wavelength corresponding to HSA, indicated that as the 
concentration of compound was increased, the fluorescence intensity of HSA decreased (Fig. 
7, Annexe Fig. 18, Table 3). Varying concentrations of HSA exhibited similar effects with each 
of the compounds. AXI in 0.0011ppb HSA was an exception. Increasing the concentration of 
AXI increased the emission spectra of HSA slightly. This effect had not been observed in the 
other concentrations of AXI used. Each HSA and AXI had an emission spectra at 343nm and 
394nm, respectively, implying this effect did not occur from an overlap in its spectra, and may 
instead occur from the formation of an AXI: HSA complex that is more fluorescent than HSA 
alone. Alternatively, this may indicate that in low concentrations of HSA the quencher may 
bind to a different site on the HSA. Such effects may occur when the HSA is relocated to a less 
polar environment (Lakowicz, 2006). Alternatively, the compound may bind to the protein 
and stabilise it through forming hydrogen bonds and hydrophobic forces, tightening the 
protein polypeptide chains, causing the helical structure of the protein to fold (Naik, Pawar, 
Tandel, & J, 2018). 
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Figure 7: (A) The effect of increasing concentrations of 3AB on the fluorescence excitation and 
emission spectra of 0.0014ppb human serum albumin. (B) 21.99ppb 3AB and 0.0014ppb HSA 
in water 
Isoactinic points were observed in each of the HSA-drug spectra of 3AB, 2AB, BZ and MA, TR, 
AXI at ≈350nm, ≈368nm, ≈329nm, ≈452nm, ≈370nm and ≈404nm, respectively (Fig. 7, Annexe 
Fig. 3). Such observations were indicative of the compound in its bound and unbound state 
at equilibrium, implying complexation (Yue et al., 2009). 
5.2.2.3 Interaction of HSA with guest compounds 
 
The decrease in intensity of fluorophores, quenched by other molecules, can be described 
using Stern-Volmer plots (Lakowicz, 2006). These can be used to determine the sensitivity of 
a fluorophore for a quencher. Data obtained from the quenching of HSA can therefore be 
treated using a Stern-Volmer plot (Eq. 10). 
𝐹0
𝐹
= 1 + 𝐾𝑆𝑉[𝑄]    Eq. 10 
In which F0= Fluorescence intensity of HSA in the absence of drug 
F= Fluorescence intensity of HSA in the presence of drug 
[Q]= concentration of drug 
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𝐾𝑆𝑉= Stern-Volmer quenching constant 
The gradient of the line of best fit corresponds to the Stern-Volmer quenching constant. In 
the current study this would describe how easily accessible the tryptophan residue (within 
the HSA) is to each of the studied compounds. The greater the constant, the more easily 
accessible the compound is (Lakowicz, 2006). 
Stern-Volmer plots were constructed by recording the fluorescence quenching of a constant 
concentration of HSA in increasing concentrations of each of the compounds. To see if the KSV 
of the compound was influenced by the HSA concentration, various concentrations of HSA 
were used, and a total of three Stern-Volmer plots constructed for each compound. The 
specific fluorophore concentrations were selected for their ability to initiate visible 
fluorescence intensity changes in the presence of the quencher. 
The concentrations of the compound used in the Stern-Volmer plots were similar for all 
compounds but AXI, which required greater concentrations. This observation may allow for 
the same stock solutions of each compound to be used for their rapid analysis in water, and 
their quenching effect on HSA. In the presence of 0.0011ppb HSA, AXI was observed to 
increase the fluorescence intensity of HSA. Such an effect was not observed with this 
quencher and the other investigated HSA concentrations. Stern-Volmer plots are only used 
for quenching effects, therefore a Stern-Volmer plot was not constructed for this specific 
sample and the results were instead fitting using a calibration graph (data in Chapter 6). 
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All other Stern-Volmer plots appeared to be linear with positive gradients, indicating the 
fluorescence intensity of HSA was decreased in a concentration dependent manner (Fig. 8, 
Annexe Fig. 19-24). 
Figure 8: Average Stern-Volmer plot of 0.00038ppb, 0.00058ppb and 0.00096ppb human 
serum albumin in increasing concentrations of TR 
 
The Stern-Volmer constants obtained were ≈1.9 x 10-3M-1, ≈5.6 x 10-3M-1, ≈6.3 x 10-3M-1, ≈3.5 
x 10-4M-1, ≈3.2 x 10-5M-1 and ≈6.2 x 10-4M-1, for 3AB, 2AB, BZ, MA, TR and AXI, respectively 
(Table 3). Lower KSVs determined for TR, when compared to BZ and its isomers, was 
characteristic of less exposure of the tryptophan residues to the compound. This indicated 
that quenching using TR was least efficient and may form a weak complex. 
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Table 3: Stern-Volmer quenching constants (KSV) observed in for 3AB, 2AB, BZ, MA, TR and AXI 
in water, in the presence of various concentrations of HSA 
Compound [HSA]/ Ppb KSV 
3AB 0.0014 0.0056 
0.0038 0.0019 
0.0067 0.0021 
2AB 0.00096 0.0046 
0.0048 0.0053 
0.0067 0.0056 
BZ 0.000048 0.0025 
0.0014 0.0057 
0.0048 0.0063 
MA 0.00048 0.035 
0.0014 0.015 
0.0067 0.018 
TR 0.00038 0.32 
0.00058 0.015 
0.00096 0.26 
AXI 0.0017 0.062 
0.0023 0.031 
0.0011 3.1 
 
KSV constants were similar for each compound, when in differing concentrations of HSA, with 
the exception of TR. In the presence of 0.00058ppb HSA lower constants were observed with 
this compound. Such an effect may indicate that using this smaller ratio of TR: HSA meant 
that less of the quencher was accessible to the fluorphore (Lakowicz, 2006). This would 
support the slight increases in the quenching constant that occurred for both TR and AXI in 
lower concentrations of HSA. 
The results were compared to those previously obtained in other studies. Larger Stern-Volmer 
constants recorded for AXI in earlier studies could be attributed to the much smaller ratio of 
HSA: AXI that had been used (Tayyab et al., 2016). Although TR and MA had been investigated 
in the presence of HSA, these studies used different methods (Tayyab et al., 2015) or 
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equations (Yue et al., 2009) to determine the KSV, preventing these results from being 
compared to the current ones. 
Although the lines of best fit on the Stern-Volmer plots differed, all studied compounds were 
able to bind to HSA. This may therefore enable their quantification in this protein, as will be 
outlined in the next chapter. 
5.3.0 Conclusion 
 
Using fluorimetry, the complexation between β-CDP and either 3AB, 2AB, BZ, MA, TR or AXI 
was characterised using the mathematical model previously proposed (Yan Lee, 2016). 
Integer values reported for the stoichiometries were attributed to partial or multiple binding 
sites on the β-CDP. Furthermore, pseudo-association constants determined had a strength in 
the order of BZ>TR>3AB>2AB>MA, respectively, implying various inclusions within the 
polymer cavity. Multimodal inclusions were hypothesised based on non-integer values for n 
and m. 
Further indication of an inclusion complex between the three isomer compounds and β-CDP 
was confirmed through NMR analysis. Downfield shifts, broadened peaks and lower integral 
values in the aromatic protons of 3AB, 2AB and BZ implied their encapsulation and an 
interaction with β-CDP. 
The effect of increasing concentrations of quencher on the fluorescence intensity of HSA was 
observed and Stern-Volmer plots constructed to provide information on the sensitivity of HSA 
for each compound. With the exception of 0.0011ppb HSA and AXI, the intensity of HSA was 
quenched in the presence of increasing quencher concentration. In this specific concentration 
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of HSA, AXI had the effect of increasing the fluorescence signal. Various KSV values for the 
other HSA concentrations and compounds used were obtained. 
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Chapter 6: Development, evaluation and application of novel 
quantification methods 
 
6.1.0    Introduction 
6.1.1    Introduction 
To improve the ability to detect the compounds selected for this study in biofluids and surface 
waters, two novel methods have been proposed. These methods aim to monitor the 
fluorescence spectra of the compounds in the presence of host molecules (β-CDP or HSA). 
Both methods have the potential to easily and rapidly provide quantitative determination of 
each compound. 
The initial method has proposed employing β-CDP to enable low concentrations of each 
compound to be analysed in buffered water and canal water. This study was based on the 
greater fluorimetric response of compounds that had previously been observed in the 
presence of cyclodextrin (Huang, He, Lu, Ge, & Guo, 2011), along with the superior 
complexing properties of its polymeric derivatives (Fülöp, Kurkov, Nielsen, Larsen, & Loftsson, 
2012). In such β-CDPs, evidence of a greater fluorescence intensity has previously been 
observed, when compared to that in monomers (Song et al., 2018). These effects were 
expected to occur as the polymeric derivative possessed several binding sites, allowing for 
multiple drug molecules to be complexed (Fülöp et al., 2012). A relationship between the 
fluorescence intensity of the complex, and the strength of the complex was additionally 
confirmed. Through the formation of these drug-β-CDP inclusion complexes, it was expected 
that the increase in fluorescence intensity could be utilised for the detection of the 
compounds. The accuracy and precision of the results was therefore evaluated, as it was 
expected that the method could enhance the amount of compound able to be detected. 
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The second method explores using the decrease in fluorescence intensity of HSA and Stern-
Volmer plots, to determine the concentration of compounds. As far as we are aware the 
literature does not provide an example of such a method. 
6.2.0    Results 
6.2.1.0 Analytical parameters in water, canal water and β-CD polymers 
 
It was stated in Chapters 4-5 that the fluorescence intensity signal of the selected compounds 
was increased in the presence of β-CDP. Furthermore, the stoichiometries and pseudo-
association constants of the complexes formed were calculated.  
To ensure precise analysis throughout the studies, calibration graphs were constructed in 
triplicate in both water and canal water, and in the absence and presence of β-CDP (Table 1, 
Annexe Fig. 8-9, Table 1-2). In the media the various graphs were linear, in the absence of β-
CDP, from as low as 13ppt, to as high as 58ppb, although this range was considerably reduced 
(≈1.34-8.93ppb) in the presence of excess β-CDP (Table 1). Expanded linearity ranges of 2AB, 
BZ, MA and TR were observed when water was used as a solvent, rather than canal water. 
This indicated that the relationship between the fluorescence intensity and concentration of 
the compounds occurred over a greater range when in a neutral pH environment, than in 
canal water. High regression coefficients and gradient Relative Standard Deviations (RSDs) 
demonstrated the accuracy and precision of the method, and low standard deviations showed 
it was repeatable (HMS, 2017). These results demonstrated that the contaminants within the 
matrix had a negligible effect that did not alter quantification in the real sample. 
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Table 1: Calibration results of 3AB, 2AB, BZ, MA, TR and AXI in water (W) and canal water (C), 
in the absence and presence of 25mg/mL, 12mg/mL, 12mg/mL, 4mg/mL, 12mg/mL and 
15mg/mL β-CDP, respectively (β-CDP in water, Cβ-CDP in canal water), n=number of 
calibration points, r=regression coefficient 
Compound Medium Calibration 
Slope Intercept n Linearity range/ ppb r 
3AB W 0.083 3.30 7 0.16-48.68 0.997 
CW 0.047 -0.0025 6 5.46-34.09 0.995 
β-CDP 0.79 2.59 6 0.65-3.03 0.996 
Cβ-CDP 8.17 7.15 6 0.65-3.25 0.997 
2AB W 6.69 1.40 7 0.013-8.19 0.999 
CW 6.68 1.21 7 0.013-8.19 0.999 
β-CDP 44.40 3.67 6 0.013-0.98 0.997 
Cβ-CDP 43.33 10.71 6 0.013-0.98 0.998 
BZ W 0.29 4.50 7 0.97-57.99 0.998 
CW 0.30 -1.05 7 1.61-48.37 0.997 
β-CDP 9.33 0.81 7 0.13-4.84 0.999 
Cβ-CDP 8.32 2.32 7 0.19-1.42 0.999 
MA W 0.48 1.02 7 0.10-2.52 0.998 
CW 0.51 0.51 7 0.10-2.52 0.998 
β-CDP 4.13 5.80 7 0.10-2.52 0.998 
Cβ-CDP 3.77 4.81 6 0.20-2.07 0.997 
TR W 0.093 2.38 7 0.75-14.93 0.994 
CW 0.10 2.25 6 0.75-6.47 0.990 
β-CDP 1.27 8.90 6 0.20-3.98 0.998 
Cβ-CDP 1.72 26.79 6 0.17-2.86 0.993 
AXI W 2.47 -6.38 6 0.30-3.01 0.996 
CW 0.92 -1.62 6 2.14-57.16 0.981 
β-CDP 2.57 50.62 6 0.15-1.21 0.997 
Cβ-CDP 0.42 83.35 6 1.34-8.93 0.992 
 
6.2.1.2  Recovery parameters 
 
In both water and canal water, good recoveries of the compounds (less than 15%) were 
recorded in triplicate (Table 2). Using three concentrations from across the linearity range, 
average recoveries of 92-108% were also obtained in the presence of β-CDP. This indicates 
the reliability of the method, and its precision for analysing all the analyte concentrations 
(Table 2). 
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Table 2: Recovery of 3AB, 2AB, BZ, MA, TR and AXI in approximately 25mg/mL, 12mg /mL, 
12mg/mL, 4mg/mL, 12mg/mL and 15mg/mL β-CDP, respectively, in water and canal water 
(+CAdd/ ppb=concentration added, ≠CDet/ ppb=average concentration detected,*%REC= average 
percentage recovery) 
Compound Water Canal water 
+CAdd/ ppb ≠CDet/ ppb *%REC +CAdd/ ppb ≠CDet/ ppb *%REC 
3AB 0.65 0.66 102.19 0.65 0.58 90.05 
1.62 1.52 93.64 1.95 1.87 96.06 
2.60 2.47 95.06 3.25 3.08 95.02 
2AB 0.41 0.39 97.11 0.013 0.013 97.52 
0.98 1.02 104.91 0.4 0.49 99.61 
0.098 0.092 93.20 0.82 0.85 104.47 
BZ 0.29 0.28 96.86 0.19 0.21 108.89 
1.93 1.79 92.70 1.93 1.90 96.36 
4.84 4.56 94.23 3.87 3.71 95.92 
MA 0.50 0.50 95.19 0.20 0.21 101.32 
1.51 1.59 107.29 1.01 1.10 108.50 
2.52 2.52 99.91 2.02 2.14 106.29 
TR 0.22 0.23 100.53 0.37 0.40 106.82 
0.49 1.58 106.00 1.49 1.56 104.56 
3.73 3.85 103.02 2.99 2.87 96.15 
AXI 0.90 0.89 96.59 1.34 1.27 94.84 
0.60 0.58 95.31 8.04 8.39 104.34 
1.21 1.14 94.28 10.72 10.23 95.46 
 
6.2.1.3    Robustness 
The robustness of the method was ensured by either employing a different fluorimeter, or 
varying the excitation and emission wavelengths used (±2-5nm). Using the AXI calibration 
graph equation from the previous study (Yan Lee, 2016), the average recoveries and 
associated % Relative Standard Deviations (RSDs) were determined in triplicate (Table 3, 
Annexe Table 6). Results obtained for either modification (recoveries ±15%) indicated the 
method was robust, and quantification of the compounds was not influenced by the changes 
made. 
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Table 3: Recovery and statistical results of 3AB, 2AB, BZ, MA, TR and AXI obtained in water on 
another fluorimeter (+CAdd/ ppb=concentration added, ≠CDet/ ppb=average concentration 
detected,*%REC= average percentage recovery, SD=standard deviation, RSD=relative standard 
deviation) 
 
Compound +CAdd/ ppb ≠CDet/ ppb *%REC SD RSD 
3AB 9.74 9.39 96.43 0 0 
29.21 26.49 90.69 0.76 7.76 
38.95 41.99 107.81 1.51 3.88 
2AB 0.098 0.10 104.15 0.0042 4.15 
0.49 0.52 106.33 0.028 5.33 
0.88 0.94 106.58 0.096 10.14 
BZ 3.87 4.19 108.28 0.17 3.97 
11.61 11.52 99.26 0.93 8.04 
17.42 18.86 108.28 0.58 3.06 
TR 14.80 7.92 106.03 0.54 6.81 
29.59 15.95 106.83 0.91 5.70 
5.92 2.84 95.15 0.15 5.26 
AXI 8.04 7.66 95.32 0 0 
9.32 10.25 109.93 0 0 
8.68 10.25 98.19 0 0 
 
 
6.2.1.4   Effect of pH 
 
To ensure the best detection of the samples, the pH of buffered water (pH≈7) was altered 
from pH=1.43 to 11.55, and the change in fluorescence intensity of 9.73ppb 3AB, 12.28ppb 
2AB, 9.67ppb BZ, 7.47ppb TR and 40.19ppb AXI investigated. Increasing the pH of 3AB, 2AB 
and AXI increased the fluorescence intensity, up to pH≈6, 4 and 5, respectively. Solvents with 
an alkalinity greater than pH≈10 decreased the intensity. A change in pH from pH=1.43 to 
11.55 had little effect on the fluorescence response of BZ, indicating a poor influence of the 
medium pH on the intensity of this compound. The most significant effect of pH was observed 
for TR, in which the greatest intensity was observed at pH=2.06-3.13, depleting from pH=4.34-
6.08, before increasing very slightly when the medium was made more basic (Fig. 1).  
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 Figure 1: Effect of pH on the maximum fluorescence intensity of 9.73ppb 3AB, 12.28ppb 2AB, 
9.67ppb BZ, 7.47ppb TR and 40.19ppb AXI 
 
Reproducible results were obtained and a maximum pH observed at a neutral pH for all 
observed compounds but TR (Fig. 1). This exhibited a greatest intensity at pH≈3. Media of 
neutral pH (pH=7) was used for all compounds with the exception of TR. This employed pH=4. 
The pH of the canal water directly from the source was measured as pH≈6.13, before dilution 
in water pH=7. This implied all the compounds analysed, with the exception of TR, could be 
detected in environments mimicking biofluids and surface waters, with minimal sample 
preparation, making the technique cost effective and rapid. 
6.2.2.0 Analysis of HSA containing samples 
6.2.2.1   Methodology for the analysis of HSA containing samples 
 
Processes that decrease the fluorescence intensity of fluorophores can occur from various 
interactions between the fluorophore and additional compounds. Regarding proteins, 
interactions with other compounds can occur from either collisional (Grigoryan, Grigoryan, & 
Ghazaryan, 2013) or static quenching (Yue, Chen, Qin, & Yao, 2009). Collisional quenching 
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occurs when the excited state fluorophore comes into contact with a quencher, causing the 
fluorophore to return to its ground state without emitting a photon. In contrast, static 
quenching occurs when the quencher and fluorophore form a non-fluorescent ground state 
complex.  
Such processes alter the fluorescence intensity of the fluorophore, and can be fitted to the 
Stern-Volmer plots previously mentioned (Chapter 4)(Eq. 1). These plots describe the 
relationship between the fluorescence intensity of a fluorophore in the presence and absence 
of various concentrations of a quencher. 
𝐹0
𝐹
= 1 + 𝐾𝑆𝑉[𝑄]    Eq. 1 
F0= Fluorescence intensity of HSA in the absence of the quencher 
F= Fluorescence intensity of HSA in the presence of the quencher 
[Q]= concentration of the quencher 
𝐾𝑆𝑉= Stern-Volmer quenching constant 
Assuming that the fluorophores are of equal accessibility to the quencher, linear Stern-Volmer 
plots would be expected. This is because both the number of collisions and complexes formed 
are proportional to the concentration of quencher. 
Differentiation between the quenching types can be achieved by measuring the fluorescence 
lifetime, or the effect of temperature on the gradients of the Stern-Volmer plots (KSV). An 
increase in temperature is likely to increase the rate of diffusion, resulting in more collisions 
and thus a higher quenching constant. Furthermore, depopulation of the excited state of the 
fluorophore is expected to decrease the fluorescence lifetime in such collisional processes. In 
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static quenching, however, the excited state fluorophore is not influenced by the quencher, 
and so the fluorescence lifetimes are unchanged. Higher temperatures might, however, affect 
the protein/ quencher complexes, causing them to dissociate. 
The number of collisions that can occur in collisional quenching processes is influenced by the 
quencher diffusion rate. KSV is therefore equal to the multiple of the fluorescence lifetime of 
the unquenched molecule (τ) and the bimolecular quenching constant of the reaction (kq). 
Previous chapters (4-5) have demonstrated that the fluorimetric spectrum of HSA both 
decreases and red shifts in the presence of the quencher, and its fluorophore is sensitive to 
the solvent (Chapter 4). 
Table 4: Stern-Volmer quenching constants (KSV) observed for 3AB, 2AB, BZ, MA, TR and AXI 
in water, in the presence of various concentrations of HSA, the shift in the emission spectra of 
HSA; n= number of calibration points and kq= the bimolecular quenching constant. 
Fluorescence lifetime of unquenched HSA (τ)= 2.8ns 
 
Compound [HSA]/ ppb KSV/ M-1 kq/ x 107 M-1s-1 n Shift observed/ nm 
3AB 0.0014 0.0056 0.20 10 23 
0.0038 0.0019 0.068 6 
0.0067 0.0021 0.075 6 
2AB 0.00096 0.0046 0.16 7 1 
0.0048 0.0053 0.19 7 
0.0067 0.0056 0.20 6 
BZ 0.000048 0.0025 0.089 6 Unobserved 
0.0014 0.0057 0.20 6 
0.0048 0.0063 0.23 7 
MA 0.00048 0.035 1.3 5 1 
0.0014 0.015 0.54 5 
0.0067 0.018 0.64 6 
TR 0.00038 0.32 11.43 7 13 
0.00058 0.015 0.54 5 
0.00096 0.26 9.3 5 
AXI 0.0017 0.062 2.2 5 1 
0.0023 0.031 1.1 5 
0.0011 N/A 
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Data from the quenching of HSA in the presence of increasing concentrations of each 
quencher compound were fitted to Stern-Volmer plots. To assess whether the quenching 
process was collisional or static, the values of KSV were studied in more detail. The bimolecular 
quenching constant limit for a diffusion-controlled quenching process is 1 x 1010 M–1s–1 (Nan, 
Hao, Ye, Feng, & Sun, 2019; Lakowicz, 2006),  and the previously measured fluorescence 
lifetime of tryptophan in water was 2.8ns (tryptophan being the main fluorophore in HSA). 
As can be observed (Table 4) the Stern-Volmer constants (gradient of linear line) did not 
exceed 0.32 M–1. The bimolecular quenching constants determined from the data (Table 4) 
were therefore no higher than 108 M–1s–1. This would therefore not rule out a collisional 
quenching process (Lakowicz, 2006). 
In addition, the absorbance spectra of the compounds was observed. An overlap between the 
absorbance spectra of each compound and the emission spectra of HSA, has been observed 
in earlier studies with HSA, and was indicative of radiationless energy transfer, and a static 
quenching process (Lakowicz, 2006). In addition, it was also noticed that high values of KSV 
were determined for AXI, MA and TR. This might indicate that these complexes were stronger 
than those formed with the other compounds. 
All of these data represent a good method to prove HSA/ drug association. 
It has previously been observed that LODs of 1.7ppb perampanel could be detected in human 
serum. Using capillary electrophoresis, the compounds were then able to be separated (Tůma 
et al., 2018). In addition, it has been observed that, when interacted, emission spectra, 
characteristic of each HSA and MA, were visible. As the concentration of MA was increased 
the peak of each the HSA and MA decreased and increased, respectively (Yue et al., 2009). 
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Based on the fact that when the interacted compounds were successfully separated the 
concentration of quencher could be quantified, and the fact that two peaks were observed 
by fluorimetry, an idea was constructed. Our working hypothesis proposes that as Stern-
Volmer plots relate the concentration of quencher to fluorescence intensity of fluorophore, 
they could be used to quantify an unknown concentration of quencher (the drug associated 
to the protein). 
The fluorescence intensity of a known concentration of HSA was therefore measured, in the 
absence and presence of increasing compound concentrations. The equation of the line of 
best fit from each linear plot was then used to determine F0/F. In a known concentration of 
HSA, once its fluorescence intensity had been collected, the concentration of the quencher 
could then be determined. 
6.2.2.2   Analytical parameters of HSA containing samples 
 
Using 5-10 concentrations (n) of each guest compound, the constructed Stern-Volmer plots 
were analytically assessed for their ability to detect the compounds. It was observed (Table 
5, Annexe Table 4) that the average linearity range of each 3AB, 2AB, BZ, MA and AXI, in the 
presence of HSA, spanned over a broad range of concentrations, particularly apparent for the 
three isomeric compounds. Different concentrations of fluorophore were observed to have 
different quenching constants, with RSDs less than 8%. The effect of fluorophore 
concentration is not, however, something often addressed. In addition, it does not feature in 
the Stern-Volmer equation, implying the quenching extent is fluorophore-concentration 
independent (Lakowicz, 2006). Although the observation had been commented on, the 
results of the study were considered with caution as no reasons, other than increased 
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sensitivity of the fluorophore, were given for this effect (Vaughns, 2007). The quenching of 
various concentrations of HSA by each compound was therefore investigated. 
High regression coefficients in each HSA concentration used, demonstrated that the method 
was accurate. Intercept values of 1, or close to 1, indicated each compound conformed to the 
Stern-Volmer equation (Castanho & Prieto, 1998). 
As previously mentioned (Chapter 5), an increase in the fluorescence intensity of 0.0011ppb 
HSA was observed in the presence of AXI. The difference between the emission wavelengths 
of each compound excluded the possibility of an overlap in its spectra, and was therefore 
attributed to the formation of an AXI: HSA complex that is more fluorescent than HSA alone. 
AXI hence may not be a quencher of HSA. Therefore, on this basis a calibration graph was 
constructed to quantify this particular complex. Regression coefficients and linearity ranges 
obtained (for AXI in 0.0011ppb HSA), of which were similar to those in the Stern-Volmer plots, 
evidenced its accuracy and implied the use of each plot to quantify the compounds. Through 
use of the individual Stern-Volmer equations each equation was applied and studied in more 
detail (Table 5, Annexe Table 4). 
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Table 5: Calibration results of 3AB, 2AB, BZ, MA, TR and AXI in water, in the presence of various 
concentrations of HSA; RSD= Relative Standard Deviation, r=correlation coefficient (applied 
data from Table 4) 
 
Compound Calibration 
[HSA]/ ppb Slope/ 
x 
108M-1 
Intercept Linearity 
range/ ppb 
r RSD/ % 
3AB 0.0014 0.0056 0.90 74.64-389.45 0.989 1.70 
0.0038 0.0019 0.96 97.36-486.82 0.992 3.30 
0.0067 0.0021 1.00 64.91-292.09 0.997 1.42 
2AB 0.00096 0.0046 1.00 49.12-212.86 0.990 7.29 
0.0048 0.0053 0.98 20.47-147.36 0.995 4.96 
0.0067 0.0056 1.00 24.56-122.80 0.997 4.20 
BZ 0.000048 0.0025 1.00 32.25-193.50 0.988 4.74 
0.0014 0.0057 0.95 24.19-225.75 0.986 2.17 
0.0048 0.0063 0.95 48.37-290.24 0.994 0.50 
MA 0.00048 0.035 1.06 1.14-20.45 0.985 1.01 
0.0014 0.015 1.00 5.11-23.86 0.992 3.91 
0.0067 0.018 1.00 2.88-18.31 0.995 3.95 
TR 0.00038 0.32 1.00 2.74-9.21 0.995 2.86 
0.00058 0.015 1.00 1.00-4.98 0.944 8.39 
0.00096 0.26 1.03 1.00-3.73 0.950 3.28 
AXI 0.0017 0.062 1.00 4.29-15.01 0.982 3.43 
0.0023 0.031 1.13 3.22-16.08 0.890 2.18 
0.0011 3.1 103.79 10.72-27.69 0.918 2.67 
 
Average recoveries obtained (less than 15%) (Annexe Table 5) for a range of compound 
concentrations in each of the three HSA solutions used in the study, indicated the method 
was both suitable and reliable for the detection of the selected compounds. 
6.2.3.0   Limits of detection and quantification 
 
To assess each method for its sensitivity and ability to quantify pharmaceutical preparations 
of drug (Elokely, Eldawy, Elkersh, & El-Moselhy, 2011), the detection limits of the compounds 
in the various media were evaluated. 
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With the exception of AXI, lower detection limits of the compounds were observed in the 
presence of canal water, than in water (Table 6). This medium had previously been 
determined to have a lower pH and different polarity to that of water (Chapter 4). This may 
play a role in the improved detection and suggest that slight protonation of the compounds 
may alter the fluorescence intensity, or influence the lifetime of the species (Lakowicz, 2006). 
As a result of such an observation, adjustment of the acidity or polarity of the drug matrix 
may enable enhancement of the detection limits of the compounds to their fullest. 
Table 6: Limit of detection and limit of quantification of 3AB, 2AB, BZ, MA, TR and AXI in water 
(W) and canal water (C), in the absence and presence of ≈25mg/mL, 12mg/mL, 12mg/mL, 
4mg/mL, 12mg/mL and 15mg/mL, respectively (β-CDP in water, Cβ-CDP in canal water), and 
in the specified concentrations of HSA 
Compound Medium Detection limit/ ppb Quantitation limit/ ppb 
3AB W 1.88 5.70 
C 1.54 4.67 
β-CDP 0.033 0.10 
Cβ-CDP 0.026 0.078 
0.0014 HSA 7.54 22.84 
0.0038 HSA 10.36 31.41 
0.0067 HSA 2.85 8.63 
2AB W 0.011 0.033 
C 0.0066 0.020 
β-CDP 0.0067 0.020 
Cβ-CDP 0.0085 0.026 
0.00096 HSA 5.25 15.90 
0.0048 HSA 1.84 5.59 
0.0067 HSA 3.18 9.63 
BZ W 0.50 1.53 
C 0.16 0.50 
β-CDP 0.023 0.071 
Cβ-CDP 0.050 0.15 
0.00048 HSA 4.75 14.38 
0.0014 HSA 4.16 12.60 
0.0048 HSA 3.74 11.33 
MA W 0.061 0.18 
C 0.034 0.10 
β-CDP 0.047 0.14 
Cβ-CDP 0.084 0.25 
0.0014 HSA 1.99 6.04 
0.00048 HSA 1.40 4.23 
0.0067 HSA 1.32 3.99 
TR W 0.45 1.37 
C 0.089 0.27 
131 
 
β-CDP 0.43 1.30 
Cβ-CDP 0.0030 0.0092 
0.00038 HSA 0.37 1.12 
0.00058 HSA 0.19 0.58 
0.00096 HSA 0.33 1.01 
AXI (3 hours) W 0.062 0.19 
C 2.38 7.22 
β-CDP 0.17 0.52 
Cβ-CDP 0.91 2.75 
AXI HSA 0.0017 HSA 1.01 3.13 
0.0023 HSA 2.70 8.19 
AXI (HSA calibration) 0.0011 HSA 31.57 95.67 
 
In the presence of β-CDP, the detection limits of 3AB, BZ and TR were enhanced in both canal 
water and water, up to 59.2, 21.7 and 29.7 times, respectively. Although not as substantial, 
β-CDP elevated the intensity of 2AB and MA in water 1.6 times and 1.3 times, respectively, 
and that of AXI in canal water 2.6 times. 
In the presence of HSA, each of the compounds were able to be detected. Increasing the 
concentration of HSA produced a greater fluorescence signal for BZ and MA and thus, lower 
detection limits of the drug could be determined. It was, however, observed that lower LODs 
of both TR and AXI were able to be detected in the presence of the protein, than in its absence. 
6.2.4.0 Advantages and limitations of the developed methods 
 
The first method utilised β-CDP to enhance the detection of all studied compounds, up to 59 
times. Results from the current study were compared to fluorimetric results from previous 
studies with β-CD monomers. In previous studies 3.2ppb TR was able to be detected in the 
presence of ethylenediamine linked β-cyclodextrin dimer (Tang, Liang, Tong, & Li, 2006), and 
30ppb BZ was detected by chemiluminescence, gaining little, if any, fluorescence 
improvements from β-cyclodextrin (X. R. Zhang, Baeyens, Der Weken, Calokerinos, & Imai, 
1995). Concentrations of all of these compounds (<1ppb) were able to be detected with β-
CDP in the current study. 
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There were, however, studies in which no better detection to that observed with monomeric 
cyclodextrins was achieved with β-CDP. 0.0096ppb MA had previously been detected using 
ethyl substituted β-cyclodextrin (Huang et al., 2011), 3.5 times lower than results from the 
current study. Such an observation would support results from previous studies, suggesting 
that each compound was included within the cyclodextrin cavity to form the most 
energetically stable complex (Perez, Jaime, & Sanchez-Ruiz, 1995). Aside from MA, all 
compounds studied had improved detection limits in the presence of β-CDP and water, when 
compared to those in its absence. The lowest concentrations of MA could be detected in canal 
water, in the absence of β-CDP, implying its intensity was influenced by the solvent. Although 
improvements in the fluorescence intensity of MA, and a complex were still observed, these 
were lower than those of the other compounds. It was for this reason that it was not 
considered cost beneficial to carry out all validation studies for this compound.  
An interaction between the compounds and HSA had previously been evidenced for MA, TR 
and AXI (Tayyab et al., 2016; Tayyab, Zaroog, Feroz, Mohamad, & Malek, 2015; Yue et al., 
2009), decreasing the fluorescence intensity of the compounds. This decrease was attributed 
to a static quenching process for MA and AXI, as a decrease in binding strength was observed 
at elevated temperatures, however, no comment on the detection of the compounds was 
made (Yue et al., 2009). 
The latter method using HSA enabled each of the investigated compounds to be determined, 
quantifying concentrations as low as 0.58ppb. It was observed that the LODs of TR were lower 
than those previously obtained in plasma and urine (200ppb and 2000ppb, respectively using 
HPLC)(Slobodzian, Hsieh, & Bayne, 1985), human plasma (500ppb through HPLC)(Tadano, 
Yuhki, Aoki, Miyazaki, & Arita, 1985), rat plasma and brain tissue (LLOQ of 53.50ppb using LC-
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MS/MS)(Yang et al., 2018). In addition, LODs were lower for MA than had previously been 
detected in rat plasma (557ppb through HPLC coupled to MS/MS)(Mehta, Shah, Lohidasan, & 
Mahadik, 2015). 
The current method did not necessarily improve detection of the compounds in biological 
samples. Lower concentrations had previously been detected in rainbow trout fillet tissue for 
BZ using RP-HPLC (6ppb)(Meinertz, Stehly, Hubert, & Bernardy, 1999), and in rat serum 
(7.1ppb in by UPLC-ES-MS/MS)(Hou et al., 2010), and lower LODs were achieved for MA using 
HPLC coupled to MS/MS (5.74ppb in rat plasma)(Sheng et al., 2014) or HPLC (1ppb in rat 
plasma or eyes)(Hou et al., 2010)(0.0004ppb and 0.0001ppb in rat blood and eyes, 
respectively)(H. Zhang et al., 2010)(0.0005ppb in rat blood)(Lai, Lin, Lin, & Tsai, 2003). Our 
method did, however, have the advantages of rapidity and simplicity, and relatively good 
performance. 
6.3.0  Conclusion 
 
The previously proposed fluorimetric method for the determination of 3AB, 2AB, BZ, MA, TR 
and AXI in water and canal water, in both the presence and absence of β-CDP was validated 
as linear, accurate and robust under the conditions outlined. All compounds were evaluated 
for successful detection in β-CDP when subject to various quality control procedures. 
Although not true of all the compounds, the compounds often had superior detection limits 
in this β-CDP to the other cyclodextrins previously investigated. In addition, the greatest 
enhancement in detection was able to be achieved for the majority of compounds when using 
a pH similar to that of biofluids and surface waters.  
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Furthermore, a method was able to be proposed and tested for the detection of the drugs in 
HSA, in which Stern-Volmer quenching plots were utilised. This proved to be a novel way in 
which to detect the compounds studied in HSA, with successful detection being achieved. 
Lower detection limits were obtained for TR and MA, than those previously reported in 
biofluids, and in the presence of HSA the compounds were able to be detected (≤10ppb). 
Both methods were found to be accurate and robust, with the ability to detect low 
concentrations of the drugs in both canal water and water, in the presence and absence of β-
CDP, and to detect concentrations of the compounds in the presence of HSA. 
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Chapter 7: Photokinetic study of TR in ethanol  
 
7.1.0 Introduction 
7.1.1 Introduction 
 
Tranilast (TR) (N-(3,4-dimethoxycinnamoyl) anthranilic acid) is a poorly soluble (Darakhshan 
& Pour, 2015) anti-allergic drug, used to treat bronchial asthma, atopic rhinitis and atopic 
dermatitis. It has been found to photodegrade under UV-A/ B irradiation (Kawabata, 
Yamamoto, Debari, Onoue, & Yamada, 2010) and fluorescent light (Naohide Hori et al., 1999) 
to form reversible cis-isomer and irreversible dimer products (Hirayama, Utsuki, & Uekama, 
1991). 
The degradation of the trans-isomer in aqueous solution has previously been quantified, 
forming 6.2% cis-isomer, and 62.5% dimer products (Naohide Hori et al., 1999). In studies 
measuring its degradation rate, the data was treated using zero-order kinetics (Utsuki, 
Hirayama, & Uekama, 1993). 
Our group has previously reported a new method for the elucidation of photokinetics, which 
has been used and applied to describe unimolecular AB(1Φ) and reversible AB(2Φ) 
photodegradation reactions. The model can be used to determine the quantum yields of the 
photoreaction and overcomes the limitations of thermal reaction orders (Maafi & Lee, 
2015a). The aim of the current study is to investigate the dependency of quantum yields on 
irradiation wavelength and demonstrate the potential use of TR in actinometry. 
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7.1.2.0 The Mathematical framework 
7.1.2.1 𝚽-order kinetics for non-isosbestic irradiation 
 
As mentioned (Chapter 1), the use of zero-, first- and second- order cannot accurately 
describe photochemical reactions. The recently proposed approach, based on Φ-order 
kinetics, can therefore be used to describe the time evolution of the concentration of the 
species through one of the related quantities, such as the medium absorbance. Φ-order 
kinetics can be applied when the medium is exposed to non-isosbestic and monochromatic 
irradiation at a constant temperature. This model overcomes issues such as multiple 
interpretations of data, allows for the quantum yields to be determined, can uniquely 
characterise photokinetic data and can allow for the drug compound to be utilised as an 
actinometer. 
The model equations for Φ-order kinetics which describe the photoreversible transformation 
of the native species (A) to its photoproduct (B) can be characterised by the forward 
(Φ𝐴𝐵
𝜆𝑖𝑟𝑟) and reverse (Φ𝐵𝐴
𝜆𝑖𝑟𝑟) quantum yields. Species A should be continuously irradiated with 
a monochromatic beam (where the non-isosbestic wavelength is 𝐼𝜆𝑖𝑟𝑟). Both species A and B 
should absorb different amounts of incident light (𝑃𝜆𝑖𝑟𝑟) and therefore have different 
absorptivities (ε), of which neither are equal to zero (𝜀𝐴
𝜆𝑖𝑟𝑟 ≠ 𝜀𝐴
𝜆𝑖𝑟𝑟 ≠ 0). 
Eq. 1 can be applied when the absorbance of the medium has been measured at the 
observation wavelength, as opposed to the irradiation wavelength. 𝐼𝜆𝑖𝑟𝑟  is the excitation light 
across the medium, whereas 𝐼𝜆𝑜𝑏𝑠  is the optical path length of the light within the sample. 
Such values may therefore differ to one another. 
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The coefficients: 𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(𝑡), 𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(0),  𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞), 𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(0),  𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(∞) are therefore the total 
absorbances of the medium (at 𝐼𝜆𝑜𝑏𝑠) at: reaction time (t), at the initial time (0) and the 
photostationary state (pss (t=∞)). At a given irradiation wavelength the reaction is monitored 
at either a specific observed wavelength (𝜆𝑖𝑟𝑟/𝜆𝑜𝑏𝑠) or the same wavelength (𝜆𝑖𝑟𝑟/𝜆𝑖𝑟𝑟). It is 
assumed that no by-products are formed: 
𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(𝑡) = 𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞) +
𝐴𝐴
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(0)−𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞)
𝐴𝐴
𝜆 𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(0)−𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(∞)
 ×  
𝐼𝜆𝑜𝑏𝑠
𝐼𝜆𝑖𝑟𝑟
 ×  𝑙𝑜𝑔
[
 
 
 
1 +
(
 10
[(𝐴𝐴
𝜆𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(0)−𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(∞)) × 
𝐼𝜆𝑖𝑟𝑟
𝐼𝜆𝑜𝑏𝑠
]
− 1
)
 × 𝑒−𝑘
𝜆𝑖𝑟𝑟 
𝐴⇌𝐵    × 𝑡
]
 
 
 
    Eq. 1 
The exponential factor, 𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟 , representing the overall rate-constant can be analytically 
represented by: 
𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟 = (Φ𝐴→𝐵
𝜆𝑖𝑟𝑟 × 𝜀𝐴
𝜆𝑖𝑟𝑟 + Φ𝐵→𝐴
𝜆𝑖𝑟𝑟  ×  𝜀𝐵
𝜆𝑖𝑟𝑟) × 𝐼𝜆𝑖𝑟𝑟 × 𝐹𝜆𝑖𝑟𝑟(∞) × 𝑃𝜆𝑖𝑟𝑟 = 𝛽𝜆𝑖𝑟𝑟 × 𝑃𝜆𝑖𝑟𝑟  
          Eq. 2 
Where Φ𝐴→𝐵
𝜆𝑖𝑟𝑟 and Φ𝐵→𝐴
𝜆𝑖𝑟𝑟  are the forward and reverse quantum yields of the reaction 
photochemical stages at the specific irradiation wavelength (𝐼𝜆𝑖𝑟𝑟), 𝑃𝜆𝑖𝑟𝑟 is the radiant power 
(in einstein dm-3), 𝛽𝜆𝑖𝑟𝑟 is a proportionality factor between the overall rate-constant and the 
radiant power, and 𝐹𝜆𝑖𝑟𝑟(∞) is the time-independent photokinetic factor which can be 
expressed as: 
𝐹∞
𝜆𝑖𝑟𝑟 =
1−10 
−(𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(∞) × (𝐼𝜆𝑖𝑟𝑟/
𝐼𝜆𝑜𝑏𝑠))
(𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(∞) × (𝐼𝜆𝑖𝑟𝑟/𝐼𝜆𝑜𝑏𝑠)
       Eq. 3 
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7.1.2.2 Elucidation method of TR photoreversible reaction 
 
The three unknown parameters (photochemical forward and reverse quantum yields and 
absorption spectrum of product B) cannot be determined using the data obtained from Eq. 1. 
An elucidation method can therefore be accomplished in three stages. 
Firstly, the photodegradation reaction under monochromatic irradiation, at a non-isosbestic 
wavelength, can be monitored at a specific wavelength by HPLC. The concentration of the 
photoproduct can be determined from: 𝐶𝐵(∞) = 𝐶(∞) − 𝐶𝐴(∞). 
The absorption spectrum of the photoproduct (𝜀𝐵
𝜆𝑖𝑟𝑟) can then be reconstructed using the 
following equation: 
ε𝐵
𝜆𝑖𝑟𝑟 =
𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞)− 𝐶𝐴(∞) × ε𝐴
𝜆𝑖𝑟𝑟  × 𝐼𝜆𝑜𝑏𝑠   
𝐶(0)−𝐶𝐴(∞) × 𝐼𝜆𝑜𝑏𝑠
     Eq. 4 
If ε𝐵
𝜆𝑖𝑟𝑟  is deduced, the reaction quantum yields at any irradiation wavelength (and thus the 
absolute values of Φ𝐴→𝐵
𝜆𝑖𝑟𝑟  and Φ𝐵→𝐴
𝜆𝑖𝑟𝑟  at any non-isosbestic or isosbestic wavelengths) can be 
determined. Φ𝐴→𝐵
𝜆𝑖𝑟𝑟  can be established using: 
Φ𝐴→𝐵
𝜆𝑖𝑟𝑟 =
𝜐0(𝑐𝑙𝑑.)
𝜆𝑖𝑟𝑟/𝜆𝑜𝑏𝑠
(𝜀𝐵
𝜆𝑜𝑏𝑠−𝜀𝐴
𝜆𝑜𝑏𝑠) × 𝐼𝜆𝑖𝑟𝑟× 𝑃𝜆𝑖𝑟𝑟× 𝐹0
𝜆𝑖𝑟𝑟  × 𝐶0
     Eq. 5 
Using the initial velocity (𝜐0
𝜆𝑖𝑟𝑟/𝜆𝑜𝑏𝑠) as obtained from: 
𝜐0
𝜆𝑖𝑟𝑟/𝜆𝑜𝑏𝑠 =
𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(0)−𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞)
𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(0)−𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(∞)
× 
𝐾𝐴⇌𝐵(𝑚𝑜𝑑.)
𝜆𝑖𝑟𝑟
 𝐿𝑛(10) × 𝐼𝜆𝑖𝑟𝑟 /𝐼𝜆𝑜𝑏𝑠   
 (10(𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑖𝑟𝑟(∞)−𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑖𝑟𝑟 (0) × (𝐼𝜆𝑖𝑟𝑟/𝐼𝜆𝑜𝑏𝑠) −
1)          Eq. 6 
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By fitting the HPLC data to the concentration profiles 𝐾𝐴⇌𝐵
𝜆𝑖𝑟𝑟  can be determined, overcoming 
the requirement for an isosbestic irradiation wavelength to be used. This value can be used 
to determine the final unknown, Φ𝐵→𝐴
𝜆𝑖𝑟𝑟  
Φ𝐵→𝐴
𝜆𝑖𝑟𝑟 =
1
𝜀𝐵
𝜆𝑖𝑟𝑟
(
𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟
𝐼𝜆𝑖𝑟𝑟× 𝑃𝜆𝑖𝑟𝑟 ×  𝐹𝜆𝑖𝑟𝑟(∞)
) − Φ𝐴→𝐵
𝜆𝑖𝑟𝑟  ×  𝜀𝐴
𝜆𝑖𝑟𝑟    Eq. 7 
The equilibrium constant 𝐾𝐴⇌𝐵
𝜆𝑖𝑟𝑟  for such non-isosbestic irradiations is equal to the ratio of the 
quantum yield values at 𝐼𝜆𝑖𝑟𝑟: 
𝐾𝐴⇌𝐵
𝜆𝑖𝑟𝑟 =
𝐶𝐵(∞)
𝐶𝐴(∞)
=
Φ𝐴→𝐵
𝜆𝑖𝑟𝑟  × 𝜀𝐴
𝜆𝑖𝑟𝑟  
Φ𝐵→𝐴
𝜆𝑖𝑟𝑟  × 𝜀𝐵
𝜆𝑖𝑟𝑟
        Eq. 8 
The quantum yields and absorption coefficients at any irradiation can then be used to 
determine the 𝐾𝐴⇌𝐵
𝜆𝑖𝑟𝑟  of the reaction for the selected irradiation wavelengths. 
The value of 𝐾𝐴⇌𝐵
𝜆𝑖𝑟𝑟  is independent of the initial concentration of the species. Lower 
concentrations than those used for the HPLC experiment can therefore be used for 
spectroscopic measurements.  
7.2.0 Results 
7.2.1  Photodegradation of TR in ethanol 
 
The electronic absorption spectrum of TR in ethanol can be categorised by broad absorption 
spectrum with two main absorption regions from 200-250nm and 260-400nm. No absorbance 
of the compound or its photoproducts was observed outside the UV region. The main 
maximum peaks are at 336nm and 200nm, with the former having a higher absorbance 
intensity. 
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Upon UV light exposure of the compound in ethanolic solution, decreases in the 260-400nm 
absorption region were observed, along with an increase in the region 200-230nm. The 
presence of isosbetic points indicates the reaction proceeds smoothly (Fig. 1). 
 
Figure 1: Evolution of the electronic absorption spectra of 1.53 x 10-5M TR, in ethanol, 
subjected to a continuous irradiation with a 330nm monochromatic beam, respectively. The 
arrows indicate the direction of the evolution of absorption maxima during photoreaction. The 
arrows and vertical lines represent the direction of the absorbance change, and the isosbestic 
points, respectively 
 
As can be observed, the photodegradation rate of the first stage of the TR conversion (trans 
⇌ cis) is greater than that of the second stage (Fig. 2). Closer observation of the first stage of 
the process indicated that after ≈1,500 seconds a plateau in the absorbance change was 
reached. Such an observation would indicate that this trans ⇌ cis conversion had finished 
before a second photoreaction began. The variation in photodegradation rate between these 
two processes, and the fact that the second photoreaction process was slower than that of 
the first stage, and did not reach a plateau, would indicate that for more reliable 
determination of the 𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟  values, only the first section of the photodegradation should be 
considered (trans ⇌ cis)(Maafi & Lee, 2015b). 
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Figure 2: Effect of irradiation on the photodegradation traces of TR (1.53 x 10-5M), in 
ethanol, subjected to continuous irradiation with a 330nm monochromatic beam 
 
Such observations would suggest various π→π* electronic transitions in the aromatic ring. As 
can be observed (Fig. 2) the time it took for TR to photodegrade was >25,000s.  
 
𝑡𝑟𝑎𝑛𝑠
Φ𝐴𝐵
𝜆𝑖𝑟𝑟  
⇄
Φ𝐵𝐴
𝜆𝑖𝑟𝑟  
𝑐𝑖𝑠 ⟶ 𝑋         Eq. 12 
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7.2.2  Modelling of TR photodegradation kinetics 
 
Ethanolic solutions of TR were exposed to different irradiation wavelengths from various 
regions of its absorption spectra (245nm, 265nm, 290nm, 300nm, 310nm, 320nm, 330nm, 
340nm, 350nm) and the photodegradation kinetics were studied. The variation in the 
absorbance was recorded at a specific observation wavelength. Successful fitting of the 
experimental traces to the Φ-order kinetics model confirmed it was a good description of the 
data (Fig. 3) 
Figure 3: Photokinetic profiles of TR in ethanol (1.53 x 10-5M) obtained at different irradiation 
wavelengths (λirr=245, 265, 290, 300, 310, 320, 330, 340 and 350nm) and observed at 
λobs=330. The circles represent experimental data, whereas the solid lines represent the fitting 
of the traces with Eq. 1 
 
Degradation of TR was more rapid at longer wavelengths, in the range 320nm-350nm, than 
at shorter wavelengths (Table 1). 
Such an observation could indicate that the photodegradation of TR spans the UV-A spectral 
range. There did not appear to be a relationship between the determined 𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟  values and 
the 𝑃𝜆𝑖𝑟𝑟 values, each independent of the other (Table 1). Such an observation would 
demonstrate that the rate of TR degradation was irradiation wavelength-specific and 
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conforms to the Φ-order kinetics model. This demonstrates the advantage of using Φ-order 
kinetics over classical thermal reaction equations, and thus that the same experiment 
performed in different conditions, or using a different concentration of compound, would 
give different results. This would cause difficulties if using thermal reaction orders. 
Table 1: Overall rate-constants, spectroscopic and kinetic parameters of TR for a set of 
monochromatic irradiation wavelengths in ethanol at 22°C 
𝝀𝒊𝒓𝒓/nm 𝑨𝒕𝒐𝒕
𝝀
𝒊𝒓𝒓/𝟑𝟑𝟎(𝟎) 𝑷𝝀𝒊𝒓𝒓x 10
7/ Einstein s-1 
dm-3) 
𝑨𝒕𝒐𝒕
𝝀𝒊𝒓𝒓𝝀𝒊𝒓𝒓(∞) 𝑲𝑨⇌𝑩
𝝀𝒊𝒓𝒓 /s-1 
350 0.50 9.11 0.341 0.0074 
340 0.50 6.68 0.436 0.0065 
330 0.51 5.33 0.454 0.0042 
320 0.52 4.62 0.399 0.0046 
310 0.50 4.03 0.313 0.0035 
300 0.51 4.20 0.283 0.0035 
290 0.51 3.08 0.241 0.0025 
280 0.54 3.63 0.192 0.0017 
265 0.51 5.19 0.145 0.00082 
245 0.50 4.17 0.318 0.00042 
 
 
 
7.2.3  HPLC monitoring of TR photodegradation kinetics 
 
HPLC monitoring of the monochromatic wavelength of TR at 330nm showed the presence of 
the parent compound and one photoproduct (Annexe Fig. 25). The concentration profiles of 
these isomers determined in the specific conditions indicated that at the photostationary 
state (Pss) ≈73% of the compound remained (trans-TR), whereas the remainder had been 
converted to the cis-isomer (Fig. 4). 
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Figure 4: (A) Evolution of TR concentration (1.53 x 10-5M) over the period of photodegradation 
and (B) the formation of its photoproduct. The reaction was monitored by HPLC under 
continuous irradiation from a monochromatic beam at 330nm (𝑃𝜆330=5.33 x 10
-7 einstein s-1 
dm3) 
 
The HPLC data was successfully fitted to the first-order equation for a photoreversible 
reaction (Eq. 1), and the rate of the overall photodegradation  𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟  was acquired as the fitting 
parameters (Eqs. 5-7). This would therefore allow for the forward and reverse quantum yields 
at the non-isosbestic wavelength to be determined (Table 2). The plateau observed in the 
HPLC data (between the trans and cis isomers) occurred at the same stage as in the 
absorbance traces (25*60=1500s), further supporting the absorption results and providing 
further evidence of multiple photoreactions. Such an observation would account for the 
changes observed in the absorption spectra (Fig. 1). 
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7.2.4  Elucidation of absorption spectra 
Eq. 4 could then be used to acquire the value of ε𝐵
𝜆𝑖𝑟𝑟. By applying Eq. 4 to TR, and using the 
spectrum of the medium at pss (∞), data from the HPLC experiment, and the value of the 
equilibrium constant, 𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟 , the full spectrum of the photoproduct could be reconstructed. 
The electronic absorption spectra of the two isomers overlap (E-, Z-). The absorption 
coefficient of the Z-isomer was lower in the regions 270-400nm, and 240nm-250nm, and 
higher from 200-230nm and 250-280nm than that of the E-isomer (Fig. 5). 
Figure 5: Electronic absorption spectra (absorption coefficient units) of E-(native) and Z-
(photoproduct) TR 
 
7.2.5  TR photodegradation quantum yields 
 
From knowledge of the photoproduct absorption coefficients, the absolute values of the 
quantum yields for both the cis and trans isomer phototransformations can be obtained for 
various wavelengths, using Eqs. 5 and 6 (Table 2). It can be observed that the quantum yield 
for the A→B transformation of TR increases with increasing irradiation wavelength (Table 2) 
and is less sensitive to wavelengths from 290-350nm. These values were consistently lower 
than those for the reverse reaction, in which 7 times increase in the quantum yields were 
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obtained from 290-350nm. The greatest variation in Φ𝐴→𝐵
𝜆𝑖𝑟𝑟  was observed from 245nm-290nm, 
in which the values of Φ𝐴→𝐵
𝜆𝑖𝑟𝑟  increased 5.5 times (Table 2). The results would suggest that the 
cis→trans quantum yields were 2 times less efficient than that of the trans→cis. 
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Table 2: Quantum yields, overall rate –constant, proportionality factor and radiant power values for TR photodegradation reactions under 
various monochromatic irradiation wavelengths
𝝀𝒊𝒓𝒓(nm) 𝑷𝝀𝒊𝒓𝒓x 
107/ 
Einstein 
s-1 dm-3 
𝑨𝒕𝒐𝒕
𝝀 𝒊𝒓𝒓
𝝀𝒊𝒓𝒓(∞) 
𝒌𝑨⇌𝑩
𝝀𝒊𝒓𝒓  𝝊𝟎
𝝀𝒊𝒓𝒓/𝝀𝟑𝟑𝟎  x 105/ 
s-1 
𝛆𝑨
𝝀𝒊𝒓𝒓/ M-1 𝛆𝑩
𝝀𝒊𝒓𝒓/ M-1 𝑭𝝀𝒊𝒓𝒓(0) 𝚽𝑨→𝑩
𝝀𝒊𝒓𝒓  𝚽𝑩→𝑨
𝝀𝒊𝒓𝒓  
245 0.326 0.405 0.00045 -0.38 18596.81 17135.70 1.19 0.0080 ± 0.30 0.017 ± 0.65 
265 0.131 0.507 0.0011 1.40 7136.29 9408.13 1.73 0.026 ± 0.015 0.044 ± 
0.025 
290 0.247 0.432 0.0029 -1.93 16357.73 14277.49 1.37 0.044 ± 0.26 0.19 ± 1.10 
300 0.295 0.330 0.0038 -4.38 19333.85 16543.82 1.26 0.050 ± 0.11 0.15 ± 0.34 
310 0.330 0.295 0.0039 -6.21 22091.30 18415.90 1.18 0.054 ± 0.073 0.15 ±  0.21 
320 0.432 0.247 0.0048 -14,63 28027.83 21412.0 1.00 0.055 ± 0.13 0.16 ± 0.36 
330 0.51 0.193 0.0055 -26.72 33273.85 23552.46 0.89 0.057 ± 0.27 0.15 ± 0.73 
340 6.68 0.131 0.0065 -39.23 3334.25 22365.76 0.89 0.058 ± 0.039 0.13 ± 0.075 
350 9.11 0.326 0.0078 -43.27 27192.99 17539.61 1.04 0.058 ± 0.13 0.12 ± 0.27 
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In addition, there is a linear correlation between the irradiation wavelengths and the ratio of 
quantum yields (Φ𝐵→𝐴
𝜆𝑖𝑟𝑟 /Φ𝐴→𝐵
𝜆𝑖𝑟𝑟 ). Such an observation would not support the quantum yield 
ratio predicted by Kasha’s rule, which states that the quantum yield is not dependent on the 
wavelength. This has previously been confirmed by our group (Maafi & Lee, 2015b), and 
would evidence the necessity for monochromatic light to be used for more accurate 
determination of quantum yields.  
The evolution of the quantum yields with irradiation wavelengths (Eq. 13 and 14) can be 
decribed by a sigmoid pattern to represent the forward quantum yield values, and a triangular 
pattern to represent those of the reverse (Fig. 6): 
 
Φ𝐴→𝐵
𝜆𝑖𝑟𝑟 = 0.0055 +
0.052
1+12 × 𝑒−0.1(𝜆𝑖𝑟𝑟−254)
   Eq. 13 
 
Φ𝐵→𝐴
𝜆265−290= 0.0057 × 𝜆𝑖𝑟𝑟 − 1.4618   Eq. 14 
Φ𝐵→𝐴
𝜆290−350= 0.0011 × 𝜆𝑖𝑟𝑟 − 0.5055    
 
This can allow for the values of the quantum yield to be determined at any irradiation 
wavelength, using the fewest experimental results. The linear relationship between the 
determined quantum yield and the calculated experiment (Fig. 6), confirmed the 
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effectiveness of the technique for the determination of the quantum yields at wavelengths 
from 254-350nm, through use of the appropriate equation (Eq. 13-14, Fig. 6). 
Figure 6: Sigmoid and triangular patterns (Eq. 13-14) obeyed by the experimental quantum 
yield values (𝛷𝐴→𝐵
𝜆𝑖𝑟𝑟  and 𝛷𝐵→𝐴
𝜆𝑖𝑟𝑟 ), using values of TR and its photoproduct measured for various 
irradiation wavelengths. Inset: Relationship between the experimental quantum yields (E𝛷) 
and calculated quantum yields (C𝛷) of 𝛷𝐴→𝐵
𝜆𝑖𝑟𝑟  and 𝛷𝐵→𝐴
𝜆𝑖𝑟𝑟   
 
7.2.6 TR actinometry 
 
It has been stated that for photostability testing quinine hydrochloride can be used as an 
actinometer, however it is limited as it is not thermally stable, and is rarely used to investigate 
photodegradation processes in solution. Through the use of Φ-order kinetics, however, drug 
compounds may be used as actinometers. 
The potential for TR to be used as an actinometer was assessed by measuring the 
photoreactivity of the species at different wavelengths (Table 1). 
The value of 𝛽𝜆𝑖𝑟𝑟 was calculated from Eq. 2 and plotted graphically to obtain a sigmoid shape 
(Fig. 7), using the following formula: 
𝛽𝜆𝑖𝑟𝑟 = 882040 × (
1
86.70735
) × 𝑒−(
𝜆𝑖𝑟𝑟−326.5
2394.32
)     Eq. 15 
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Furthermore, the actinometry equations can be applied to determine the radiant power of 
TR, from an unknown light source, within this wavelength range: 
 
𝑃𝜆𝑖𝑟𝑟 =
𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟
𝛽𝜆𝑖𝑟𝑟
          Eq. 16 
 
If the variation in absorbance is observed at 330nm and fitted to Eq. 1 then the value of 
𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟can be determined. This will allow for 𝛽𝜆𝑖𝑟𝑟 to be calculated, and thus the deduction of 
𝑃𝜆𝑖𝑟𝑟. 
Figure 7: Relationship between 𝛽𝜆𝑖𝑟𝑟 with irradiation wavelength, 𝛽𝜆𝑖𝑟𝑟 is expressed in 
einstein-1dm3. Inset: Linear relationship between experimental radiant power (E𝑃𝜆𝑖𝑟𝑟) and 
calculated radiant power (C𝑃𝜆𝑖𝑟𝑟) 
 
The success and reliability of TR as an actinometer was evidenced by a good linear correlation 
between both the experimental and calculated power values (Fig. 7). 
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7.2.7 Effect of TR concentration 
 
Various concentrations of TR in ethanol from within the linearity range were selected (2.06 x 
10-5-3.86 x 10-6M) to investigate their effect on the photodegradation rate of TR. Each solution 
was subject to a particular irradiation wavelength (λirr=330nm), and the wavelength 
monitored at λobs=330nm, maintaining a constant radiant power. The kinetic profiles and 
overall rate-constants are presented in Table 3. 
Table 3: Initial concentration, overall rate-constants, absorbance at the photostationary 
phase and photokinetic factor of TR photodegradation measured at 330nm 
𝑪𝑻𝑹(𝟎) x 10
-5/ 
M 𝑨∞
𝝀 𝒊𝒓𝒓
𝝀𝒐𝒃𝒔(𝒕) 
𝑭∞
𝝀𝒊𝒓𝒓 𝒌𝑻𝑹
𝝀𝒊𝒓𝒓/ s-1 % degradation 
2.06 0.542 1.32 0.0072 16.24 
1.53 0.412 1.49 0.0076 36.30 
1.38 0.374 1.54 0.0078 42.17 
1.15 0.312 1.64 0.0080 51.72 
0.918 0.256 1.74 0.0082 60.41 
0.84 0.251 1.75 0.0083 61.28 
0.77 0.225 1.80 0.0084 65.27 
0.61 0.173 1.90 0.0086 73.31 
0.54 0.155 1.94 0.0087 76.06 
0.38 0.107 2.04 0.0090 83.52 
 
The data was well fitted to the Φ-order equation, and it was observed that there was 16% 
degradation over two minutes when higher concentrations of TR were used (2.06 x 10-5M), 
when compared to the 83%, in the presence of 3.83 x 10-6M TR. 
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Figure 8: Effect of increasing TR concentrations on the photodegradation traces of TR in 
ethanol when irradiated at 330nm and observed at 330nm 
 
 According to Eq. 3 the reduction in photodegradation rate is related to the photokinetic 
factor, as this photokinetic factor is influenced by the absorbance of the species. 
Linear relationships between 𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟  and 𝐹𝑃𝑝
𝜆𝑖𝑟𝑟 were established with an intercept close to zero 
and high correlation coefficient (Fig. 9). Such an observation would indicate that the 
photoreaction is concentration dependent and thus zero- and first-order reaction 
mechanisms are unsuitable and unreliable for the treatment of photodegradation kinetic data 
of this compound. 
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Figure 9: Linear relationship between TR concentration and overall rate-constant of 
photodegradation and photokinetic factor 𝐹𝑃𝑝
𝜆𝑖𝑟𝑟, when irradiating various concentrations 
(3.83 x 10-6M-2.06 x 10-5M) at 330nm and observing at 330nm 
 
7.3.0 Conclusion 
 
The kinetic data of TR under non-isosbestic irradiation was able to be described by Φ-order 
kinetics. The method allowed for determination of the quantum yield and the application of 
TR in actinometry, allowing for reliable data to be gathered on the photodegradation 
reaction. In addition, it outlined the importance of the factor of 𝛽𝜆𝑖𝑟𝑟 to describe the 
photoreactivity of drugs, and that use of Φ-order kinetics over zero-, first- and second- order 
kinetics had the advantage of reliability. 
The strategy of considering the kinetics in two stages has proven to be useful. The fitting of 
the first stage to Eq. 1 alone indicated that the above choice was correct. It additionally 
provided proof that the cis⇌trans mechanism obeyed Φ-order kinetics. 
The elucidation of the kinetics after showed that the quantum yields of the forward reactions 
are different from those of the reverse ones. Both are wavelength dependent. The strategy 
facilitated the modelling factor of 𝛽𝜆𝑖𝑟𝑟 that can be used for actinometry, and the effect of 
concentration. 
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Chapter 8: Photokinetic studies, using HSA and β-CDP, on two 
photounstable molecules in buffer 
 
8.1.0 Introduction 
8.1.1 Introduction 
 
In previous studies TR and AXI have been found to be photounstable (Hirayama, Utsuki, & 
Uekama, 1991; Yan Lee, 2016). In addition, many drugs are photounstable in blood, 
influencing their detection and correct administration (Nilsson, 2010). Such effects can occur 
when compounds bind to a protein, as the amount of free drug available to undergo 
photodegradation is reduced (Iain Love, Graeme T. Smith, 2013). Such an effect can be 
influenced by both the matrix and the drug compound (Corey M. Ohnmacht, 2013). The 
European Medicines Agency has therefore declared that the compound in the blood matrix 
should be stable immediately after sampling (Achim Freisleben et al., 2011). If such 
degradation processes can be slowed the stability of the compound can be improved, 
allowing for it to be kept for a longer period of time, in the case that further tests are required 
(Dixon, Mbeunkui, & Wiegel, 2015). 
Cyclodextrins have been used to provide stability against photodegradation as they are 
capable of including compounds within their cavity, affecting the molecular rotation of the 
compound (Iglesias-García, Brandariz, & Iglesias, 2010). If the group of the compound 
involved in the photodegradation process is included, the rotations of the double bond 
(involved in the photodegradation process) are restricted, limiting the space in which the 
compound can undergo changes. This has the effect of reducing the rate at which the 
photoreaction occurs (Bortolus, Monti, Energia, & Area, 1996). 
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Photostability studies on TR and AXI have previously been carried out in cyclodextrins. It has 
been observed that in the presence of β-CDP greater stability of AXI was achieved than 
through use of the β-CD monomer, however, this study did not investigate the rate constants 
of the degradation (Yan Lee, 2016). In addition TR has been studied in the presence of γ-
cyclodextrin (Hirayama et al., 1991; Utsuki, Hirayama, & Uekama, 1993), and the rate of both 
the isomerisation and dimerization of the compound slowed (Utsuki et al., 1993). Although in 
the latter study a relationship between the rate of compound degradation and the 
concentration of cyclodextrin was established, β-CDP was not employed. Furthermore, there 
are fewer studies which use HSA to provide photostability. The use of HSA for photostability 
has been previously utilised for folic acid, in which it was observed that tryptophan in HSA 
was found to be able to act as a photosensitizer, reducing the amount of photoproduct 
formed (Vorobey, Steindal, Off, Vorobey, & Moan, 2006). 
The current study therefore aims to investigate the photokinetic behaviours of AXI and TR in 
the presence of various concentrations of HSA or β-CDP, and apply the Φ-order kinetic model, 
developed by our group, to the data to determine the individual rate constants. 
8.1.2 𝚽-order kinetic model 
 
The rate at which the concentration of a compound is altered can provide information on the 
quantity of its active ingredient remaining when the target site is reached. This can provide 
information on the amount of drug that should be initially administered. The rates at which 
such a photochemical reaction proceeds are dependent upon a number of factors. Theoretical 
and experimental methods currently used for determining the kinetics of photochemical 
reactions do not take all influencing factors into consideration (Ibhadon, Arabatzis, Falaras, & 
Tsoukleris, 2007), often using the same Arrhenius equations applied to thermodynamic 
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studies in order to determine the rate-constants (Montazerozohori, Nasr-Esfahani, & Joohari, 
2012). 
These methods are limited as they take temperature effects into consideration 
(Montazerozohori et al., 2012), but not other factors influencing the rate of photodegradation 
(Ibhadon et al., 2007). A Φ-order kinetic model has been proposed by our group. This model 
accounts for factors known to influence the rate of photochemical reactions, allowing for 
reaction rates to be characterised and data obtained in different conditions to be compared. 
This is expected to improve the accuracy and precision of photochemical kinetic results. 
The photokinetic traces of a compound can be obtained by irradiating the photounstable 
compound and monitoring its UV-absorption spectra. This data can then be fitted to the Φ-
order kinetic model by plotting the irradiation time against the absorbance determined by 
using the following equation: 
𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(𝑡) = 𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞) +
𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(0)−𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞)
𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(0)−𝐴𝑡𝑜𝑡
𝜆 𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞)
 ×  
𝐼𝜆𝑜𝑏𝑠
𝐼𝜆𝑖𝑟𝑟
 ×  𝑙𝑜𝑔
[
 
 
 
1 +
(
 10
[(𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(0)−𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟
𝜆𝑜𝑏𝑠(∞)) × 
𝐼𝜆𝑜𝑏𝑠
𝐼𝜆𝑖𝑟𝑟
]
− 1
)
 × 𝑒−𝑘
𝜆𝑖𝑟𝑟 
𝜆𝑜𝑏𝑠   × 𝑡
]
 
 
 
    Eq. 1 
 
In this equation 𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟(0) and 𝐴𝑡𝑜𝑡
𝜆𝑖𝑟𝑟(∞) indicate the total absorbance of the reaction solution 
before irradiation, and at specific time (t), when an equilibrium between the parent and 
photoproduct has been reached. The wavelength at which the sample is irradiated and 
observed is represented by λirr and λobs, respectively, and the light pathlength is represented 
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by 𝐼𝜆𝑖𝑟𝑟 and  𝐼𝜆𝑜𝑏𝑠, respectively. By fitting the Φ-order kinetic model to the experimental data, 
the rate constant 𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟  can be determined. Full elucidation on the acquisition of this model 
can be found in previous papers (W. Maafi & Maafi, 2013). 
8.2.0 Results 
 
8.2.1 Effect of light on the absorbance spectrum of the compounds  
 
The photoproducts of TR and AXI have previously been attributed to a cis-isomer and dimer 
((2) International Application Published Under the Patent Cooperation Treaty (PCT), 2012; 
Naohide Hori et al., 1999; Sparidans, Iusuf, Schinkel, Schellens, & Beijnen, 2009). Both 
photoproducts of TR had been confirmed using GC-MS, the dimer having a higher m/z 
(Kakegawa, Mitsou, Matsumoto, Satoh, Akagi, 1985). In addition, LC/MS/MS had also been 
used to confirm AXI formed a cis-isomer (Sparidans et al., 2009), and the formation of a dimer 
was evidenced by comparisons with compounds containing AXI ((2) International Application 
Published Under the Patent Cooperation Treaty (PCT), 2012). In the literature a cis-isomer is 
formed when the π double bonds of a trans-isomer are destroyed. This allows the σ-bond to 
rotate and reform (Barlow & Mountford, 2014). 
 
163 
 
As the compounds were ascertained to have a low solubility in water (Nagai & Ito, 2014; Yan 
Lee, 2016) they were prepared in 10%/2.5% (v/v) ethanol: water (TR, AXI, respectively). After 
irradiation for a day (≈7 hours), the electronic absorption spectra recorded for each TR and 
AXI was broad, with maximum absorption peaks situated at ≈330nm and ≈360nm, 
respectively. No absorbance of the compounds was observed outside the UV region.  
 
Figure 1: Evolution of the electronic absorption spectra of (A) 1.5 x 10-6M TR, and (B) 1.24 x 
10-5M AXI in buffer pH=7, subjected to continuous irradiation with a (A) 350nm and (B) 330nm 
monochromatic beam, respectively (total irradiation time of 5.4 x 103Ms at a radiant power 
of 𝑃350/ 𝑃330= Einstein s
-1dm-3) The arrows indicate the direction of the evolution of absorption 
maxima during photoreaction. Isosbetic points at (B) 230nm and 360nm (solid lines) 
 
Using light of a specific energy, continuous irradiation of the compounds decreased the 
maximum absorption spectra of TR and AXI in the regions of ≈280-370nm, and ≈270nm-
350nm, respectively. The shape of the photoproducts and TR overlapped and no other 
features were observed. Weak increases in the spectra of AXI at ≈330nm and ≈380nm, and 
quasi-isosbetic points at ≈330nm ≈360nm were observed. No additional features were 
observed (Fig. 1). The changes in the specific peaks represented by arrows, and the isosbetic 
points, illustrated by solid lines (Fig. 1), would imply a one-step reaction (Mauser & Gauglitz, 
1998). Each compound took >6,000s to degrade in these conditions, forming a photoproduct 
which absorbed at different wavelengths to that of the parent compound, and absorbed a 
0
0.01
0.02
0.03
0.04
0.05
205 255 305 355
A
b
so
rb
an
ce
Wavelength/ nm
TR
0
0.1
0.2
0.3
0.4
210 260 310 360
A
b
so
rb
an
ce
Wavelength/ nm
AXI
A B 
164 
 
smaller quantity of light at its characteristic λmax. Such a degradation had previously been 
reported for TR and AXI (Utsuki et al., 1993; Yan Lee, 2016) in pH=7 and ethanol, respectively. 
Although the behaviour of AXI was similar to that previously observed by our research group 
(Yan Lee, 2016), the absorption in the earlier study was greater at ≈380nm and ≈230nm. This 
may indicate a greater ratio of a particular photoproduct was being formed, as can occur 
when the environment of the compound is altered, as this can influence the recombination 
of the compound to form its photoproducts (Bortolus et al., 1996). 
 
8.2.2 AB3 (3𝚽) order kinetics of TR and AXI in water pH=7 
 
Graphical representation of the compounds in the presence and absence of a macromolecule 
show that in the absence of a macromolecule each compound degraded exponentially and 
then linearly (Fig. 2), indicative of more than one photodegradation process and different 
reaction rates of each stage. The region between the exponential and linear phase 
represented the ‘photostationary phase’. In such a region it is expected that formation of the 
photoproduct occurs at the same rate as the degradation of the reactant compound. 
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For such photoreactions a model has been proposed by our group (M. Maafi & Maafi, 2016). 
The specific model allows for experimental trace data obtained for species involved in 
consecutive photoreactions to be described as it considers the various photodegradation 
processes (Fig. 2). 
 
 
Figure 2: Effect of irradiation on the photodegradation traces (circles) of (A) TR (1.5 x 10-6M), 
and (B) AXI in buffer pH=7 (1.24 x 10-5M), subjected to continuous irradiation with a (A) 
350nm/ (B) 330nm monochromatic beam (total irradiation time of 4.0 x 103Ms at a radiant 
power of 𝑃350/𝑃330 = Einstein s
-1dm-3), fitted to the AB3 (3𝛷) order kinetics model (solid lines), 
example of photostationary phase outlined (solid lines), processes, rate constants and ε values 
used for the fitting 
 
After continuous irradiation for ≈6,000s neither compound reached a plateau, indicating their 
photoreactions continued indefinitely. This prevented the concentration of the second 
photodegradant, and thus the absorption coefficient at the end of the photoreaction from 
being determined, preventing accurate fitting to the AB3 (3Φ) order equation. 
By substituting a value for the end of the photoreaction into the equation, only a loose fitting 
to the proposed AB3 (3Φ) order kinetics model could be obtained. Successful fitting of the 
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data to this model supported the hypothesis that multiple photoreactions were occurring, 
allowing for the estimated values of the theoretical individual rate constants, εB1 and εB2, to 
be determined (Fig. 2). 
The photodegradation rate of AXI was found to be greater for the 𝐵1 →
𝐵2 phototransformation process than that of the 𝐵2 → 𝐵3 process, whereas opposite trends 
were observed for TR. As the 𝐴 → 𝐵 process was faster than that of 𝐵1 → 𝐵2 or 𝐵2 → 𝐵3 for 
both photoreactions, and followed an exponential trend, it may indicate an 𝐴 ⇄ 𝐵 reversible 
reaction (Yan Lee, 2016). We therefore propose to consider and discuss the different stages 
of the photoreaction separately. 
Conditions used for the photoreaction of AXI, including, solvent, host molecule, irradiated 
wavelength and observation wavelength, differed between the current study and the earlier 
study by our group, preventing the rate-constants from being compared, however the 
photodegradation of AXI in this earlier study, was investigated in detail (Yan Lee, 2016). In 
addition (Chapter 7) a higher 𝑘𝐴⇌𝐵
𝜆𝑖𝑟𝑟  was obtained for TR in ethanol, than that in buffer, when 
all other conditions were held constant. Such an observation would indicate that the 
photodegradation rate of this compound was lower in buffer than in ethanol. 
To determine the specific photoproducts that could be identified for TR, LC/MS was carried 
out on both unirradiated and irradiated samples. In the unirradiated sample the presence of 
one chromatogram and a molecular ion [M+H+] at an m/z ratio of 328.3 corresponded to the 
molecular mass of TR. After irradiation two peaks (2,3)(Fig. 3) were observed, each with a 
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molecular ion [M+H+] at an m/z ratio of 328.3, confirming the presence of two isomeric 
compounds (Fig. 3).  
Figure 3: 6.11 x 10-4M TR (A) irradiated SIM mass spectrum [M+H+] and (B) total ion count 
chromatogram full scan 
 
8.2.3 Effect of HSA and β-CDP on the photostability of the compounds  
 
Each of the compounds had previously been found to complex with, or bind to β-CDP or HSA. 
The photostability of the compounds in the presence of each of these macromolecules was 
therefore assessed to determine the influence of the macromolecule concentration on the 
photodegradation rate. 
The macromolecules themselves were firstly subject to light irradiation to ensure they were 
photostable, and absorbed at a different wavelength to the compound. The lack of 
absorbance spectra changes after ≈4 hours continuous irradiation of each molecule 
confirmed they were both photostable. The electronic absorption spectra of HSA was 
characterised by two absorption regions at ≈220 and ≈260-300nm, and that of β-CDP had a 
maximum absorption peak at 250nm. As thus, neither macromolecule absorbed in the 
absorption region of the species enough to influence the analysis of the compounds. 
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When irradiated at their maximum absorbance wavelength, each compound in the presence 
of either macromolecule exhibited similar behaviours (Fig. 4). 
 
Figure 4: Evolution of the electronic absorption spectra of (A) 1.5 x 10-6M TR and (B) 1.24 x 10-
5M AXI in buffer pH=7 in various concentrations of HSA ((A) 1.14 × 10−5-1.24 × 10−4M/ (b) 8.0 
x 10-7M-9.92 x 10-5M) and β-CDP (0-30mg/mL), subjected to a continuous irradiation with a 
(A) 350nm/ (B) 330nm monochromatic beam (total irradiation time of 4.0 x 103Ms at a radiant 
power of 𝑃350/𝑃330 = Einstein s
-1dm-3). The arrows indicate the direction of the evolution of 
absorption maxima during photoreaction. Isosbetic points at 230nm and 360nm (solid lines) 
 
No changes in the shape of the maximum absorption spectra of the compound were observed 
throughout irradiation, implying the compounds had a similar degradation process in both 
the presence and absence of each macromolecule. 
In the presence of a macromolecule, greater absorbances in AXI at ≈380nm resulted in a 
significantly clearer isosbestic point at ≈360nm. These would indicate a larger proportion of 
this specific photoproduct was formed. In addition, the change in absorbance was the same 
for either compound when in the presence of a macromolecule, as that in its absence, 
undergoing absorbance decreases at 350nm and 330nm for TR and AXI, respectively. Such 
trends had previously been observed for AXI in β-CDP (Yan Lee, 2016). 
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In addition, the differences between the rate of degradation in the presence and absence of 
each macromolecule were compared and it observed that the trends were similar, however, 
in the presence of a macromolecule a 𝐵2 → 𝐵3 conversion process was not clearly evident for 
either compound (Fig. 5). This observation would indicate that when using this concentration 
of macromolecule all, or almost all of the compound molecules were complexed with β-CDP, 
and thus the photoproducts were being formed less rapidly. 
Increasing the concentration of macromolecule gradually decreased the overall rate at which 
TR photodegraded (Fig. 5), however, this relationship was unclear for AXI (Fig. 5). For more 
reliable treatment of the data the section of the data indicative of an 𝐴 ⇄ 𝐵 reversible 
reaction was fitted to the Φ–order kinetics model (Eq. 1). 
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Figure 5: Effect of irradiation on the photodegradation traces (circles) of (A) TR (1.5 x 10-6M), 
and (B) AXI in buffer pH=7 (1.24 x 10-5M) (triangles), and (A) TR and (B) AXI in the presence of 
HSA ((A)1.14 × 10−5M/(B) 9.92 x 10-5M), and (C) AXI in the presence of β-CDP (0-30mg/mL) 
(circles), subjected to continuous irradiation with a (A) 350nm/ (B) 330nm monochromatic 
beam (total irradiation time of 4.0 x 103Ms at a radiant power of 𝑃350/𝑃330 = Einstein s
-1dm-
3), with the data up until the first photostationary phase fitted to the 𝛷–order kinetics model 
(solid lines) 
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8.2.4 Effect of HSA and β-CDP on the photokinetic rate constants of the 
compounds  
 
Similar absorption spectra observed for both the parent compounds and their photoproducts 
enabled the Φ–order kinetic model to be applied at a non-isosbestic wavelength, at which 
both the parent and its photodegradant could absorb. This would allow the specific benefits 
of the method to be exploited. 
Input of the conditions the experiment was carried out in, initial absorbance reading, final 
absorbance reading, and time, enabled the data to be fitted to this semi-empirical model (Eq. 
1)(Fig. 6). An appropriate rate-constant was inputted into the equation and adjusted 
accordingly. 
Figure 6: Effect of increasing HSA concentration (B) 8.0 x 10-7M-9.92 x 10-5M and β-CDP (A) 0-
30mg/mL, on the photodegradation traces (circles) of (A) 1.5 x 10-6M TR and (B) 1.24 x 10-5M 
AXI in buffer pH=7, subjected to continuous irradiation with a (A) 350nm/(B) 330nm 
monochromatic beam (total irradiation time of 4.0 x 103Ms at a radiant power of 𝑃350/𝑃330= 
Einstein s-1dm-3), and fitted to the 𝛷–order kinetics model (solid lines) 
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such a fitting would provide an indication of the gradient of the curves, and thus be 
representative of the reaction rate. Successful fitting using data from all the macromolecule 
concentrations studied enabled the rate-constants of the individual reactions occurring to be 
compared (Table 1). 
Table 1: TR and AXI overall reaction rates and photoreaction reduction percentages in various 
concentrations of HSA and β-CDP 
Compound Concentration of 
host molecule/ 
mg/mL 
𝑨 𝑯𝑺𝑨
𝜷𝑪𝑫𝑷
𝝀𝒊𝒓𝒓 (𝟎) 𝒌𝑻𝑹/𝑨𝑿𝑰
𝝀𝒊𝒓𝒓
/s-1 
𝑷𝝀𝒊𝒓𝒓 
(Einstei
n s-1 dm-
3) 
𝒌𝑻𝑹/𝑨𝑿𝑰
𝝀𝒊𝒓𝒓 (𝑨𝑯𝑺𝑨/𝜷𝑪𝑫𝑷
𝝀𝒊𝒓𝒓 = 𝟎)
𝒌𝑻𝑹/𝑨𝑿𝑰
𝝀𝒊𝒓𝒓 /(𝑨𝑯𝑺𝑨/𝜷𝑪𝑫𝑷
𝝀𝒊𝒓𝒓 ≠ 𝟎)
 
 
HSA 
TR 0 0.0571 0.0065 0.426 1 0 
0.012 0.0646 0.006 0.43 1.08 7.69 
0.023 0.0593 0.0057 0.429 1.14 12.31 
0.075 0.0582 0.0042 0.425 1.55 35.38 
0.12 0.0575 0.0027 0.426 2.41 58.46 
0.14 0.0587 0.002 0.425 3.25 69.23 
0.16 0.0578 0.0012 0.428 5.42 81.54 
0.19 0.0574 0.0005 0.427 13 92.31 
AXI 0 0.181 0.003 0.428 1 0 
0.19 0.166 0.0026 0.43 0.84 -19.57 
0.37 0.197 0.0022 0.425 1.21 17.39 
0.75 0.197 0.0022 0.428 1.04 4.35 
0.12 0.197 0.0017 0.425 1.28 21.74 
1.49 0.196 0.0035 0.426 1.64 39.13 
β-CDP 
TR 0 0.0536 0.0093 0.428 1 0 
10 0.0568 0.0075 0.425 1.44 30.77 
15 0.0560 0.0059 0.426 1.86 46.15 
20 0.0560 0.0056 0.427 2.5 60 
25 0.0552 0.0016 0.426 4.06 75.38 
30 0.0573 0.00022 0.425 29.55 96.62 
AXI 0 0.3 0.0053 0.428 1 0 
10 0.3 0.005 0.43 1.06 5.66 
15 0.290 0.0049 0.425 1.51 33.96 
20 0.3 0.0048 0.428 1.10 9.43 
25 0.3 0.0047 0.425 1.13 11.32 
30 0.3 0.0046 0.426 1.15 13.21 
 
% k 
Reduce
d 
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Lower rate-constants obtained using greater concentrations of macromolecule and fitted to 
the Φ–order kinetics, confirmed each macromolecule was affecting the photodegradation 
rate (Table 1). Comparison of the rate-constants obtained in the presence of various 
concentrations of macromolecule, with those in its absence, allowed for the percentage 
reduction in rate constant to be ascertained. The addition of the highest investigated 
concentration of each macromolecule reduced the rate-constant of each compound by 
similar amounts, ≈90% and ≈35% for TR and AXI respectively. Similar reductions in the rate-
constants were observed in either of the macromolecules. Such an effect may indicate each 
macromolecule was capable of photoprotecting these compounds in the specific conditions, 
and that more photoprotection was provided for TR than AXI. 
 
Figure 7: Linear relationships between various HSA (squares) or β-CDP (circles) concentrations 
(A) 1.14 × 10−5-1.24 × 10−4M/ (B) 8.0 x 10-7M-9.92 x 10-5M, and 0-30mg/mL, respectively, on 
the overall kinetic rate-constant of TR or AXI transformation. Data taken from Table 1. λirr/λobs 
= (A) 350/350, (B) 330/330, for TR and AXI, respectively 
 
Plots of the rate-constant against various concentrations of macromolecule were linear (Fig. 
7), with high correlation coefficients. The plots could therefore provide an indication of the 
rate-constant for a given concentration of host compound in these conditions. 
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Significant differences in the linear gradients of the plots for each compound, in the presence 
of increasing concentration of macromolecule, indicated the reduction in the rate-constants 
was proportional to the concentration of the macromolecule (Fig. 7). The gradients were 
steeper in β-CDP than in HSA. Such an observation would suggest that in the studied 
concentrations of macromolecule, β-CDP could reduce the rate-constant more rapidly than 
HSA. 
This could therefore be considered a new method for identifying the occurrence of a HSA/ 
drug complex. It would be an interesting application of photokinetics to proteins and β-CDP. 
Through the formation of more stable compounds, and knowledge of the photokinetic rate 
constants, it is expected that the method could provide enhanced stability of the compounds 
in the bloodstream, allowing for accurate dosing, and thus allow for smaller concentrations 
of the drug to be administered. In addition, it would be expected to improve quantification of 
the compounds, allowing for them to be detected after a longer period of time, and with more 
accuracy. 
8.2.5 Effect of HSA and β-CDP on the linear degradation phase of the 
compounds 
 
As previously stated (8.2.2) the AB3 (3Φ) order kinetics model could not reliably describe the 
data. The section of the photokinetic trace data which was not fitted to the Φ-order kinetics 
model appeared to be linear. Lines of best fit, with high correlation coefficients, could 
therefore be constructed, passing through the traces, and the gradient used to estimate the 
rate of this stage of the photoreaction. 
An example of the concentration of the host on the traces and reaction rate is given (Fig. 8). 
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 Figure 8: Effect of increasing β-CDP concentration (0-30mg/mL) on the photodegradation 
traces of AXI (1.24 x 10-5M) in aqueous solution, fitted to the linear relationships, and the effect 
of the concentration on the individual rate constants 
 
It can be observed (Fig. 8) that for this specific phase of the photoreaction there was a poor 
relationship between the rate-constant and the concentration of the macromolecule. Such 
an effect could imply that the macromolecule concentration did not necessarily influence the 
rate of this specific stage of the photoreaction. 
Different methods were used to determine the rate-constant of the two phases of 
photodegradation, and the phases had different trendline shapes. As a consequence results 
obtained from only a single phase could be compared. 
Nonetheless, the effects may occur from movement restriction of the compound, or 
potentially the presence of tryptophan, reducing the amount of photoproduct formed. 
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8.3.0 Conclusion 
 
The results indicate that both compounds could photodegrade exponentially and then 
linearly, indicating the formation of two or more photoproducts. The lack of plateau observed 
in the absorbance reading after >6,000s continuous irradiation only allowed an estimated 
fitting to the AB3 (3Φ) order kinetics. Fitting of the first ‘phase’ of the traces to the Φ–order 
kinetics model for an 𝐴 ⇄ 𝐵 reversible reaction, however, was achieved. 
In the presence of either HSA or β-CDP, similar effects on the degradation trends of the 
compounds were observed, as in its absence, obeying Φ–order kinetics. Comparisons of the 
rate-constants obtained using the various concentrations of macromolecule suggested that 
the rate of the reaction was progressively reduced as the concentration of macromolecule 
increased. 
Such results were indicative that the macromolecules were able to provide photostability to 
the compounds. 
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Chapter 9: Conclusion 
 
9.1 Conclusions 
 
Poor detection of pharmaceuticals in biofluids and surface waters can have costly or 
hazardous consequences as decisions are made based on such results. There is therefore the 
necessity for a reliable, rapid and sensitive technique. Currently available methods tend to be 
either costly and time-consuming or unreliable and often challenging as the drug compounds 
may interact with species in the sample media or environment. Such effects as light and the 
presence of proteins can have effects, influencing the drug compounds, causing their 
structure to change and affecting their spectral properties. There is a lack of techniques able 
to accurately determine concentrations of drug compounds in serum samples, that has the 
requirements for routine analysis. Furthermore, there are no specific methods for reliably 
assessing the kinetics of drugs that are photounstable and thus difficult to detect, current 
methods often treating the data using zero-, first- and second-order equations. Such 
equations do not account for factors influencing the extent of the photoreaction. Therefore 
there may be multiple interpretations of the data. 
To allow for improved detection, and to enhance the spectral signal of 3AB, 2AB, BZ, MA, TR 
and AXI, β-CDP was added to each compound in both neutral and canal water samples. The 
shift and an increase in the fluorescence spectra in both media demonstrated the successful 
complexation of each compound with β-CDP.  
The increases in signal were characterised by determining the stoichiometry and inclusion 
complex of each compound, to provide information on the complex binding strength, and the 
number of guest molecules each β-CDP unit was capable of complexing. The unknown 
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molecular weight of β-CDP was overcome by utilising a recently proposed mathematical 
equation. Such a method enabled the determination of both the inclusion complex and 
stoichiometry. 
Poor detection in serum samples was able to be overcome through the development of a 
novel, easy to implement method. The technique addressed the obstacles of spectral changes 
and allowed for the detection of all compounds, when in the presence of the protein 
constituting the majority of serum, HSA. 
The two proposed fluorimetric methods for the determination of the six compounds was 
evaluated and found to be reliable and accurate for routine analysis of the compounds in both 
canal water and HSA. 
The photokinetic traces of TR and AXI were both able to form three photoproducts, the first 
part of which was able to be described by the newly proposed Φ-order equation for 
unimolecular and photoreversible reactions, obeying an A⇌B mechanism when subjected to 
non-isosbestic irradiation. Along with previous studies, this implies both TR and AXI could be 
described by Φ-order kinetics. 
The use of the Φ-order equation was applied for the determination of the quantum yield of 
TR to indicate its photoreactivity. Application of the equations enabled the development of 
drug actinometers and the proposed method was able to demonstrate that both the quantum 
yield and βirr were wavelength dependent, a factor not taken into account when interpreting 
photokinetic data. 
The photostability of each TR and AXI was then ascertained in the presence of HSA and in β-
CDP, and the data was well fitted to the Φ-order equation. The model was able to 
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demonstrate that the photodegradation rate of either compound was reduced when 
presented with either HSA or β-CDP. This reduction provided evidence that not only were the 
compounds stabilised against photodegradation, but that when interacted with either 
macromolecule they continued to obey Φ-order kinetics. 
Common problems encountered when detecting pharmaceuticals in biofluids and surface 
waters were addressed in the study. Results from each method indicated the benefit for the 
methods to be used for future pharmaceutical samples in biofluids and surface waters. 
9.2 Further studies 
 
Although the study was only carried out with six compounds, there is the potential for further 
work in all three areas of this work. 
The use of β-CDP to facilitate compound detection in canal water could be extended to other 
compounds and other surface waters, and may even be applied to compounds in media, such 
as less complex biofluids. 
Studying the effect of temperature on the compound-β-CDP inclusion complexes could 
indicate the temperature at which a most stable complex is formed, and that at which it 
begins to dissociate. Through observing the lifetime of the species it may be possible to obtain 
information on the effect of β-CDP on the non-radiative energy loss processes competing with 
fluorescence. 
The method developed to enable quantification of the compounds in HSA could not only be 
conducted using other compounds, to determine whether the method was only restricted to 
the six compounds investigated, but could be investigated with other fluorescent proteins to 
see if the method could be extended to these. 
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In addition, further information on the binding of the compound to HSA may be achieved by 
studying the effect of temperature and fluorescent lifetime of the species on the Stern-
Volmer plot, as this can provide information on the quenching mechanism and thus provide 
an indication as to the interactions that may exist between the compound and protein. By 
studying the effect of HSA binding site markers, such as Ketoprofen and Warfarin, on the 
fluorescence of the compounds it could be determined which binding site each compound 
has a preference for, which may be useful for determining whether thereis competition 
between compounds for a particular binding site, altering the concentration of free drug. 
The photodegradation of photounstable compounds, other than TR and AXI, may be 
investigated and be able to be modelled using Φ-order kinetics, and it could be investigated 
whether β-CDP or HSA are able to enhance photostability of compounds other than those 
used in this study, and whether other proteins, which may be present in biofluids or other 
pharmaceutical-containing commonly analysed samples, are able to provide photostabilising 
effects to compounds. 
Furthermore, the study could be expanded, and other instrumentation used to collect 
additional data. Optimised ROESY NMR data could be used to determine the mode and 
stability of compound-β-CDP complex, and SEM and IR could be used to provide information 
on how the compound is complexed and the interactions that may be involved. 
 
 
 
 
184 
 
  
Annexe 
185 
 
Annexe 
 
Figure 1: Excitation and emission spectra of 24.33ppb (A) 3AB, (B) 0.41ppb 2AB, (C) 38.74ppb BZ, (D) 
2.02ppb MA, (E) 1.49ppb TR and (F) 3.01ppb AXI in water (Water)(dashed lines), and (A) 0.65ppb 
3AB, (B) 0.33ppb 2AB, (C) 0.97ppb BZ, (D) 1.01ppb MA, (E) 1.49ppb TR and (F) 3.01ppb AXI in (A) 
25.20mg/mL, (B) 12.0mg/mL, (C) 4.32mg/mL, (D) 12.17mg/mL, (E) 11.98mg/mL and (F) 15.08mg/mL 
β-CDP, respectively (β-CDP)(plain lines), at room temperature, the maximum spectra of which are 
labelled 
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Figure 2: Excitation and emission spectra of (A) 29.24ppb 3AB, (B) 1.64ppb 2AB, (C) 48.37ppb BZ, (D) 
2.02ppb MA, (E) 0.75ppb TR and (F) 2.41ppb AXI in canal water (C)(dashed lines), (A) 0.65ppb 3AB, 
(B) 0.33ppb 2AB, (C) 1.93ppb BZ, (D) 1.01ppb MA, (E) 0.75ppb TR and (F) 1.21ppb AXI in (A) 
25.13mg/mL, (B) 12.03mg/mL, (C) 4.09mg/mL, (D) 12.01mg/mL, (E) 11.98mg/mL and (F) 
15.02mg/mL β-CDP(Cβ-CDP)(plain lines), respectively, at room temperature, the maximum spectra 
of which are labelled 
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Figure 3: Excitation and emission spectra of (A) 0.0014ppb, (B) 0.0048ppb, (C) 0.0014ppb, (D) 
0.0014ppb, (E) 0.0038ppb and (F) 0.0017ppb HSA in water (dashed lines), and (A) 38.95ppb 3AB in 
0.0014ppb HSA, (B) 24.56ppb 2AB in 0.0048ppb HSA, (C) 24.19ppb BZ in 0.0014ppb HSA, (D) 
28.97ppb MA in 0.0014ppb HSA, (E) 7.47ppb TR in 0.0038ppb HSA and (F) 3.01ppb AXI in 0.0017ppb 
HSA (plain lines), at room temperature, the maximum spectra of HSA is labelled, along with the 
maximum emission spectra of the drugs (included in bold) 
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Figure 4: Comparison of the emission spectra of 5.7ppb 3AB, 5.73ppb 2AB, 9.67ppb BZ and 2.52ppb 
MA in water 
Figure 5: Comparison of the emission spectra of 5.7ppb 3AB, 5.73ppb 2AB, 9.67ppb BZ and 2.52ppb 
MA in (A) water and (B) canal water 
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Figure 6: Excitation and emission spectra of 3.01ppb AXI in water and ethanol (98/2)(dashed lines), 
and 3.01ppb AXI in 15.08mg/mL β-CDP, respectively (plain lines), at room temperature, the 
maximum spectra of which are labelled 
Figure 7: Emission spectra of 2.41ppb AXI in water: ethanol solution after 3 hours, and 2.41ppb AXI 
in water: ethanol solution and 15.22mg/mL β-CDP water: ethanol solution after 3 hours 
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Figure 8: Evolution of calibration concentrations of (A) 3AB, (B) 2AB, (C) BZ and (D) MA in buffer 
pH=7, (E) TR in pH=4 and (F) AXI in water and ethanol (98/2), at room temperature  
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Figure 9: Evolution of calibration concentrations of (A) 3AB, (B) 2AB, (C) BZ, (D) MA, (E) TR and (F) 
AXI in canal water, at room temperature 
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Figure 10: Evolution of the fluorescence emission spectra of (A) 2.60ppb 3AB, (B) 0.98ppb 
2AB, (C) 2.90ppb BZ and (D) 4.19ppb MZ in water and (E) 1.49ppb TR in buffer pH=4, with 
increasing concentrations of β-CDP, at room temperature   
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Figure 11: Effect on maximum intensity of various concentrations of AXI after 3 hours in water and 
ethanol (98/2)(dashed line) and ≈15mg/mL β-CDP, at room temperature (solid lines)  
Figure 12: Isotherms of varying (A) 3AB, (B) 2AB, (C) BZ and (D) MA concentrations ((A) 0.65-3.25ppb, 
(B) 0.04-0.82ppb, (C) 0.97-4.84ppb and (D) 0.50ppb-2.49ppb, respectively), in water 
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Figure 13: Isotherms of varying concentrations of (A) TR (1.49-9.71ppb) in buffer pH=4, and (B) AXI 
(0.3-0.6ppb) (after 3 hours) in water and ethanol (98/2), with increasing concentrations of β-CDP, at 
room temperature  
Figure 14: Determination of coefficient ‘n’ for (A) 3AB, (B) 2AB, (C) BZ and (D) TR complexes 
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Figure 15: Determination of coefficient ‘n’ for MA complexes 
 
Figure 16: Determination of coefficient ‘m’ for (A) 3AB, (B) 2AB, (C) BZ and (D) MA complexes 
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Figure 17: Determination of coefficient ‘m’ for TR complexes 
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Table 1: Statistical results of 3AB, 2AB, BZ, MA, TR and AXI in water (W) and canal water (C), and calibration of AXI in 0.0011ppb HSA, RFI= Relative 
Fluorescence Intensity, s.d.= Standard deviation 
Compound 3AB 2AB BZ MA TR AXI 
Medium W C W C W C W C W C W C HSA 
Gradient/ x 
108M-1 
Average 0.083 
 
0.047 
 
6.69 6.68 0.29 0.30 0.48 0.51 0.093 0.10 2.47 0.92 0.031 
s.d. 0.00055 
 
0.000033 
 
0.030 0.12 0.0057 0.0037 0.013 0.013 0.0022 0.00057 0.017 0.0024 0.00084 
RSD/ % 1.44 
 
0.069 
 
0.53 1.77 1.95 1.25 0.82 2.63 2.37 0.56 0.69 2.61 2.67 
Intercept/ 
RFI 
Average 3.30 
 
-0.0025 
 
1.40 1.21 4.50 -1.05 1.02 0.51 2.38 2.25 -6.38 -1.62 103.79 
s.d. 0.83 
 
0.86 
 
0.85 0.51 1.75 0.58 0.37 0.23 0.42 0.090 1.80 2.56 2.90 
RSD/ % - 
 
- 
 
- - - - - - - - - - - 
Average regression 
correlation coefficient 
0.997 
 
0.995 0.999 0.999 0.998 0.997 0.998 0.998 0.994 0.990 0.996 0.981 0.918 
Average linearity 
range/ ppb 
0.16-
48.68 
5.46-
34.09 
0.013-
8.19 
0.013-
8.19 
0.998 
0.97-
57.99 
1.61-
48.37 
0.10-
2.52 
0.10-
2.52 
0.75-
14.93 
0.75-
6.47 
0.30-
3.01 
2.14-
57.16 
10.72-
27.69 
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Table 2: Analytical parameters of 3AB, 2AB, BZ, MA, TR and AXI, in water (W) and canal water (C),in approximately 25mg/mL, 12mg/mL, 12mg/mL, 
4mg/mL, 12mg/mL and 15mg/mL β-CDP, respectively, RFI= Relative Fluorescence Intensity, s.d.= Standard deviation 
 
 
 
 
 
 
 
Compound 3AB 2AB BZ MA TR AXI 
Medium W C W C W C W C W C W C 
Gradient/ x 
108M-1 
Average 0.79 8.17 44.40 43.33 9.33 8.32 4.13 3.77 1.27 1.72 2.57 0.42 
s.d. 0.14 0.23 0.57 1.30 0.084 0.25 0.12 0.12 0.0059 0.036 0.036 0.015 
RSD/ % 2.12 2.78 1.28 3.01 0.90 3.02 2.95 3.07 0.46 2.10 1.39 3.67 
Intercept/ RFI Average 2.59 7.15 3.67 10.71 0.81 2.32 5.80 4.81 8.90 26.79 50.62 83.35 
s.d. 2.65 2.44 3.48 4.41 2.56 4.84 2.45 4.10 5.40 0.052 5.16 4.40 
RSD/ % - - - - - - - - - - - - 
Average regression 
correlation coefficient 
0.996 0.997 0.997 0.998 0.999 0.999 0.998 0.997 0.998 0.993 0.997 0.992 
Average linearity range/ 
ppb 
0.65-
3.03 
0.65-
3.25 
0.013-
0.98 
0.013-
0.98 
0.13-
4.84 
0.19-
1.42 
0.10-
2.52 
0.20-
2.07 
0.20-
3.98 
0.17-
2.86 
0.15-
1.21 
1.34-
8.93 
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Figure 18: The effect of increasing concentrations of (A) 3AB, (B) 2AB, (C) BZ, (D) MA, (E) TR 
and (F) AXI on the fluorescence excitation and emission spectra of a specified concentration of 
human serum albumin 
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Table 3: Fluorescence features of HSA in the presence and absence of 3AB, 2AB, BZ, MA, TR 
and AXI 
a The maximum excitation and emission spectra of the compounds, alone are underlined, 
whilst shoulders are displayed in brackets 
b The Stoke’s shift is calculated from the difference in the energy of the maximum emission 
spectra and the maximum excitation spectra of the compound 
c The fluorescence intensity of the numerator corresponds to either the maximum 
fluorescence intensity of 0.0014ppb HSA in water, 0.0014ppb HSA in 38.95ppb 3AB, 0.0048ppb 
HSA in water, 0.0048ppb HSA in 24.56ppb 2AB, 0.0014ppb HSA in water, 0.0014ppb HSA in 
24.19ppb BZ, 0.0014ppb HSA in water, 0.0014ppb HSA in 28.97ppb MA, 0.0038ppb HSA in 
water, 0.0038ppb HSA in 7.47ppb TR, 0.0017ppb HSA in water or 0.0017ppb HSA in 3.01ppb 
AXI, respectively (Flobsis equal to Fl0,G,i
λobs) 
d The fluorescence intensity of the denominator corresponds to the fluorescence intensity of 
0.0014ppb, 0.0048ppb, 0.0014ppb, 0.0014ppb, 0.0038ppb and 0.0017ppb HSA in water, 
respectively 
 
Figure 19: Average Stern-Volmer plot of 0.0014ppb, 0.0038ppb and 0.0067ppb HSA in 
increasing concentrations of 3AB 
 
 
Compound Medium Fluorescence 
excitation 
(nm)a 
Fluorescence 
emission 
(nm) 
Stoke’s shift 
(nm)b 
Flobs
Flobs
c 
HSA Water 280 343 63 1 
3AB 274 359 85 0.57 
2AB 280 343 63 0.89 
BZ 280 - - - 
MA 280 343 63 0.68 
TR 280 343 63 0.63 
AXI 282 339 57 0.92 
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Figure 20: Average Stern-Volmer plot of 0.00096ppb, 0.0048ppb and 0.0067ppb HSA in 
increasing concentrations of 2AB 
 
Figure 21: Average Stern-Volmer plot of 0.000048ppb, 0.0014ppb and 0.0048ppb BZ HSA in 
increasing concentrations of BZ 
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Figure 22: Average Stern-Volmer plot of 0.00048ppb, 0.0014ppb and 0.0067ppb HSA in 
increasing concentrations of MA 
 
 
Figure 23: Average Stern-Volmer plot of 0.00038ppb, 0.00058ppb and 0.00096ppb HSA in 
increasing concentrations of TR 
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Figure 24: Average Stern-Volmer plot of 0.0017ppb and 0.0023ppb HSA in increasing 
concentrations of AXI
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Table 4: Quenching calibration graphs of 3AB, 2AB, BZ, MA, TR and AXI in the presence of various concentrations of HSA, RFI= Relative Fluorescence 
Intensity, s.d.= Standard deviation 
 
  
Compound 3AB 2AB BZ MA TR AXI 
Concentration 
of HSA/ Ppb 
0.001
4 
0.0038 0.0067 0.000
96 
0.004
8 
0.006
7 
0.0000
48 
0.004
8 
0.0014 0.000
48 
0.001
4 
0.006
7 
0.000
38 
0.000
58 
0.000
96 
0.00
17 
0.002
3 
Gradie
nt/ x 
106M-1 
Avera
ge 
0.005
6 
0.0019 0.0021 0.004
6 
0.005
3 
0.005
6 
0.0025 0.006
3 
0.0057 0.035 0.015 0.018 0.32 0.015 0.26 0.06
2 
0.031 
s.d. 0.000
10 
0.0000
64 
0.0000
29 
0.000
34 
0.000
26 
0.000
23 
0.0001
2 
0.000
36 
0.0000
29 
0.000
39 
0.000
57 
0.000
72 
0.009
2 
0.17 0.008
6 
0.00
21 
0.000
67 
RSD/ 
% 
1.70 3.30 1.42 7.29 4.96 4.20 4.74 2.17 0.50 1.01 3.91 3.95 2.86 8.39 3.28 3.43 2.18 
Interce
pt/ RFI 
Avera
ge 
0.90 0.96 1.00 1.00 0.98 1.00 1.00 0.95 0.95 1.06 1.00 1.00 1.00 1.00 1.03 1.00 1.13 
s.d. 0.031 0.016 0.0042 0.019 0.006
7 
0.013 0.0078 0.017 0.017 0.014 0.008
3 
0.006
7 
0.014 0.003
7 
0.009 0.00
74 
0.009
5 
RSD/ 
% 
3.43 1.68 0.42 1.94 0.68 1.33 0.78 1.79 1.77 1.29 0.83 0.67 1.42 0.37 0.97 0.74 0.84 
Average 
regression 
correlation 
coefficient 
0.989 0.992 0.997 0.990 0.995 0.997 0.988 0.994 0.986 0.985 0.992 0.995 0.995 0.944 0.950 0.98
2 
0.890 
Average 
linearity range/ 
ppb 
74.64
-
389.4
5 
97.36-
486.82 
64.91-
292.09 
49.12
-
212.8
6 
20.47
-
147.3
6 
24.56
-
122.8
0 
32.25-
193.50 
48.37
-
290.2
4 
24.19-
225.75 
1.14-
20.45 
5.11-
23.86 
2.88-
18.31 
2.74-
9.21 
1.00-
4.98 
1.00-
3.73 
4.29-
15.0
1 
3.22-
16.08 
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Table 5: Percentage recoveries of 3AB, 2AB, BZ, MA, TR and AXI obtained in the presence of the specified concentrations of human serum albumin (+CAdd/ 
ppb=Concentration added, ≠CDet/ ppb=Average concentration detected,*%REC= Average percentage recovery, [HSA]= Concentration of HSA 
 
Compound [HSA]/ 
ppb 
+CAdd/ 
ppb 
≠CDet/ 
ppb 
*%REC [HSA]/ 
ppb 
+CAdd/ 
ppb 
≠CDet/ 
ppb 
*%REC [HSA]/ 
ppb 
+CAdd/ 
ppb 
≠CDet/ 
ppb 
*%REC 
3AB 0.0014 292.09 261.19 92.63 0.0038 389.45 368.90 91.80 
 
0.0067 292.09 305.85 101.86 
285.95 357.43 303.02 
264.56 346.27 283.74 
97.36 92.65 98.01 194.73 191.29 94.93 
 
197.67 194.73 91.67 
101.12 168.28 167.66 
98.01 194.98 170.16 
194.73 167.96 96.01 97.36 97.95 98.76 97.36 94.11 102.09 
214.43 98.60 
178.47 105.47 
2AB 0.00095 49.12 55.17 100.88 0.0047 24.56 24.14 99.62 0.0067 122.80 114.92 96.81 
 45.07 27.71 109.59 
48.42 21.54 132.13 
98.24 107.68 105.43 98.24 109.47 109.36 49.12 
 
50.45 107.82 
 93.80 103.37 56.88 
109.26 109.47 51.56 
196.49 211.57 104.99 147.36 125.89 97.98 7.37 6.70 91.98 
224.64 140.37 6.70 
182.65 166.93 6.94 
BZ 0.00048 24.19 25.52 96.11 0.0014 15.48 13.41 87.16 0.0047 48.37 51.07 110.88 
22.25 13.71 54.24 
21.97 13.35 55.60 
145.12 126.77 97.00 24.19 22.23 99.86 145.12 138.86 94.17 
162.85 25.91 132.27 
132.70 24.31 138.86 
290.24 301.75 104.81 241.87 216.26 92.01 290.24 259.56 92.74 
206 
 
 
 
 
300.05 219.19 259.19 
310.80 232.22 288.36 
MA 0.00048 6.28 6.70 93.39 0.0014 3.92 
 
3.80 107.51 
 
0.069 3.92 4.43 101.55 
6.70 4.43 3.66 
6.70 4.43 3.87 
17.27 18.22 111.02 23.55 
 
23.05 103.52 
 
11.77 11.96 93.14 
19.64 23.05 10.47 
19.64 27.02 10.47 
1.57 1.69 107.35 51.02 46.96 94.83 17.27 19.63 98.89 
1.69 49.09 16.27 
1.69 49.09 15.33 
TR 0.00038 1.49 1.44 93.93 0.00058 1.49 1.65 97.99 0.00096 0.45 0.51 106.65 
 1.34 1.37 0.51 
1.43 1.37 0.41 
5.97 6.69 106.07 2.24 2.36 105.19 1.49 
 
1.68 101.66 
 6.84 2.36 1.45 
5.47 2.36 1.42 
8.96 7.89 95.39 5.97 5.82 92.16 2.99 2.54 91.10 
9.08 5.35 2.54 
8.69 5.35 3.08 
AXI 0.0017 3.22 2.97 95.91 0.0023 3.22 3.66 106.15 0.0011 8.04 9.25 110.03 
3.51 2.98 8.64 
2.78 3.61 8.64 
9.65 8.38 105.54 9.65 8.72 100.57 
 
16.08 15.93 90.73 
11.08 10.57 13.93 
11.08 9.82 13.90 
16.08 14.07 93.18 16.08 17.07 102.47 26.79 29.77 105.37 
14.07 17.86 27.13 
16.81 14.49 27.80 
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Table 6: Percentage recoveries obtained for 3AB, 2AB, BZ, MA, TR and AXI, after making small 
changes in the wavelengths used (±2-5nm)(+CAdd/ ppb=Concentration added, ≠CDet/ ppb=Average 
concentration detected,*%REC= Average percentage recovery 
 
Compound Wavelengths 
used/ nm 
+CAdd/ 
ppb 
≠CDet/ 
ppb 
*%REC Wavelenth 
used/ nm 
≠CDet/ 
ppb 
*%REC 
3AB λexc 306 
λemi 448 
9.74 10.99 107.41 λexc 302 
λemi 444 
9.39 96.43 
10.99 9.39 
9.39 9.39 
29.21 30.23 107.15 31.83 99.84 
31.83 25.42 
31.83 30.23 
38.95 41.45 111.93 44.66 114.67 
44.66 44.66 
44.66 44.66 
2AB λexc 331 
λemi 426 
0.049 0.051 104.48 λexc 327 
λemi 422 
0.051 98.37 
0.051 0.051 
0.051 0.042 
0.49 0.50 106.94 0.47 94.12 
0.52 0.44 
0.56 0.47 
0.88 1.01 107.59 0.89 97.08 
0.91 0.87 
0.94 0.82 
BZ λexc 288 
λemi 362 
3.87 4.19 103.01 λexc 284 
λemi 358 
4.19 103.01 
4.19 3.99 
3.58 3.78 
11.61 12.34 102.76 12.95 106.27 
11.32 11.12 
12.13 12.95 
17.41 18.04 105.94 18.65 109.45 
18.25 18.86 
19.06 19.67 
MA λexc 376 
λemi 519 
0.11 0.12 110.03 λexc 372 
λemi 515 
0.12 110.03 
0.12 0.12 
0.12 0.12 
0.84 0.76 95.92 0.81 97.87 
0.81 0.90 
0.86 0.76 
1.96 1.94 100.39 1.94 92.88 
1.94 1.74 
2.04 1.79 
TR λexc 328 
λemi 446 
0.75 0.83 111.55 λexc 318 
λemi 436 
0.83 111.55 
0.83 0.83 
0.83 0.83 
7.47 7.49 101.79 7.49 98.95 
7.81 6.54 
7.49 8.13 
14.93 13.20 87.00 13.52 96.21 
12.89 14.47 
208 
 
12.89 15.11 
AXI λexc 336 
λemi 396 
7.72 7.66 99.29 λexc 332 
λemi 392 
7.66 99.29 
7.66 7.66 
7.66 7.66 
8.04 7.66 106.05 8.96 100.68 
8.96 7.66 
8.96 7.66 
9.32 8.96 96.05 10.25 100.67 
10.25 8.96 
7.66 8.96 
 
 
Figure 25: HPLC spectra of 1.53 x 10-5M TR in ethanol solution, at room temperature, when 
irradiated for 0 mins (dashed line) and 30 minutes (sold line) in the presence of UV light 
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